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The skin a major organ of the body plays a crucial role in the confidence level 
of humans as people with skin diseases/problems are often withdrawn, shy, 
depressed and have a feeling of inferiority when relating with others. The increasing 
incidence of skin diseases of fungal origin and resistance to antifungals is a great 
health burden to the victims and dermatologists who struggle to restore the skin’s 
health of their patients. Resistance to antibiotics has increased greatly as a result of 
the increasing population of Human Immunodeficiency Virus/Acquired Immune 
Deficiency Syndrome (HIV/AIDS) infected individuals, especially in the African 
region. The side effects of skin disease antibiotics (especially in HIV/AIDS 
individuals) and lengthy period of therapy are major shortcomings of both the old 
and newly developed range of antifungals.  
Hence, there is a need to develop an effective, cheap and readily available 
antifungal from a natural origin in order to combat skin diseases. Members of the 
Rutaceae are popularly used in the production of skin care products commercially 
and in traditional medicine systems as a result of their active compounds such as 
tannins, phenols, flavonoids, terpenes, alkaloid and coumarins which have 
antifungal activities against several skin diseases and infections. These compounds 
not only possess antifungal activity but are relevant in the inhibition of processes 
involved in the pathogenesis of skin disease. Such processes include inflammation 
which arises from oxidative stress. Scientific literatures have shown a link between 
inflammation and oxidative stress as it plays a crucial role in the pathogenesis of 
chronic inflammatory diseases such as atopic dermatitis (AD) (eczema/ringworm). 
Restoration of the redox balance through the use of antioxidants from natural origin 
could be a ground-breaking approach in the treatment of inflammatory skin 
conditions. 
In this study, the antioxidant activities of leaf extracts of seven plants 
belonging to the Rutaceae family (Agathosma mucronulata, A. ovata, Calodendrum 
capense, Coleonema album, C. pulchellum, Murraya koenigii and M. paniculata) 
were investigated using the oxygen radical absorbance capacity (ORAC) method.  
The results, expressed as µmol trolox equivalents/g shows that all the plant tested 





was recorded for A. ovata (1202.5) followed by C. pulchellum (1126.7), A. 
mucronulata (1045.5), C. album (942.2), M. paniculata (930.7), M.  koenigii (339.8) 
and C. capense (301.7). 
The antifungal activity of the leaf extracts of C. capense, Coleonema album, 
C. pulchellum, Murraya koenigii and M. paniculata against Trichophyton rubrum 
(ATCC 28188), T. mentagrophytes (ATCC 9533) and Microsporum gypseum 
(ATCC 24102) was investigated using the micro well dilution method. Ground leaf 
material of each plant used was extracted non-sequentially with petroleum ether, 
acetone, methanol and ethanol. Out of the 20 extracts from the five plants tested, 
Coleonema pulchellum methanol extract (0.195 mg/ml) and M. koenigii ethanol 
extract (0.391 mg/ml) gave the best antifungal activity against T. rubrum. 
Coleonema album and C. pulchellum methanol extracts gave the best antifungal 
activity against T. mentagrophytes with a MIC value of 0.390 mg/ml. Coleonema 
pulchellum methanol (0.049 mg/ml) and C. album methanol (0.195 mg/ml) extracts 
gave the best antifungal activity against M. gypseum. A total of 16 extracts out of 
the 20 extracts from the five plants inhibited the growth of at least one fungal strain 
with MIC values ranging from 0.049 mg/ml to 1.022 mg/ml.  
Apart from plant extracts, essential oils are popularly utilised in the treatment 
of skin diseases. The antifungal activity of essential oil volatiles of Agathosma 
mucronulata, A. ovata, Calodendrum capense, Coleonema album, C. pulchellum, 
Murraya koenigii and M. paniculata against T. rubrum and T. mentagrophytes were 
investigated. Essential oil derived from leaves of the plants was used. The essential 
oil volatiles of A. ovata, A. mucronulata, C. album, C. pulchellum, C. capense and 
M. paniculata totally inhibited the growth of T. rubrum with final mycelia diameters 
of 0.3 cm and Fungal Growth Index (FGI) of 0%. Out of all the essential oils tested, 
only the essential oil volatiles of C. album and M. paniculata totally inhibited the 
growth of T. mentagrophytes. The volatiles of these essential oils also had a 
fungicidal effect on both fungal species as there was no further growth when the 
fungi were subcultured after a 7 day exposure to the treatments. Overall, the 
essential oil volatiles of the plants tested had remarkable antifungal activity against 
T. rubrum compared to T. mentagrophytes. Essential oils of plants from the 
Rutaceae family have been reported to contain mainly terpenes which could be 





The essential oil composition of Agathosma mucronulata, A. ovata, 
Calodendrum capense, Coleonema album, C. pulchellum, M. koenigii and M. 
paniculata leaves was investigated. Agathosma ovata leaves essential oil yielded  
forty-three components with  β-myrcene (22.03%), 1,6-octadiene-3-ol, 3, 7-
dimethyl-2-aminobenzoate (18.75%), trifluoroacetyl-lavandulol (12.97%), trans-β-
ocimene (11.81%), β-ocimene (5.65%), bicyclo germacrene (5.10%), β-
phellandrene (3.47%), thujone (2.07%), β-pinene (1.88%) and caryophyllene 
(1.74%) as the major components. The major components of A.  mucronulata leaf 
essential oil are: β-myrcene (34.05%), β-pinene (18.24%), caryophyllene (7.4%), 
(1S)-2,6,6-trimethylbicyclo[3.1.1]hept-2-ene (6.09%), D-limonene (6.06%), 
eucalyptol (5.46%), bicyclo germacrene (5.38%), trans-β-ocimene  (4.21%), 2,4,4-
trimethyl-2-vinyl-guaia-1(10),11-diene  (3.00%) and β- ocimene  (2.36%) of the 
thirthy- three components.  Compounds found in essential oil of both  A. ovata and 
A. mucronulata are trans-β-ocimene, β-ocimene, caryophyllene, β-myrcene and 
bicyclogermacrene.  
The essential oil  of C. capense leaves is composed of sixty- three 
compounds of which cis-β-farnesene (44.30%), naphtalene,1,2,3,5,6,8a-hexahydro-
4,7-dimethyl-1-(1-methylethyl)-,(1S-cis) (4.88%), β-phellandrene  (4.07%), 1,6-
cyclodecadiene,1-methyl-5-methylene-8-(1-methylethyl)-,[S-(E,E)] (3.68%), cis-β-
farnesene (3.29%), β-bourbonene (2.87%), caryophyllene (2.86%), gamma-
muurolene  (4.01%), bicyclo[5.2.0],nonane,4-methylene (2.03%), isolongifolene, 
9,10-dehydro (1.64%), trans-α-bergamotene (1.59%) and trans-β-ocimene (1.53%) 
are the major components. 
Caryophyllene (24.91%), trans-β-ocimene (9.49%), β-myrcene (7.96%) and 
octahydro-7-methyl-3-methylene-4-(1-methylethyl)-β-copaene (7.53%) are the 
major components of C. album essential oil while bicyclo[3.1.0]hex-2-ene,4-methyl-
1-(1-methyethyl)-β-phellandrene (32.04%), (+)-3-carene (10.88%), β-ocimene 
(9.46%), gamma-elemene (8.95%) and α-pinene (7.43%) are the major 
components of C. pulchellum essential oil. The major (≥ 1.5 %) components of the 
oil found in both essential oil of C. album and C. pulchellum are caryophyllene, 
bicyclo[3.1.0]hex-2-ene,4-methyl-1-(1-methyethyl)-β-phellandrene, α-pinene, 
gamma-elemene and carene. However, the common bioactive compounds exist in 





Essential oil of M. koenigii yielded a total of twenty-three components. The 
major components of the essential oil are: caryophyllene (42.54%), (4aR-trans)-
guaia-9, 11-diene (23.35%), alpha-guaiene (10.71%) and humulene (6.93%). The 
sister species, M. paniculata essential oil yielded forty-two components of which 1, 
6, 10-dodecatriene,7,11-dimethyl-3-methylene (38.62%), 1,6-cyclodecadiene,1-
methyl-5-methylene-8-(1-methylethyl) (19.0%), caryophyllene (10.63%), gamma-
elemene (8.55%) and bicyclo[3.1.1]hept-2-ene,2,6-dimethyl-6-(4-methyl-3-pentenyl) 
(5.42%) are the major components. The major (≥1.5%) components of the oil found 
in essential oil of both species are: caryophyllene and bicyclo[3.1.1]hept-2-ene,2,6-
dimethyl-6-(4-methyl-3-pentenyl). However, the two compounds are present in 
different quantities in the essential oil of the two plants. The essential oil derived 
from all the plants (seven) used in this study contains caryophyllene as part of their 
main components. The compound however exists in each of the essential oil in 
different quantities.  
It is not certain if essential oil purchased from organic product companies will 
consist of the same compounds and exhibit the same level of antifungal activity. 
The mode of action of the essential oil volatiles on the mycelia growth is also not 
known. It was deemed necessary to investigate the antifungal activity of essential 
oil (commercially produced) of two highly utilised Rutaceae plants and their mode of 
action on the fungal strains.  
Antifungal activity and essential oil components of Agathosma betulina and 
C. album were investigated. Essential oil of C. album (EOCM10) and A. betulina 
(EOBUCB10) were purchased from Still Pure, Cilliers street, Western Cape. 
Agathosma betulina and C. album oil (10 µl each) was subjected to analysis using 
Gas Chromatography Mass Spectrometry (GCMS). There was inhibition/reduction 
of fungal growth in all the plates exposed to essential oil volatiles. However, the 
rates of inhibition varied between the fungal species, oil tested and the different 
volumes tested. The volatiles from A. betulina oil has a stronger inhibitory effect 
than C. album oil; with the highest inhibition recorded at 40 µl. Susceptibility to 
essential oil volatiles is more pronounced in T. rubrum than in T. mentagrophytes. 
The best inhibition was recorded in T. rubrum exposed to volatiles from 40 µl of A. 





fungi. The same volume of A. betulina oil had a fungistatic effect on T. 
mentagrophytes with a FGI of 7 %. 
Mycelia from T. rubrum exposed to 40 µl essential oil volatiles did not grow 
when subcultured on a fresh plate of agar. This is an indication that the volatiles 
totally degraded the hyphae and spores. However, all the other fungal species 
subcultured produced mycelia after 7 days of incubation. Essential oil analysis of A. 
betulina and C. album using GCMS revealed the presence of terpenes. The major 
components of the essential oil of A. betulina were 1-menthone (36.35%), D-
limonene (29.84%) and 6-methoxy-3(2H)-pyridazinone (8.35%) while that of C. 
album were β-pinene (28.92%), (1R)-2,6,6-trimethylbicyclo[3.1.1]hept-2-ene 
(27.37%) and β-phellandrene (22.70%). The essential oils from both plant species 
is composed mainly of volatile monoterpenes. 
The mode of action of the essential oil volatiles was revealed under electron 
microscopy. The volatiles inhibited fungal growth by inhibiting the production of 
spores.  Agathosma betulina oil (40 µl) resulted in the total destruction of hyphae 
and spores of T. rubrum.  This total destruction is irreversible as the subcultured 
mycelia did not grow after 7 days of incubation on fresh agar thus indicating the 
fungicidal action of the essential oil volatiles. This is noteworthy as fungicidal action 
is needed to avoid reinfection and resistance of fungal strains which has been 
attributed to the survival of fungi spores. 
The outcome of this study gives credence to the use of some of the plants in 
skin and haircare products. The results of this study highlight the prospects of some 
of the plants used in this study as suitable candidates for the formulation of an 
effective skin antifungal/ointment of natural origin. These plants may offer a source 
of bioactive compounds for the treatment of symptoms involved in the pathogenesis 








CHAPTER 1. INTRODUCTION 
Nature has bestowed a vast quantity of plant resources to the human race for 
survival on planet earth. These resources supply the primary needs of humans in the 
form of food, clothing, shelter, raw materials and of course medicine. Therefore, 
without plants the human race will cease to exist. The Rainbow Nation (South Africa) 
is known all over the world by plant scientists as a country with outstanding plant 
resources which are being extensively utilised in the horticulture industry, medicinal 
plant markets and for the production of art and crafts and natural products. These 
plant resources come from nine biomes each of which are unique and offer an 
amazing reflection of nature in the different parts of the country. 
1.1. South Africa and its floral biodiversity 
 The Cape Floral Kingdom (CFK) is the smallest of the world’s six Floral 
Kingdoms (COWLING et al., 1992). Considering its size, it is the richest of the 
world’s six Floral Kingdoms. The CFK is one of the 25 Global Biodiversity Hotspots 
(MYERS et al., 2000) with a high degree of endemism and threatened biodiversity 
(HOLMES et al., 2012). The CFK is one of the most diverse regions in the world 
(GOLDBLATT and MANNING, 2002).  
The CFK comprises a land area of 90,000 km2, less than 5% of the total area 
of the southern Africa (GOLDBLATT, 1978, 1997). Plant species richness of the 
CFK is exceptional with a remarkable familial and generic composition (BOND and 
GOLDBLATT, 1984; GOLDBLATT, 1997; GOLDBLATT and MANNING, 2002). It 
remains one of South Africa most valuable assets and it includes the majestic Table 
Mountain and Cape Peninsula (which is now a national park) with 17 nature reserves 
and 307 km of coastline (HOLMES et al., 2012).  
 
1.2. Aesthetic value and healing power of the “Cape green gold” 
The CFK is home to valuable ornamental, aromatic and medicinal plants. The 
CFK vegetation offers a myriad of plants with unique scents and forms, which 
captivates the minds of nature lovers. The CFK is home to several plants known 
locally and internationally for their great horticultural value. These plants have been a 





plants. Some of these plants whilst being of great horticultural value are also of high 
medicinal value and are among the highly traded medicinal plants in the South 
African traditional medicine markets, popularly referred to as Muthi markets. The 
knowledge of the therapeutic value of South African medicinal plants is being used 
as a clue by researchers for the formulation and production of tinctures, ointments 
and essential oils from natural origin for the treatment of diseases. Pure essential oil 
from South Africa endemic aromatic plants is marketed locally and internationally 
and has in turn support the rapid establishment of natural product companies in 
South Africa and an increased interest in South African aromatic plants. 
 
1.3. Aromatic plants meeting the needs of humans from time immemorial 
The appeal of scented flowers and leaves and their by-products is as 
irresistible today as it was in the first fragrant plot, the “Garden of Eden” 
(ALLARDICE, 1992). A garden should appeal to all senses especially the sense of 
smell and sight (LA CROIX, 1984). Aromatic plants have been used for innumerable 
purposes among which are food and drink flavouring, scenting of clothes and to uplift 
the spirits of humans for many centuries (ALLARDICE, 1992). Aromatic plants 
possess volatile substances in the form of essential oils in one or more parts of the 
plant (SKARIA et al., 2007). The term essential oil is associated with fragrance or 
perfumes representing the essence or active constituents of aromatic plants 
(SKARIA et al., 2007). Many essential oils are used commercially for the production 
of perfumes (LA CROIX, 1984).   
The use of fragrances for pleasure is very old; an Egyptian papyrus from 
around the 16th century BC gives recipes for perfumes, cosmetics and deodorants 
(LA CROIX, 1984). Perfume was integral to ancient Egypt civilizations and the 
perfumes were derived from aromatic plants (ALLARDICE, 1992). The Egyptians 
used perfumes as an offering to their Gods and the aromatic products were prepared 
and kept in a small room in their temples (SKARIA et al., 2007). According to 
SKARIA et al., (2007), incense and aromatic oils were used in religious ceremonies 
and to ward off evil spirits.  
Aromatic plants were first imported by the Ishmaelite traders who travelled 
from Gilead with their camels bearing spices, balm and myrrh and the Egyptians 





The oil of cedar wood collected from the dense forests of Mount Lebanon was in 
much demand by the Egyptians who used it for religious rites, fragrant cosmetics 
and ointments and they believed that cedarwood was imperishable and could 
preserve life (ALLARDICE, 1992). The Hebrews got the knowledge about aromatic 
perfumes from their countrymen who were held as prisoners by the Egyptians 
(SKARIA et al., 2007). Cedar wood was used to construct the famous temple Diana 
at Ephesus and it was one of the Seven Wonders of the World (ALLARDICE, 1992).  
In Elizabethan times and earlier, floors were strewed with aromatic herbs such 
as Acorus calamus, chamomile, thyme, hyssop and lavender (LA CROIX, 1984). For 
several thousands of years, the “Incense Road” between Arabia and Egypt was 
travelled by the wealthy spice caravanserai and the rewards for a successful incense 
merchant were great and the entire economy of the kingdom of Sheba in the south of 
Africa depended on the sale of Frankincense and Myrrh (ALLARDICE, 1992). In 
ancient Egypt, women used cinnamon oil (from Nepal) combined with honey, myrrh 
and almonds to make a perfume for the feet and legs (ALLARDICE, 1992). The 
Egyptians also had knowledge about the efficacy of aromatic plants in healing 
diseases and this pool of knowledge was applied in medical care (SKARIA et al., 
2007).  
1.4. Use of aromatic plants in aromatherapy and human health since “the days 
of old” 
 When plague was a fact of life, lice and fleas were man’s constant 
companions and waste was disposed through the nearest open window, scented 
flowers were used for their antiseptic qualities and also to mask the odour (VEREY, 
1981). In an attempt to stop the spread of plague in Athens, Hippocrates fumigated 
streets with aromatic plants (SKARIA et al., 2007). Herbs were grown and utilized 
not only for their scents but also for their medicinal uses (LA CROIX, 1984) and 
some of them have remarkable application as therapeutic agents in pharmaceutical 
and drug industries (SKARIA et al., 2007). A rhythm exhibiting calmness is 
produced when essential oil with a sedative effect is inhaled as it stimulates the 
sense of smell and the emotional centre of the brain (SKARIA et al., 2007). “The 
breeze of essential oils of the world has blown from yesterday’s narrow definition as 
a symbol of luxury to indispensable necessities for both the rich and poor from the 





LA CROIX (1984) highlighted that scented plants have always played a vital 
role in the traditional cottage garden and today, there seems to be a renaissance of 
interest in aromatic and fragrant plants. An old man said when he was young; he did 
put bergamot (Moranda) into his hair-grease as “it pleased the girls” (LA CROIX, 
1984). Essential oil from several aromatic plant species have been incorporated into 
skin and hair care products. The family Rutaceae which includes citrus is known for 
the presence of punctuate oil glands and almost all the members have aromatic 
leaves (LA CROIX, 1984). 
1.5. The Rutaceae, a family of green aromatics in the treasure-box of the
 Rainbow Nation 
Rutaceae species are among the most traded plants in the international 
herbal medicine market. The family Rutaceae has several members of economic 
importance (CHASE et al., 1999). The Rutaceae family also known as the citrus 
family is a large group of about 161 genera and 1815 species (worldwide), with 21 
genera and 289 species native to southern Africa. The most notable globally are the 
species of Citrus that produce both the citrus fruits of commercial importance 
(lemons, oranges, mandarins, tangerines, limes, kumquats, etc.) and the essential 
oils used in perfumery, species of Pilocarpus are the source of pilocarpine, a drug 
used to treat glaucoma, and species of Boronia, Choisya, Poncirus, and Skimmia 
that are used as ornamentals (CHASE et al., 1999). Several species of the family 
Rutaceae are popularly used as medicinal plants due to the presence of highly 
therapeutic components found in them. The majority of the native Rutaceae species 
in southern Africa are endemic to the Cape region of South Africa. Some Rutaceae 
species are extensively exported to other countries of the world due to their essential 
oils which have unique scent and therapeutic components. Examples are the 
Agathosma species, Coleonema album and others. The Rutaceae species have 
been a green gold plant family in South Africa.  
The economic and medicinal value of Rutaceae species of South African 
origin cannot be over-estimated. The export value and commercial importance of 
Rutaceae species popularly known as Buchu have been recorded since the early 
18th and 19th centuries. In the late eighteen century, Buchu leaves were dried, baled 
and exported to Europe and America and for over 30 years, buchu oil has been 





agathosma/). Agathosma species is exported in large volumes for use as a fixative in 
the food industry (COETZEE et al., 1999). PAPPE (1857) recorded that Buchu 
leaves is an article of export and listed their medicinal uses.  
The medicinal value of Buchu is attributed to the essential oil of the leaves 
(PAPPE, 1857). MACOWAN (1893) advocated that the oil from Buchu should be 
distilled in the Cape instead of exporting the raw materials for distillation. PILLANS 
(1910) recorded that up to five shillings per pound of Buchu leaves were being 
realised in the London market. The standard buchus of commercial importance were 
Barosma betulina, B. crenulata and B. serratifolia and among the commercial 
buchus, B. betulina is the most valued in all pharmacopoeias of other countries 
(PHILLIPS, 1917). A plantation of Buchu was established in Kirstenbosch and the 
local production of Buchu oil was encouraged (PHILLIPS, 1917).   
Most of the species of Rutaceae have gland-dotted leaves and a large 
proportion of the family is relatively rich in essential oils (SWAIN, 1963). In the field, 
Rutaceae species can be easily recognized by the conspicuously dotted oil cells on 
the leaves (WIART, 2006). Several Rutaceae species have been used to treat 
diseases of the respiratory tract, to reduce fever, and to promote digestion on 
account of their essential oils and a growing body of evidence suggests that 
coumarins of the Rutaceae have anti-tumor activities (WIART, 2006). Oil produced 
by several genera of the family is used in perfumes and as medicine while other 
species are used as ornamentals (MABBERLEY, 2008). Ruta chalepensis is used in 
traditional medicine in many countries to treat a variety of diseases like rheumatism, 
neuralgia, menstrual bleeding, fever, arthritis, hepatic diseases, antifertility, and 
gastrointestinal disorders (GUNAYDIN and SAVCI, 2005; GONZALEZ-TRUJANO 
et al., 2006). In the Italian countryside, R. graveolens leaves were set under the bed 
to repel bugs and mice (GUARRERA, 1999). A decoction of Ruta species also has 
been used topically against scabies, lice, and fleas, to repel insects and to treat 
intestinal worms in livestock (FEO et al., 2002).  
The antimicrobial activity of the chloroform, methanol and water extracts of 
leaves, fruits and barks of Aegle marmelos was tested against Bacillus subtilis, 
Staphylococcus aureus, Klebsiella pneumoniae, Proteus mirabilis, Escherichia coli, 





significantly higher activity against above mentioned bacteria than that of the other 
extracts (POONKOTHAI and SARAVANAN, 2008). 
Extracts of Aegle marmelos leaves gave remarkable antibacterial activity 
against Escherichia coli, K. pneumoniae, Proteus vulgaris, Micrococcus luteus, 
Enterococcus faecalis and Streptococcus faecalis (SARADHA and RAO, 2010). 
Hesperidin rich species of the Rutaceae have been reported to have anti-allergic 
effects (KUBO and MATSUDA, 1992) and significant anti-inflammatory and 
analgesic effects (GALATI et al., 1994). Clausena excavata extracts have been 
reported to show anti-cancer, antimicrobial, antioxidant, antifungal, antiviral, 
antidiabetic, immunomodulatory and antiplasmodial activities (ARBAB et al., 2012). 
Since Pilocarpus species have been confirmed to be a potent stimulant of the 
secretory system, showing sialagoue, diuretic and diaphoretic activities(CORRÊA, 
1969), infusions of their leaves have been used to treat fevers, stomatitis, bronchitis, 
gout, psoriasis, kidney diseases and several other illnesses (HOLMSTED et al., 
1975). It is noteworthy that these Rutaceae species (Pilocarpus species) contain the 
Imidazole alkaloid, pilocarpine which has been utilised in ophthalmology (WEBER, 
1876) for the treatment of glaucoma (KOROLKOVAS, 1996) and hence has made 
the genus one of the most important plants in the Brazilian flora (PINHEIRO, 1997). 
The effectiveness of pilocarpine in the treatment of xerostomy (dry mouth) caused by 
the chemotherapy of throat cancer or those of the head area (MILLER, 1993; 
VALDEZ et al., 1993) has been reported. 
Zanthoxylum americanum Mill., leaf, fruit, stem, bark and root extracts 
exhibited a broad spectrum of antifungal activity and inhibited at least eight out of 
eleven fungal strains (including Candida albicans, Cryptococcus neoformans and 
Aspergillus fumigatus) representing diverse opportunistic and systemic pathogens 
and thus justify the popular use of this plant in North American traditional medicine 
for fungal infections (BAFI et al., 2005). The essential oil extracted from the epicarp 
of Citrus sinensis (L.) Osbeck exhibited absolute fungitoxicity against ten post-
harvest pathogens (SHARMA and TRIPATHI, 2006). In an analysis of the chemical 
composition and antifungal activity of the essential oil of Haplophyllum tuberculatum 
(AL BURTAMANI et al., 2005), the oil affected the mycelial growth of Curvularia 
lunata and Fusarium oxysporum in a dose-dependent manner, but had no effect on 





components of the oil were α- and β-phellandrene, limonene, β-ocimene, β-
caryophyllene and myrcene. 
The quality and quantity of essential oil derived from five species of 
Coleonema have been characterised (BAŞER et al., 2006). Forty-three compounds 
were characterized in the oil of C. album representing 99.1% of the total 
composition. Main compounds were β-phellandrene (30.4%) and myrcene (20.5%). 
Forty-three compounds were characterized in the oil of C. aspalathoides 
representing 94.1% of the oil with sabinene (24.0%), terpinen-4-ol (12.2%), p-
cymene (12.1%), linalool (11.3%) and α-pinene (9.1%) as main constituents. In the 
oil of C. calycinum, 35 compounds were characterized representing 99.4% of the 
total volume. β-phellandrene (42.0%) and linalool (11.0%) were the main 
constituents. Monoterpene hydrocarbons were the main constituents in three oil 
samples of C. pulchellum. Myrcene (63.0%) was the main constituent in the oil of C. 
virgatum in which 23 compounds were identified representing 97.3% of the total. The 
presence of coumarins, terpene and terpenoids is responsible for the various 
medicinal use of Rutaceae species among which is the use for skin diseases of 
fungal origin.  
1.6. Significance of the study 
There is a strong relationship between the skin and emotions in humans as 
embarrassment causes blushing, anxiety causes cold and a sweaty palm and anger 
reddens the face (WELLER et al., 2008). The relationship between the skin and 
mind is quite complex and the incidence of psychiatric abnormalities is higher among 
patients with skin disorders than the general population (WELLER et al., 2008). Skin 
diseases can have a negative effect on the physical and psychological wellbeing of 
an individual (APPGS, 2013). Psychological problems associated with skin disease 
patients include feelings of anxiety, anger, shame, stress, social isolation and a low 
self-esteem (APPGS, 2013). The presence of disfiguring skin lesions can distort the 
emotional development of a child as they can become withdrawn or aggressive 
(WELLER et al., 2008) and can be a reason to be absent at school (APPGS, 2013).  
Chronic skin disease is capable of ruining the quality of life as it interferes with 
work, social activities (WELLER et al., 2008; APPGS, 2013), sexual relationships 
(APPGS, 2013), causes pain and itching and thus makes a patient feel like an 





can cause misery (COOPOOSAMY and NAIDOO, 2011) and their physical 
appearances may be a source of stigmatization (COOPOOSAMY and NAIDOO, 
2011; APPGS, 2013). Feelings of stigmatisation and rejection are common in 
patients with chronic skin diseases (WELLER et al., 2008). The increased incidence 
of resistance of skin fungal diseases to antibiotics is of great concern. The situation 
is more prominent among HIV/AIDS individuals thus adding to the burden of skin 
diseases in Africa as a region. Owing to the high incidence of HIV/AIDS in South 
Africa (GLOBAL INFORMATION AND ADVICE ON HIV AND AIDS, 2016), there is 
an urgent need for the development of new medicines to cure various HIV/AIDS 
opportunistic infections most especially skin diseases.  
Skin diseases are often more associated with HIV/AIDS infected individuals 
as a result of a decrease in their immunity. South Africa has the highest population of 
HIV/AIDS positive individuals in Africa and the KwaZulu-Natal region has the highest 
incidence in South Africa. The African continent has a high prevalence of HIV/AIDS 
and hence is in dire need of appropriate and adequate management of dermatologic 
diseases (HU et al., 2011). In many developing countries, health care centers are 
often run by clinical officers or nurses (rather than physicians) who act as the primary 
care workers but have inadequate training on the diagnosis of dermatologic 
conditions (SATIMIA et al., 1998; HAY and MARKS, 2004).  
 Skin diseases apart from being a form of stigmatization among HIV/AIDS 
positive individuals, can also have an adverse effect on the economic growth of a 
society/country as it reduces the productivity of those infected. Dermatitis of the hand 
can destroy a manual worker’s earning capacity such as with hairdressers, nurses, 
cooks, and mechanics (WELLER et al., 2008). In times of unemployment, people 
with skin diseases find it difficult to get a job (WELLER et al., 2008). 
Hence, the need to develop a plant based remedy as a cure for skin diseases 
is crucial as it will relieve the burden of skin diseases among HIV/AIDS individuals 
and the general populace. The Rutaceae family plants are generally rich in terpenes 
and coumarins (and its derivatives) which have been reported to have anti-
dermatophytic properties. Natural products offer a cheap, affordable and accessible 
option for the treatment of several diseases, including skin diseases of fungal origin 
such as eczema and ringworm which are often referred to as ‘Atopic Dermatitis’ 





they are good source of natural pigments such as carotenoids; and other skin health 
enhancing compounds which include vitamins, A, B and E. 
 In an attempt to achieve an increased therapeutic rate of treatments of skin 
diseases, a combination of topical and oral anti-inflammatory drugs has been used 
(SOARES et al., 2013). Natural products offer a variety of anti-inflammatory 
(YASSER and NABIL, 2012) and anti-oxidant agents (KOSTOVA, 2006) which can 
counter the oxidative stress, dryness, scaling and inflammations that comes into play 
during the pathogenesis of skin diseases. Rutaceae family plants are known to be a 
source of coumarins, terpenes, flavonoids and other therapeutic agents that have 
been reported to be effective in the treatment of skin diseases and alleviation of 
oxidative stress and inflammation.  
Extracts and tinctures from several Rutaceae species have been incorporated 
into skin care products. Thus, if the extracts can enhance skin beauty, they may also 
contain vital ingredients that can heal skin diseases. Various Rutaceae species have 
been used to treat skin diseases in the traditional medicine system of different 
African countries.  
1.7. Aims and objectives 
The aims and the objectives of this study are to; 
 Investigate the antioxidant activity of the selected Rutaceae species as 
oxidative stress is responsible for skin inflammation and crucial in the 
pathogenesis of atopic dermatitis/ringworm; 
 Investigate the antifungal activities of leaf extracts of selected Rutaceae plant 
species against Trichophyton rubrum (ATCC 28188), T. mentagrophytes 
(ATCC 9533) and Microsporum gypseum (ATCC 24102); 
 Investigate the antifungal activities of the commercially produced essential oils 
of two popular South African endemic Rutaceae species, Coleonema album 
and Agathosma betulina against Trichophyton rubrum and T. 
mentagrophytes; 
 Investigate the effects of essential oil on the fungal cell morphology and 
growth such as mycelia diameter, hyphae and spore production; and  
 Analyse the bioactive compounds present in the essential oils of the selected 
plants in order to be able to determine the compounds that could be 





CHAPTER 2. LITERATURE REVIEW 
2.1. HIV/AIDS: a trauma to the human race 
The human race has been ravaged by diseases such as malaria, polio, 
smallpox, cholera, tuberculosis, hepatitis, yellow fever, influenza, whooping cough, 
bird flu, meningitis, syphilis and cancer, which have led to loss of lives but have been 
recently controlled through the production of vaccines and drugs. “HIV/AIDS” 
emerged during the 20th century and has been a great trauma to the human race 
ever since. The disease finds its way into the human body mostly during moments of 
pleasure (sexual intercourse) and through the use of unsterilized sharp objects. The 
syndrome inflicts pains not just to the body but also to the soul and psychologically 
leaves the victims depressed. This depression coupled with the stigmatization by the 
public and in worst cases by loved ones makes the patient to lose hope and drains 
them of the strength to continue the journey of life. Irrespective of colour, race, 
financial and societal status, the syndrome drowns humans in a pool of shame, 
anxiety, pain and unavoidable diseases which are often referred to as “Opportunist 
Infections” (OI). One of the major symptoms of a full blown HIV/AIDS condition is the 
manifestation of diseases and infections on the skin. 
 
2.2. The human skin, a vital irreplaceable organ 
The skin is a vital organ in humans as it is closely related to the identity of an 
individual. The skin reveals an individual’s race and in some cases the tribe to which 
they belong. More importantly, the skin serves as a key indicator of an individual’s 
state of health. The human skin is a unique organ that permits terrestrial life by 
regulating heat and water loss from the body whilst preventing the entry of harmful 
chemicals or microorganisms (WILLIAMS, 2003). The skin is the largest organ of the 
human body which amounts to 10% of the body weight of an average individual and 
can be classified into four main layers according to its structure and function 
(WILLIAMS, 2003);  
 The innermost subcutaneous fat layer; 
 The overlying dermis; 





 The outermost layer of the tissue 
The subcutaneous fat layer, or hypodermis, bridges the overlying dermis and the 
underlying body constituents. This layer of adipose tissue principally serves to 
insulate the body and to provide mechanical protection against physical shock. The 
subcutaneous fatty layer can also provide a readily available supply of high-energy 
molecules, whilst the principal blood vessels and nerves are carried to the skin in this 
layer. 
The dermis is typically 3-5mm thick and is the major component of human skin. It 
is composed of a network of connective tissue predominantly collagen fibrils which 
provides support while elastic tissue provides flexibility, embedded in a 
mucopolysaccharide gel (WILKES et al., 1973). Numerous structures are embedded 
within the dermis. They include: blood and lymphatic vessels, nerve endings, 
pilosebaceous units (hair follicles and sebaceous glands), and sweat glands (eccrine 
and apocrine). There are 3 main appendages found on the surface of human skin 
that originate in the dermis. These have been described in detail by KATZ and 
POULSEN (1971). Hair follicles are found over the entire surface of the skin with the 
exception of the sole of the feet, palms of the hands and the lips. The sebaceous 
gland associated with hair follicles secretes sebum which is composed of free fatty 
acids; waxes and triglycerides which lubricates the skin surface and helps to 
maintain the pH of the skin surface at around 5. Eccrine (or sweat) glands and 
apocrine glands also originate in the dermal tissue. The eccrine glands secretes 
sweat (a dilute salt solution at a pH of around 5) in response to heat and emotional 
stress. The apocrine glands are located near the dermo-epidermal layer but are 
limited to specific areas of the skin including the axillae, nipples and ano-genital 
regions.  
The epidermis is a complex multiple layered membrane. It contains no blood 
vessels and hence nutrients and waste products must diffuse across the dermo-
epidermal layer in order to maintain tissue integrity. The epidermis contains four 
histologically distinct layers which from the inside to the outside are: the stratum 
germinativum, stratum spinosum, stratum granulosum and stratum corneum.  
Studies have shown that the stratum corneum barrier is highly compromised for 
patients with AD with transepidermal water loss from the body increasing by up to 





An intact, healthy skin has a highly effective barrier against the ingress of micro-
organisms but hosts microbial flora which include bacteria and yeasts, and if 
breached, it can result in skin disease/infection (WILLIAMS, 2003).  
 
2.3. Skin diseases: a health burden across the globe 
Skin diseases and their complications are a significant burden on the health 
system of several nations (ATRAIDE et al., 2011). In assigning health priorities, skin 
diseases are sometimes regarded as small-time players in the global league of 
illness compared with diseases that cause significant mortality, such as HIV/AIDS, 
community-acquired pneumonias, and tuberculosis (HAY et al., 2006). However, 
skin problems are generally among the most common diseases seen in primary care 
settings in tropical areas, and in some regions where transmissible diseases such as 
Tinea imbricata or onchocerciasis are endemic; they become the dominant 
presentation (HAY et al., 2006).  
Skin diseases are not usually recognized as a major public health problem in 
developing countries, despite the fact that recent reports by the World Health 
Organization (WHO) estimates that 21–87% of the general population in developing 
countries has a skin disease. Problems with the skin are among the main reasons for 
seeking healthcare, amounting up to 24% of primary care visits, and are one of the 
most common causes of morbidity (SCHMELLER, 1998; NNORUKA, 2005). In 
many Sub-Saharan African countries, infections and infestations make up the 
majority of skin diseases which accounts for 85% of skin diseases in Tanzania, 78% 
in Malawi, 71.5% in Ethiopia, and 40.1% in Uganda (GIBBS, 1996). In addition to the 
immense burden of skin disease in Africa, diseases such as dermatitis and prurigo 
are commonly either untreated or over-treated with strong topical steroids and 
antibiotics which have been found to cause considerable side effects 
(JOBANPUTRA and BACHMANN, 2000). The health consequences of 
dermatologic disease extend beyond the individual (FIGUEROA et al., 1998). 
Hence, the public health is at risk since common skin conditions include parasitic 
infestations and infections (FIGUEROA et al., 1998).  
Several factors which include occupation, nutrition, genetic, environment, 
race, age, and habits can influence the pattern of skin diseases (PARTHASARADHI 





resulting from skin infections and diseases are generally lower than that of other 
health conditions, it is important to meet people’s needs for effective remedies for 
skin conditions for a number of reasons: 
 Skin diseases are so common to the extent that patients represent large 
numbers in primary health care settings. Children particularly tend to be 
affected, adding more burden of disease to a group which is already 
vulnerable; 
 Generally, families must meet the costs of skin disease treatment from an 
overstretched household budget, and such expenses in turn reduce the 
capacity to purchase essential items such as food (HAY et al., 1994); 
 Screening the skin for signs of disease is an important strategy which gives a 
clue to the presence of a wide range of illnesses; and 
 Morbidity is significant through disfigurement, disability, or symptoms such as 
intractable itch, which can contribute to social isolation and in worse scenarios 
the reduction in quality of life. 
Skin diseases can also result in psychological or mental disorders (MURRAY 
et al., 2013). In health clinics, skin diseases constitute up to 15% of all attendances. 
The rate of treatment failure, above 80%, are common as shown from results of 
studies assessing success in the management of skin diseases in primary care 
settings in the developing world (FIGUEROA et al., 1998). 
 
2.4. Skin diseases in Africa, the culprits and way forward 
The World Health Organization’s report on the global burden of disease 
indicate that skin diseases were associated with mortality of 20,000 in Sub-Saharan 
Africa in 2001(WORLD HEALTH ORGANIZATION, 2005). The distribution of 
dermatomycoses, their aetiological agents and the predominating anatomical 
infection patterns varies with geographical location and a wide range of 
environmental and cultural factors (MALE, 1990; MACURA, 1993).  
Naturally, dermatophytes thrive at surface temperatures between 25 to 28ºC 
and human skin infections are thus supported by warm and humid conditions 
(HAVLICKOVA et al., 2008). Superficial fungal infections are relatively common in 
tropical countries and are aggravated by wearing of occlusive clothing; crowded 





hygienic practices (HAVLICKOVA et al., 2008). Fungal, bacterial and parasitic skin 
diseases flourish in a hot and humid climate (NAAFS et al., 2013). The regional 
incidence of dermatophyte infections is not static due to booming mass tourism; 
international sports activities and increasing migration (HAVLICKOVA et al., 2008).  
 Skin lightening creams are a significant cause of disease in urban women (DOE 
et al., 2001; DEL GUIUDICE and YVES, 2002). People who wear closed shoes may 
more often develop athlete’s foot and mycosis pedis. Fungal infections form part of 
the most commonly diagnosed skin diseases in the Africa region (HAVLICKOVA et 
al., 2008). Fungal species of Trichophyton are the most common dermatophytes 
associated with fungal skin diseases in Africa (HAVLICKOVA et al., 2008). The 
overall incidence of Tinea in Sub-Saharan Africa for the year 2005 was estimated to 
be 78 million (HAY et al., 2006).  
2.4.1. The increased burden of skin diseases resulting from HIV/AIDS 
In Sub-Saharan Africa, skin diseases are dominated by bacterial and fungal 
infections and their clinical expressions are often modified by HIV-induced immune-
suppression (HAY et al., 2006). The HIV/AIDS epidemic in Africa further adds to the 
burden of skin disease (HU et al., 2011). Worldwide, dermatophytoses frequently 
associated with people living with HIV/AIDS is 20-40% more than in the general 
population (D'ANTUONO et al., 2001). Skin manifestations are often the first sign of 
HIV infection and conversion to AIDS (NNORUKA, 2005; TSE, 2007) and 90% of 
individuals with HIV/AIDS are diagnosed with skin disease at some point during the 
course of the disease (PENNYS, 1995; FIGUEROA et al., 1998; MOSAM et al., 
2004; NATIONAL AIDS AND STI CONTROL PROGRAM, 2008).  
Fungal infections of the skin and nails represent the majority of all mycoses 
(HAVLICKOVA et al., 2008) and are among the most common skin disease 
manifestation in HIV/AIDS patients. They can occur at any stage of the disease and 
some of the dermatoses are unique to HIV infection while others are common 
conditions, which also occur in HIV-negative individuals (NATIONAL AIDS AND STI 
CONTROL PROGRAM, 2008). Patients with HIV infection exhibit a wide range of 
skin pathology which includes bacterial, fungal, and viral infections, skin tumors, 
inflammatory and eczematous eruptions, and drug rashes (RUDIKOFF, 2002). 
Anyone caring for HIV-infected individuals could be burdened by the unusual 





problems may have a prolonged course and may cause diagnostic and treatment 
challenges in HIV/AIDS-positive individuals (NATIONAL AIDS AND STI CONTROL 
PROGRAM, 2008).  
In addition to ordinary and esoteric skin infections, tumors, and drug 
reactions, HIV-infected patients typically exhibit unusually dry skin, and may thus 
display inflammatory or eczematous eruptions (RUDIKOFF, 2002). These include 
seborrheic dermatitis, psoriasis, pruritic popular eruption of HIV, eosinophilic 
folliculitis, papular urticaria, prurigo nodularis, and notably, a dermatosis that strongly 
resembles AD (RUDIKOFF, 2002). 
2.4.2. Prevalence of skin diseases in HIV/AIDS individuals and the 
microorganisms responsible for the infections/diseases 
In a study involving 186 HIV-positive patients, 175 (94%) suffered from one or 
more cutaneous disorders (HO and WONG, 2001). It is impossible from the current 
literature to estimate the prevalence of AD in HIV-infected children and adults 
(RUDIKOFF, 2002). According to the HIV/AIDS Epidemiological Surveillance Report 
for the WHO African Region 2005 Update, recent trends in HIV prevalence show that 
nearly 30% of women aged 15 to 49 attending antenatal clinics in southern Africa are 
infected (BALDRIDGE et al., 1988). More than 60% of all the people living with 
HIV/AIDS across the world live in Sub-Saharan Africa (BALDRIDGE et al., 1988). 
The population of hospital admissions for dermatologic diseases in HIV/AIDS 
individuals as a proportion of the admissions for dermatologic disease in all 
individuals has drastically increased from nearly 40% to 60% in various regions of 
South Africa (MOSAM et al., 2004).   
Dermatophytoses manifests as an opportunistic infection which is four times 
more prevalent in acquired immunodeficiency syndrome (AIDS) patients 
(GOODMAN et al., 1987). The most common clinical manifestation of 
dermatophytosis is Tinea pedis (athlete’s foot) and nail infections, which can come 
into play at any time during the course of illness in HIV-positive patients (BHAGRA 
et al., 2013). The incidence of dermatophyte infection of the glabrous skin has been 
reported to be approximately 40% in these patients (ELMETS, 1994). Tinea 
infections and onychomycosis are common in HIV disease (TSE, 2007). The 
features are similar to the HIV negative individuals (TSE, 2007). Tinea unguium 





produces sub-ungual hyperkeratosis, onycholysis and nail discoloration (TSE, 2007). 
Generally, the increased number and severity of skin disorders are associated with 
declining immunity (RAJU et al., 2005). The spectrum of skin disorders depends on; 
the immunologic stage as reflected by CD4 count, concurrent use of HAART and the 
pattern of endemic infections (TSE, 2007). 
The frequently isolated species are Trichophyton rubrum, T.mentagrophytes, 
and Epidermophyton floccosum (FERNANDES et al., 1998). Microsporum gypseum 
is a geophillic dermatophyte, which is rarely isolated from skin lesions of 
immunocompromised patients (BHAGRA et al., 2013). Microsporum gypseum may 
cause ringworm of the scalp and hair and Tinea corporis (ringworm of the glabrous 
skin) in immunocompetent hosts (PANDEY and PANDEY, 2013). The most common 
skin disorder identified in HIV/AIDS individuals was fungal infections (TSE, 2007). 
 
2.4.3. Fungi as major causative agents of skin diseases in humans   
Fungi have emerged as major causes of human diseases in recent times, 
especially in immunocompromised individuals (ELDER et al., 2005), causing 
considerable morbidity and mortality (MURRAY et al., 2013). Fungi are eukaryotic 
organisms that are different from other eukaryotes as a result of the presence of a 
rigid cell wall composed of chitin, glucan and a cell membrane in which ergosterol is 
substituted for cholesterol as a major sterol component (ELDER et al., 2005; 
MURRAY et al., 2013). Fungi may be unicellular or multicellular; yeasts are usually 
unicellular while molds are multicellular organisms consisting of threadlike tubular 
structures known as hyphae (ELDER et al., 2005; MURRAY et al., 2013).  
The hyphae are closely associated to form a mat-like structure called a 
mycelium (MURRAY et al., 2013). The hyphae may produce a specialised structure, 
the conidia, an asexual reproductive element which is easily airborne and serves as 
a means of fungus dissemination (MURRAY et al., 2013). Fungal spores can survive 
dry and harsh conditions and can tolerate a range of pH conditions (ELDER et al., 
2005). The size, shape and certain developmental features of the conidia are critical 






2.4.3.1. Classification of fungi 
There are two main groups of fungi: the molds and yeasts (ELDER et al., 
2005). In the molds, fungal cells are joined together to form filaments called hyphae 
(ROBERTS et al., 1990). The hyphae branches to form an interwoven mass called 
the mycelium (ELDER et al., 2005) on which the fungus produces its spores 
(ROBERTS et al., 1990). The type and number of spores produced varies among 
species and is used as an identification tool in mould fungi (ROBERTS et al., 1990). 
Yeasts in contrast to molds are predominantly unicellular, usually with round oval 
cells (ROBERTS et al., 1990). These cells reproduce by budding, a process 
involving the development of a protuberance at the poles of the cell; which develops 
into a daughter cell which eventually separates from the parents (ROBERTS et al., 
1990).  
In some yeasts, the budding cell becomes elongated in the form of a chain 
known as a pseudomycellium. Some yeasts produce a true mycelium which is 
similar to, and cannot be distinguished from, that produced by molds (ROBERTS et 
al., 1990). A small number of fungi are dimorphic, meaning that they are capable of 
growth in either the yeast or mould form depending on the environmental conditions 
they are exposed to during growth (ROBERTS et al., 1990). A number of the human 
fungal pathogens are dimorphic in nature (ROBERTS et al., 1990). 
2.4.3.2. Types of fungal diseases in humans and their mode of survival  
There are approximately 100,000 species of fungi distributed globally. A 
greater number of fungal infections in both temperate and tropical countries are 
superficial infections of the skin (HAVLICKOVA et al., 2008). The most common 
pathogens in practice are dermatophytes, yeasts and molds (HAVLICKOVA et al., 
2008). Fungal diseases of the human keratinized tissue may be caused by 
dermatophytes, non-dermatophytic fungi or a combination of both (PATEL et al., 
2006).  
The dermatophytes are a phylogenetically related group of filamentous 
ascomycetes (PATEL et al., 2006), parasitic fungus (HARUNA et al, 2011) which 
can be classified into the genera Epidermophyton, Microsporum and Trichophyton 
(PATEL et al., 2006; HARUNA et al, 2011) as characterized according to the 
formation and morphology of their conidia (WEITZMAN and SUMMERBELL, 1995; 





allow them to grow in keratinized tissues on the host (PATEL et al., 2006). Fungi 
that are able to use the protein keratin for growth are referred to as keratinophilic 
fungi (PATEL et al., 2006). All dermatophytes are keratinophilic but not all 
keratinophilic fungi are dermatophytes (PATEL et al., 2006). The distinct 
characteristic between the two is based on the fact that dermatophytes grow on a 
living host while the other fungus does not require a living host (PATEL et al., 2006). 
Dermatophytes produce proteolytic enzymes known as keratinases (SOARES 
et al., 2013). These enzymes hydrolyze keratin which is the main protein constituent 
of hair, nails and skin (SIMPANYA, 2000; HARUNA et al, 2011; SOARES et al., 
2013) thus causing injuries (SIMPANYA, 2000) and an inflammation by the host 
immune response to the metabolic by-products (HARUNA et al, 2011). The extent of 
the infection can be mild to severe, depending on the immune response of the host 
(AKCAGLAR et al., 2011). The severity of the infection is partly dependent on the 
reaction of the host to the invading organism, and other factors, such as the species 
or virulence of the infecting strain, the reaction of the host to the metabolic products 
produced by the fungus, anatomic site of infection, and environmental factors 
(SOARES et al., 2013).  
In mammals, keratin, collagen and elastin constitute 25% of the body mass 
(SOARES et al., 2013). The enzymes needed to hydrolyse these macromolecules 
can be found in infected tissues and is thus regarded as being essential to the 
virulence of dermatophytes (SIMPANYA, 2000). The ability of a dermatophyte to 
cause an infection in the host is dependent on several factors, among which are the 
"escape" mechanisms of the host resistance, which includes dry skin, a slightly 
acidic pH, the fungicidal effect of fatty acids, the continuous regeneration of skin, the 
state of the keratinized layer and other factors, such as competition with the normal 
skin microbiota (ERBAGCI, 2004). The infection is initiated through the inoculation of 
arthrospores deposited on the skin and favoured by a pre-existing skin lesion or 
abrasion (SIDRIM and ROCHA, 2004) and established by the “remarkable ability of 
the microorganisms to degrade keratin” (SIMPANYA, 2000; ABDEL-RAHMAN, 
2001; MACÊDO et al., 2005).  
Animals are reservoirs of zoophilic dermatophytes and their zoonotic 
infections are of significant importance (CABAÑES, 2000; BARANOVA et al., 





of the normal microbiota of humans but pathogens that infect keratinized tissues, 
nails or hair of healthy individuals (BAEZA et al., 2007; MONOD, 2008). 
Transmission can occur by direct contact or from exposure to desquamated cells 
(SANTOS et al, 2006). Direct inoculation through breaks in the skin often occurs in 
individuals with depressed cell-mediated immunity (SANTOS et al, 2006). The 
choice of appropriate treatment is determined by the site and extent of the infection 
and the species involved as well as by the efficacy, safety profile, and kinetics of the 
available drugs (FERNANDEZ-TORRES et al., 2002).  
Superficial disease caused by non-dermatophytes is limited to the stratum 
corneum, hair or both (PATEL et al., 2006). The dermatophytes usually do not 
invade living tissues but colonize the outer layer of the skin (HARUNA et al, 2011). 
The growth of fungi on the host leads to manifestation of skin diseases as there is 
little or no host immune response (PATEL et al., 2006). The fungi Trichophyton 
tonsurans, T. mentagrophytes and Microsporum gypseum causes Tinea (popularly 
referred to as ringworm) such as Tinea capitis (ringworm of the scalp and hair), 
Tinea corporis (ringworm of the glabrous skin), Tinea unguium (nail infection) and 
Tinea manuum (ringworm of the hand) (HARUNA et al, 2011). 
2.4.4. Classification of Human mycoses 
Human mycoses are classified into; superficial, cutaneous and subcutaneous 
mycoses, the endemic mycoses and opportunistic mycoses (MURRAY et al., 2013). 
Superficial mycoses are limited to the superficial surfaces of the skin and hair 
(MURRAY et al., 2013). The fungal species responsible for this type of mycoses 
include Piedraia hortae, Hortae werneckii, Malassezia furfur and Trichosporon spp 
(MURRAY et al., 2013).  
Cutaneous mycoses infects the keratinized layer of skin, hair and nails and 
can be symptomatic with signs like itching, scaling, broken hairs, ring-like patches of 
the skin, and thickened discoloured nails (MURRAY et al., 2013). Fungi of the 
genera Trichophyton, Microsporum and Epidermophyton are responsible for 
cutaneous mycoses and the infections involving these organisms are referred to as 
dermatophytoses (MURRAY et al., 2013). Cutaneous disease involves the 
epidermis and dermis and results to an inflammatory reaction similar to that of 
contact dermatitis (PATEL et al., 2006). The most frequent type of onychomycosis 





between 18% and 40% of all onychopathies (ZIMMERMAM-FRANCO et al., 2013). 
Dermatophytes, most especially Trichophyton rubrum and T. mentagrophytes are 
the primary cause of 90% of onychomycosis (KAUR et al., 2008).  
Subcutaneous mycoses involve the deeper layers of the skin such as the 
cornea, muscle, and connective tissues (MURRAY et al., 2013). The fungus finds its 
way to the tissues by traumatic inoculation and remains localised causing abscess 
formation, non-healing ulcers and draining sinus tracts (MURRAY et al., 2013). The 
infections may be caused by hyaline molds such as Acremonium species, Fusarium 
sp and pigmented or dermatiaceous fungi such as Alternaria spp, Cladosporium sp 
and Exophiala sp. 
Endemic mycoses, also often referred to as systemic mycoses are caused by 
dimorphic fungal pathogens such as Histoplasma capsulatum, Blastomyces 
dermatitidis, Coccidiodes immitis, C. posadasii, Paracoccidiodes brasiliensis, and 
Penicillium marneffei (MURRAY et al., 2013). The fungi exist in two morphological 
forms; yeast or spherules at 37ºC and molds at 25ºC (MURRAY et al., 2013).  
Opportunist mycoses are infections caused by fungi that are human 
commensals. With the exception of Cryptococcus gattii and C. neoformans these 
organisms exhibit a low level of virulence and are responsible for infection in 
individuals that are debilitated and immunosuppressed (MURRAY et al., 2013). The 
most common species in this group is the yeasts Candida sp, the molds Aspergillus 
sp and Pneumocystis jirovecii (MURRAY et al., 2013). Infections caused by 
pathogenic fungi (mycoses) can be classified into 3 groups namely superficial, 
subcutaneous and systemic (ROBERTS et al., 1990).  
Superficial infections are the most common and are responsible for a great 
deal of morbidity in the general population (ROBERTS et al., 1990). The major 
superficial mycoses which may affect the hair, skin, nail and mucous membranes 
are: ringworm caused by dermatophytes, candidiosis caused by species of Candida 
and Pityriasis versicolor caused by Malassezia furfur (ROBERTS et al., 1990). 
Superficial fungi can be grouped according to their habitats into anthropophilic, 
zoophilic and geophilic organisms (HAVLICKOVA et al., 2008). 
Anthropophilic fungi generally cause superficial dermatomycoses which are 
characterised by relatively low inflammatory activity because of an immunological 





1993). Household dust may serve as a reservoir of antropophilic dermatophytes 
which can preserve dermatophyte spores for years (HAVLICKOVA et al., 2008).  
Zoophilic germs are found in animals, but are also sporadically transmitted to 
humans by cats, dogs (Microsporum canis), guinea pigs and rabbits (Trichophyton 
mentagrophytes var. granulosum) (HAVLICKOVA et al., 2008). They are associated 
with highly inflammatory and infectious skin infections (HAVLICKOVA et al., 2008). 
Geophilic fungi grow in the soil and only intermittently infect humans (MACURA, 
1993). The result of which varies from high to low inflammation (HAVLICKOVA et 
al., 2008). Microsporum gypseum strains which are common geophilic pathogens 
are more virulent when isolated from humans than those isolated from the soil and 
occasionally causes an epidemic spread under favourable growth conditions 
(FARAH et al., 2000).  
A high number of superficial fungal infections of the skin are caused by five or 
six species of dermatophytes, of which Trichophyton rubrum is the most common 
(ALY, 1994). As described in the clinical manifestations and global patterns of 
superficial fungal infections, the predominant species of dermatophytes vary 
according to their clinical localisation (FREEDBERG et al., 2003). Most of the basic 
fungal skin infections are caused by dermatophytes and the major clinical 
manifestations are detailed below (HAVLICKOVA et al., 2008). 
Tinea corporis (ringworm of the glabrous skin) 
This affects the trunk, often in exposed areas like the abdomen or limbs, 
causing red patches (HAVLICKOVA et al., 2008). It is more often seen in children 
than in adults and occurs most frequently in hot climates (MACURA, 1993). 
Dermatophytes of the genera Trichophyton and Microsporum are the most common 
causative agents (HAVLICKOVA et al., 2008).  
Tinea capitis (ringworm of the scalp) 
This is a dermatophyte infection of the scalp and hair and seems to affect 
young children globally (MACURA, 1993). Presentation depends on the aetiology 
and can be non-inflammatory, inflammatory or black dot type. The non-inflammatory 
form is most commonly caused by M. audouinii or M. ferrugineum and usually begins 
as a small erythematous papule surrounding a single hair shaft, which spreads to 





(HAVLICKOVA et al., 2008). The inflammatory type is usually associated with 
zoophilic or geophilic germs such as M. canis and M. gypseum respectively 
(HAVLICKOVA et al., 2008). Black dot Tinea capitis (ringworm of the scalp and hair) 
is caused by T. tonsurans or T. violaceum. The fungus Trichophyton verrucosum is 
highly contagious and virulent and is the only dermatophyte with the ability to grow 
well at 37ºC (HAVLICKOVA et al., 2008). Ringworm of the scalp and hair caused by 
T. verrucosum can result in irreversible scarring and alopecia (HAVLICKOVA et al., 
2008). It is widespread and a well-known occupational disease of cattle keepers 
(MACURA, 1993). 
Tinea cruris (ringworm of the groin) 
This presents as an itchy red rash in the groin and surrounding area and is 
prevalent in young men living in a warm climate (MACURA, 1993). It can coexist 
with Tinea pedis (athlete’s foot) if the infection is spread by scratching the feet and 
then the groin (HAVLICKOVA et al., 2008). The most common agents are 
Epidermophyton floccosum, T. mentagrophytes and T. rubrum (HAVLICKOVA et al., 
2008). 
Tinea unguium (onychomycosis, nail infections) 
The causative agents of onychomycosis include dermatophytes, Candida spp 
and non-dermatophytic molds (HAVLICKOVA et al., 2008). Dermatophytes are the 
most common culprits of onychomycosis in temperate Western countries, while 
Candida and non-dermatophytic molds are more frequently involved in countries with 
a hot and humid climate (CHI et al., 2005). Trichophyton rubrum is the most 
common dermatophyte associated with onychomycosis. Others include T. 
interdigitale, Epidermophyton floccosum, T. violaceum, M. gypseum, T. tonsurans, 
and the cattle ringworm fungus, T. verrucosum (MACURA, 1993). The fungus T. 
soudanense is considered by some to be an African variant of T. rubrum rather than 
a full-fledged separate species. It should be noted that T. interdigitale is still 
sometimes referred to as T. mentagrophytes var. interdigitale. The latter should be 
used to describe the zoophilic form of the dermatophyte, and T. interdigitale used to 
describe its anthropophilic form (HAVLICKOVA et al., 2008). Recent genetic 
research has shown that T. mentagrophytes var. granulosum is the same as T. 





(MACURA, 1993) and non-dermatophytic molds, in particular members of the 
genera Scytalidium (now Neoscytalidium), Scopulariopsis and Aspergillus.  
Tinea pedis (athlete’s foot) 
This is a very common infection which occurs in one out of five adults and the 
incidence increases with age from adolescence (MALE, 1990). It occurs more 
frequently in people who wear occlusive shoes (MACURA, 1993). It may be 
associated with several different fungi which includes yeasts, the most common 
being T. rubrum and T. interdigitale (formerly T. mentagrophytes var. interdigitale). 
The incidence of Tinea pedis (athlete’s foot) has increased in the developed world 
during the past 30 years and its prevalence is around 10% (NELSON et al., 2003). 
The “One hand two feet syndrome” is characterised by dermatophyte infection of 
both feet and one hand is common in patients with lower immunocompetence 
(HAVLICKOVA et al., 2008). The condition is frequently associated with T. rubrum. 
 
2.4.5. Nail infections caused by fungi 
Dermatophytes are the most common nail pathogen and only 3 species are 
often responsible for nail infections (ROBERTS et al., 1990). Dermatophyte infection 
of the nails is associated with athlete’s foot (ROBERTS et al., 1990). There is a 
spread of ringworm infection from the skin of the feet, usually toe webs to toe nails 
and other parts of the body like groin, hands and fingernails (ROBERTS et al., 
1990). Hence, dermatophytoses of the nails is often associated with current or past 
ringworm infection of the feet and it spreads with the use of communal bathing 
places and its prevalence is highest in adult males (ROBERTS et al., 1990). The 
widespread occurrence of T. rubrum nail infections could be a reflection of the 
persistent nature of skin infections resulting from this species, its relative resistance 
to therapy and its ability to invade nail keratin better than other species (ROBERTS 
et al., 1990).  
All species of fungus responsible for nail infections are endemic on the floors 
of communal places. Thus, the incidence of infection is high in regular users of 
public/communal facilities; these include regular swimmers, sportsmen, coal miners, 
members of the armed forces and any other regular user of communal showers and 





predominantly due to Candida species, particularly Candida albicans (ROBERTS et 
al., 1990). These organisms are commensals of the mouth, gastrointestinal tract, the 
vagina and to a lesser extent the skin. There is no concrete evidence that yeasts are 
keratinolytic (ROBERTS et al., 1990). However, it is likely that they have some 
proteolytic activity which destroys the integrity of the keratin (ROBERTS et al., 
1990). In chronic paronycia, a chronic inflammation beneath the nail fold and 
secondary disruption of the nail plate, C. albicans is the predominant organism 
(ROBERTS et al., 1990). Dermatophytes slowly destroy the nail keratin, causing the 
nail to crumble and T. rubrum is the most common nail pathogen (ROBERTS et al., 
1990). Fungal skin infections are treated with topical preparations containing azoles 
which may be in the form of creams, lotions, sprays but are not specifically 
formulated for nail infection as the vehicle does not allow adequate penetration of the 
antifungal agent into the nail and hence are not recommended (ROBERTS et al., 
1990).  
2.4.6. Treatment of Mycosis  
Azoles are the most widely used antifungals in clinical practice, and thus are 
also the most studied by the scientific community regarding their mode of action, 
pharmacological properties, and the resistance mechanisms which have been 
developed by microorganisms (VANDEPUTTE et al., 2012). Azole antifungals are 
also highly researched by pharmaceutical companies, who seek to improve their 
efficacy and to develop the perfect antifungal (VANDEPUTTE et al., 2012). Azoles 
are cyclic organic molecules which can be divided into two groups on the basis of the 
number of nitrogen atoms in the azole ring (Fig 2.1): the imidazoles contain two 
nitrogen atoms, and the triazoles contain three nitrogen atoms (MAERTENS, 2004). 
Azole drugs target the ergosterol biosynthetic pathway of the fungus by 
inhibition of a key enzyme, the lanosterol 14-alpha demethylase, encoded by the 
ERG11 gene (VANDEPUTTE et al., 2012). This inhibition occurs through the binding 
of the free nitrogen atom of the azole ring to the iron atom of the heme group of the 
enzyme (VANDEPUTTE et al., 2012). This results in the accumulation and 
metabolism of 14-alpha methylated sterol species and gives impetus to the synthesis 
of toxic compounds, which are unable to successfully replace ergosterol 
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In 1944, the first azole was synthesized by Woolley (WOOLLEY, 1944), but it 
was not considered as a potential antifungal agent by the scientific community until 
1958 (VANDEPUTTE et al., 2012). Clotrimazole, econazole, and miconazole were 
made available for treatment in the late 1960s (FROMTLING, 1988). Their use was 
however restricted to external application as a result of their high toxicity when 
administered orally (BURGESS and BODEY, 1972; TETTENBORN, 1974). In 1968, 
miconazole became the first antifungal made available for parenteral injection, but 
due to its toxicity and relatively limited range among fungal species (HEEL et al., 
1980), its use decreased to the point that it was no longer commercialized 
(VANDEPUTTE et al., 2012).  
In the 1970s, a new class of antimycotic drugs was developed, the azoles. 
The first azole made available for systemic use was clotrimazole. However, its use 
was limited largely because of its irregular concentrations in the blood. Miconazole 
was the first effective azole for systemic infections, but its shortcoming is that it could 
only be given intravenously and it offered few advantages over amphotericin, aside 
from lessened toxicity (STEVENS, 1977). The first azole to be orally available was 
ketoconazole and it showed consistent blood levels (BORELLI et al., 1979).  
In 1981, the Food and Drug Administration (FDA) approved a new antifungal 
known as ketoconazole which was developed by HEERES and his co-workers 
(HEERES et al., 1979). Susceptibility to ketoconazole was documented for various 
Candida species. Ketoconazole also shows activity against dermatophytes. This 
drug was the only antifungal made available for the treatment of systemic fungal 
infections caused by yeasts for the next ten years (VANDEPUTTE et al., 2012). 
However, there are several drawbacks to this drug as it is poorly absorbed when 
administered orally and no ketoconazole form has ever been developed for 
intravenous injection (VANDEPUTTE et al., 2012).  
Another shortcoming of the drug is that it cannot pass through the 
cerebrospinal barrier and is less active in immunosuppressed patients (VAN DER 
MEER et al., 1980; BRASS et al., 1982; PERFECT et al., 1982; FROMTLING, 
1988). It causes some severe side effects such as a decrease in the level of 
testosterone or glucocorticoids production and liver and gastrointestinal 
complications (PONT et al., 1982; LEWIS et al., 1984; DISMUKES et al., 1985). For 





available for use by clinicians in 1990 and it provided several advantages over the 
use of imidazole (VANDEPUTTE et al., 2012). Fluconazole has a high hydro-
solubility and can therefore be easily injected intravenously (VANDEPUTTE et al., 
2012). It is almost completely absorbed through the gastrointestinal tract, and it 
diffuses throughout the whole body including the cerebrospinal fluid (ARNDT et al., 
1988, BRAMMER et al., 1990). Fluconazole was the gold-standard treatment of 
fungal infections during the 1990s as a result of its good pharmacokinetic properties 
as well as its wide range of activity (VANDEPUTTE et al., 2012).  Unfortunately, 
fluconazole was over-prescribed by physicians for prophylaxis or treatment, this led 
to an increase in resistance to azole drugs (VANDEPUTTE et al., 2012). Moreover, 
fluconazole is almost ineffective against most molds (VANDEPUTTE et al., 2012). 
 Itraconazole was approved and made available by the FDA in 1992 and it 
possesses a broad spectrum of activity across fungal species comparable to 
ketoconazole and wider than fluconazole, but less toxic than ketoconazole 
(VANDEPUTTE et al., 2012). However, itraconazole is hydrophobic and is thus 
more toxic than fluconazole (VANDEPUTTE et al., 2012). Thus, a new itraconazole 
formulation with an enhanced absorption and a decreased toxicity was approved by 
the FDA in 1997 (BARONE et al., 1998) and an injectable formulation of 
itraconazole was made available in 2001 (BOOGAERTS et al., 2001). Fluconazole 
and itraconazole are still not the perfect antifungals as they have some non-
negligible drug interactions with such drugs that are prescribed in chemotherapy or 
with AIDS treatment (VANDEPUTTE et al., 2012). These interactions can lead to a 
decrease in azole concentration or in the worse scenario an increase in toxicity 
(ALBENGRES et al., 1998).  
New generation triazoles have also been developed, voriconazole and 
posaconazole were approved by FDA in 2002 and 2006, respectively. Ravuconazole 
is presently in the clinical trial phase of drug development (VANDEPUTTE et al., 
2012). They possess a wide range of activity as they show good activity against 
several fungus among which are Candida and other dermatophytes (SABO and 
ABDEL-RAHMAN, 2000; CHIOU et al., 2000). While the new generation triazoles 
have been more effective against Candida (CHIOU et al., 2000) as compared to 
classical triazoles, their side effects and drug interactions are similar to those 





Likewise, fungal isolates resistant to the classical triazoles are also cross-resistant to 
the new generation triazoles (VANDEPUTTE et al., 2012). 
In the treatment of fungal infections on the skin, topical medications are 
suitable only for early or mild infections, especially those caused by T. rubrum, the 
main fungus responsible for athlete’s foot (SOARES et al., 2013).  Systemic therapy 
is usually used in nail infections (onychomycosis) and infections caused by zoophilic 
dermatophytes which are the microorganisms involved in the development of 
ringworm of the scalp and hair, and glabrous skin (TANI et al., 2007; WHITE et al., 
2008). The growth of dermatophytes of all genera is inhibited by terbinafine and is 
the main drug of choice for the treatment of dermatophytoses (SOARES et al., 
2013).  
Naftifine and terbinafine are a group of synthetic drugs, the allylamines, which 
were identified with the clinical treatment of superficial mycoses (BALFOUR and 
FAULDS, 1992). Allylamine has been reported to show fungicidal activity against a 
variety of dermatophytes, molds and certain dimorphic fungi, and fungistatic activity 
against Candida albicans (ABDEL-RAHMAN and NAHATA, 1997; MCCLELLAN et 
al., 1999). Its mechanism of action involves blocking the biosynthesis of ergosterol, 
an essential component of the fungal cell membranes through the inhibition of fungal 
squalene epoxidase (ABDEL-RAHMAN and NAHATA, 1997).  
In comparative studies, the incidence of adverse effects related to the use of 
terbinafine orally was lower than that detected in the treatment with griseofulvin and 
similar to that of itraconazole (ABDEL-RAHMAN and NAHATA, 1997). Griseofulvin, 
a weakly fungistatic agent, toxic to fungal cell nuclei has been the mainstay of 
systemic treatment for dermatophyte nail infections for the past 30 years (ROBERTS 
et al., 1990). It is prescribed in a dose of 1g daily to be taken with meals and need to 
be used for a period of 12-18 months in the case of toenail infection and 6-12 
months in the case of fingernail infections (ROBERTS et al., 1990). Although 
Griseofulvin is devoid of serious side effects in the treatment of nail infection, its cure 
rate is approximately 30% making it an imperfect antifungal as it needs to be taken 
for a long period of time (ROBERTS et al., 1990). Ketoconazole is active against 
dermatophytes but in the case of nail infections its use is limited as a result of its side 
effects (ROBERTS et al., 1990). Griseofulvin controls the development of 





(SOARES et al., 2013). Griseofulvin is orally administered and the treatment varies 
depending on the clinical form of the mycosis (GUPTA et al., 2001) and must be 
prolonged in cases where the infection is severe (DEACON, 1998). The drug has 
been reported to interfere with the polymerization of microtubules in its mechanism 
of action and thus causing abnormalities in cell division due to achromatic spindle 
formation and abnormal growth, probably resulting from the disruption of intracellular 
transport associated with microtubules (ODDS, 2003). The imidazole derivatives 
currently represent a major advancement in the oral and topical treatment of 
superficial mycoses (KATZUNG et al., 1998). 
 In the treatment of dermatophytoses, clotrimazole (topical), ketoconazole, 
itraconazole and fluconazole are commonly used as they are easily absorbed 
through the gastrointestinal tract and maintain an effective activity (KATZUNG et al., 
1998). In therapy, antifungal azoles used in the clinic fall into two groups: the 
imidazoles (ketoconazole, clotrimazole, miconazole, and econazole) and triazoles 
(fluconazole, voriconazole, itraconazole and posaconazole) (SOARES et al., 2013). 
The use of imidazoles is limited to the treatment of superficial mycoses while the 
triazoles have a wider application (SOARES et al., 2013).  
Chronic infections of dermatophytoses are treated with intense drugs such as 
terbinafine, itraconazole and fluconazole, which are the most used (ABDEL-
RAHMAN et al., 1998; FERNÁNDEZ-TORRES et al., 2001; FERNÁNDEZ-
TORRES et al., 2003). In an attempt to achieve an increased therapeutic rate of 
treatments, a combination of topical and oral anti-inflammatory drugs has been used 
(SOARES et al., 2013). In recent times, there have been cases of treating 
onychomycosis using topical amorolfine and ciclopirox (GUPTA et al., 2001).  
Itraconazole shows a broad in vitro activity against the dermatiaceous fungi. 
Fluconazole is sensitive and showed resistance against the key dermatophytes 
(OLSEN et al., 2000) but has limited activity against molds and other filamentous 
fungi. Voriconazole which is structurally related to fluconazole shows a spectrum 
similar to that of itraconazole.  
2.4.6.1. Mode of action of antifungals 
There is a large variety of antifungal drugs; their cellular targets are however 
limited due to the similarity that exists between fungi and host cells (SOARES et al., 





(MARTINEZ-ROSSI et al., 2008). Mode of action involves: direct membrane 
damage, disruption of microtubules and inhibition of mitosis, inhibition of other 
processes within the fungal cell such as protein, glucan and ergosterol synthesis (Fig 
2.2) (MURRAY et al., 2013). Ergosterol is the most common sterol found in the 
fungal plasma membrane (MURRAY et al., 2013). Azoles inhibit ergosterol synthesis 
by binding to lanosterol demethylase which is a specific enzyme in ergosterol 
biosynthesis (MURRAY et al., 2013). The active binding site of lanosterol 
demethylase contains a heme domain (HITCHCOCK, 1991; VAN DEN BOSSCHE, 
1991). Azoles bind to the iron atom of the heme domain using a specific nitrogen 
atom in the azole ring nucleus and thus preventing the demethylation of lanosterol 
(JOSEPH-HORNE and HOLLOMON, 1997). Azoles may also target lipids of the 
fungal plasma membranes (JOSEPH-HORNE and HOLLOMON, 1997) and may 
interact with the 3-ketosteroid reductase, an enzyme in methylsterol biosynthesis. 
The principal effect of azoles is to inhibit a cytochrome, P-450, which is dependent 
on the fungal enzyme system and is involved in the final stages of ergosterol 
biosynthesis (ROBERTS et al., 1990).   
The current treatment against the dermatophytoses is based on antifungal 
drugs, mainly the imidazolic derivatives and allylamines (ZIMMERMAM-FRANCO et 
al., 2013). However, various shortcomings have been associated with synthetic 
antifungal drugs which range from its high price, adverse reactions and its slow 
action (ZIMMERMAM-FRANCO et al., 2013). Fluconazole and itraconazole are still 
not the perfect antifungals, since they have some non-negligible drug interactions 
with such drugs that are used in chemotherapy or with AIDS treatment. These 
interactions can result in a decrease in azole concentration or even an increase in 
toxicity (ALBENGRES et al., 1998). In addition to ketoconazole’s rare hepatotoxicity, 
resistance most especially in patients with AIDS was reported (ROSENBLATT et al., 
1980; HORSBURGH and KIRKPATRICK, 1983; WARNOCK et al., 1983; 
RODRIGUEZ-TUDELA et al., 1995). The treatment can also increase the chances 
of recurrence and resistance of strains when the drugs are not properly administered 
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2.4.6.2. Skin disease resistance and other shortcomings of antifungals  
The incidence of resistance to antifungal agents may be increasing 
(DENNING, 1995; JOHNSON et al., 1995; WALSH et al., 2000; DODGSON et al., 
2004; PUJOL et al., 2004; BLIGNAUT et al., 2005) with drug resistant fungal strains 
as a particular common causative pathogen of infection in high-risk patient groups, 
such as HIV/AIDS patients (JOHNSON et al., 1995; PANKHURST, 2001). The 
reports of recurrences of infections are usually attributed to the discontinuation of 
therapy (SOARES et al., 2013). The frequent use of azoles (especially fluconazole) 
in the treatment and prevention of fungal infections has led to reports of emerging 
resistance to antifungal agents (MURRAY et al., 2013). The resistance to azoles has 
been reported in 32% of symptomatic and in 14% of asymptomatic patients 
(REVANKAR et al., 1996; MAENZA et al., 1997; MARTINS et al., 1997). The 
prevalence correlates with the amount of cluster of differentiation 4 (CD4) cells, the 
fungal load, and the duration and doses of therapy (MAENZA et al., 1996). 
VUFFRAY et al., (1994) showed that resistance can also occur in patients with high 
single doses of fluconazole. There is no evidence showing that fungi have the ability 
to destroy or modify antifungal agents as a means of achieving resistance to 
antibiotics (MURRAY et al., 2013). Unlike in bacteria cells, antifungal resistance 
genes are not transmissible from cell to cell (MURRAY et al., 2013).  
The biochemical mechanisms that may be responsible for drug resistance in a 
fungus involves a decrease in drug uptake, structural alterations in the target site 
and an increase in drug efflux or in intracellular target levels, gene amplification, 
gene transfer, gene deletion, point mutations, loss of cis- and trans-acting regulatory 
elements and transcriptional activation (KAMAI et al., 2004). Fungal resistance to 
antifungals develops slowly and involves the emergence of intrinsically resistant 
species or a gradual and stepwise alteration of the functions and structures of the 
fungal cell that leads to resistance to an agent which the species have been exposed 
to (MURRAY et al., 2013).  
It is noteworthy that the use of immune-modulating drugs, concomitant 
infections such as HIV and the nutritional status of the host are more crucial factors 
that determine the outcome of the infection than the ability of an antifungal to inhibit 
or totally destroy the infecting organism (MURRAY et al., 2013). The in vitro 





al., 2013). Intrinsic resistance allows all normal members of a species to tolerate a 
particular drug while acquired resistance means that a resistant strain emerges from 
a population that was previously drug-sensitive (KAMAI et al., 2004). The clinical 
resistance to griseofulvin, or relapses after treatment, is common in 
dermatophytoses (SOARES et al., 2013).  
At present, antibiotics and antifungals play a vital role in the control of fungal 
diseases (SOARES et al., 2013). However, some of these antifungals have 
shortcomings such as toxicity, fungistatic activity and a limited spectrum of action or 
resistance (GARCÍA-SOSA et al., 2011). As a result of these shortcomings, there is 
a need to develop innovative antifungal products of natural origin (ZIMMERMAM-
FRANCO et al., 2013). 
 
2.5. Plants, a source of therapeutic compounds  
The search for plants with therapeutic activities dates back centuries 
(SOARES et al., 2013). Thousands of plants have been used by people of all races, 
in the form of poultices, infusions, decoctions and others (SOARES et al., 2013). 
The increased interest in plants with medicinal properties have resulted into an 
alternative therapeutic approach because of the prospect of isolating substances 
with significant efficacy and a lower side effects (QUEIROZ et al., 2009). Plants have 
been used in medicine for several centuries, having been extensively used in folk 
medicine because they represent an economical alternative and are applicable to 
various pathologies (ROJAS et al., 2006). Plants are an important source of 
biologically active compounds which serve as models for the synthesis of a large 
number of drugs (YUNES and CALIXTO, 2001; SIMÕES et al., 2003).  
Natural products have been a great resource for investigation into drug 
research and thus giving impetus to chemical research and discovery of new drugs 
(CHIN et al., 2006). The success of natural products results from several factors 
which include their great chemical biodiversity and the effects of evolutionary 
pressure in creating biologically active molecules (HARVEY, 2007). These agents 
are synthesized by manipulating the natural product, thus demonstrating that the 
synthesis of molecules can be used to discover and develop novel agents of 
therapeutic value (WILSON and DANISHEFSKY, 2006). Special attention has been 





compounds with antifungal activities in nature (WOJTASZEK, 1997; GURGEL et al., 
2005).  
 
2.5.1. Plants as a potential source of antifungals 
 A high percentage of antifungal drugs have some connection with natural 
products (SOARES et al., 2013). These natural products can be used as therapeutic 
agents, a source of raw materials for synthesis and can serve as prototypes for new 
pharmacologically active models (BRAZIL, 2006). The polyenes and griseofulvin are 
natural products (BUTLER, 2005). Griseofulvin is produced by Penicillium 
griseofulvum (KAR, 2003) while polyenes (amphotericin B and nystatin) were 
isolated from Streptomyces species (DI SANTO, 2000). Pharmacological research 
into medicinal plants and their derivatives serve as a crucial tool for drug 
development (SOARES et al., 2013). Among the antifungal compounds sourced 
from nature are the coumarins. The potential of coumarins as dermatophyte-specific 
antifungal agents has been reported (MERCER et al., 2013).  
The coumarins are a very large class of compounds found throughout the 
plant kingdom (EGAN et al., 1990; EGAN and O’KENNEDY, 1992; FINN et al., 
2002) but abundant in certain plant families including the Rutaceae. Coumarins are 
plant-derived polyphenolic compounds which are best known for their anti-
inflammatory, anti-thrombotic (e. g. warfarin) and vasodilatory properties (RIVEIRO 
et al., 2010). Coumarins have been reported to possess antimicrobial properties 
(DUNCAN et al., 2004; WU et al, 2009; DEKIC et al., 2010; KUMAR et al., 2012). 
Generally, coumarins are poorly water-soluble, but the coumarin glycosides are 
significantly more water-soluble but with reduced/no antimicrobial activity and are 
readily available or can be easily synthesized (LIM et al., 2004).  
Although, the coumarins are distributed throughout all parts of the plant, the 
highest levels of coumarins occur in the fruits, followed by the roots, stems and 
leaves (LACY and O’KENNEDY, 2004). Environmental conditions and seasonal 
changes can influence the natural occurrence of coumarins in different parts of the 
plant (JAIN and JOSHI, 2012). Approximately 1,300 coumarins have been isolated 
from natural sources (MELLO et al., 2003). MERCER et al., (2013) described for the 





using a prodrug approach. A variety of pharmacologically active coumarins and their 
derivatives have been isolated from Rutaceae species. 
 
2.5.2. Isolation of coumarins and other bioactive compounds from Rutaceae 
species 
 Clausena excavata is rich in coumarins and several coumarins have been 
isolated from the plant. HE et al. (2000) reported a O-terpenoidal coumarin named 
excavacoumarin A isolated from the plant. Chemical investigation on the fruits and 
stems of C. excavata led to the isolation and identification of a coumarin, namely 
clausenaexcavin (LAPHOOKHIEO et al., 2009). Lenisin A was isolated from the 
aerial part of C. excavata (HE et al., 2006). The isolation and identification of 
chemical constituents of the leaves of C. excavata cultivated in a greenhouse yielded 
10 new furanonecoumarins named clauslactones A, B, C, D, E, F, G, H, I, and J , 
together with a known carbazole, clauszoline M, and a coumarin, umbelliferone (WU 
and FURUKAWA, 1982). TAKEMURA et al., (2004) reported the presence of a 
dimeric coumarin, diseselin B, and 3 phenylpropanoids, lenisin A-C, together with 
eight O-terpenoidal coumarins, isolated from the aerial part of C. excavata. 
Clausenidin, O-methylmukonal, 3- formyl-2,7-dimethoxycarbazole, and clauszoline-J, 
were isolated from the rhizomes and roots of C. excavata (KONGKATHIP et al., 
2010).  
 HONG et al., (2000) isolated two O-terpenoidal coumarins named 
excavacoumarin A and B from the leaves of C. excavata. Phytochemical 
investigation on the aerial part of C. excavata by HONGPING et al., (2000) led to the 
isolation of six O-terpenoidal coumarins, named excavacoumarins B, C, D, E, F and 
G. XIN et al. (2008) reported that three coumarins containing a C10 terpenoid side 
chain, clauslactones R, S and T, together with 14 known coumarins, were isolated 
from the leaves and stems of C. excavata. The coumarins, excavatins A-M have 
been isolated from C. excavata (THUY et al., 1999). Moreover, four furanone-
coumarins, clauslactones- N, -O, -P and -Q were isolated from the leaves and twigs 
of C. excavata (TAKEMURA et al., 2000). 
 A carbazole alkaloid, clausine-L and 11 known compounds were isolated 
from the leaves of C. excavata (WU and FURUKAWA, 1982). A dimeric coumarin, 





terpenoidal coumarins, were isolated from the aerial parts of Clausena lenis 
(ARBAB et al., 2011). Two geranyl coumarins have been isolated from the leaves of 
Clausena anisata and identified as anisocoumarins I and J (NGADJUI et al., 1991). 
The coumarin, 7-[(2′E,6′E)-7′-carboxy-5′(ζ)-hydroxy-3′-methylocta-2′,6′-dienyloxy]-
coumarin, was isolated from the leaves of C. suffruticosa (BEGUM et al., 2010). 
Clausena dentata contains sabine, biofloractriene, borneol and β-bisabolol 
(RAJKUMAR and JEBANESAN, 2010). 
The leaves of Murraya paniculata yielded four coumarins; auraptene, 
gleinadiene, 5,7-dimethoxy-8-(3-methyl-2-oxo-butyl)coumarins and toddalenone 
(AZIZ et al., 2010). The coumarin 7-methoxy-8-(2′-isovaleryloxy-3′-hydroxy-3′-
methylbutyl) coumarin, also known as murrayatin was isolated from the leaves of 
Murraya exotica (BARIK et al., 1983). Trioxygenated C-8 prenylated coumarin, 
5,6,7-trimethoxy-8-(2′,3′-dihydroxyisopentenyl)-coumarin was isolated from the 
leaves of Murraya gleinei together with the coumarins: meranzin-hydrate, meranzin, 
murralongin, murrangatin and scopoletin (WICKRAMARATNE et al., 1984). The 
ethanolic extract of the fruit of Murraya omphalocarpa yielded coumurrayin, 
mexoticin, 3,5,6,7,3′,4′,5′-heptamethoxyflavone and 5,7-dimethoxy-8-(3′-methyl-2′-
oxobutyl) coumarin (WU et al., 1980).  
Essential oils possess antiviral (HAYASHI et al., 1995), antioxidant (DEANS 
et al., 1992) and anticancer activities (HAILAT et al., 1995; ARUNA and 
SIVARAMAKRISHNAN, 1996) as well as bactericidal effects (DEANS and 
RITCHIE, 1987; DEANS et al., 1992; TASSOU et al., 1995; BARATTA et al., 1998; 
FYFE et al., 1998; MANGENA and MUYIMA, 1999) and are commonly utilized to 
enhance skin beauty and treat skin diseases. The use of essential oil is determined 
by various factors which include chemical, physical, and sensory properties, which 
differ greatly from one essential oil to the other (GEDIYA et al., 2011). Essential oils 
are effective when used topically as they contain very small molecules capable of 
penetrating through the skin, and subsequently act by using their lipophilic fraction to 
react with the lipid parts of the skin cell membranes (ABURJAI and NATSHEH, 
2003).   
Aromatic plants and oils have been used for thousands of years, as incense, 
perfumes, cosmetics, and for their medicinal and culinary applications (ABURJAI 





derived from natural sources such as in plants (GEDIYA et al., 2011). Limonene has 
been reported to inhibit lipopolysaccharide induced inflammation and inflammatory 
cell migration (SOUZA et al., 2003). Limonene has been reported to display strong 
5-lipoxygenase inhibitory activity (BAYLAC and RACINE, 2003). 
MOOLLA (2006) investigated the chemical composition of Agathosma ovata 
essential oil and identified 145 compounds in 10 different samples. They all contain a 
large number of common monoterpenes with very similar compositions and minor 
quantitative variations (MOOLLA, 2006). The similar compounds found in all the 
samples include: sabinene, p-cymene, β-pinene, α-pinene, α-thujene, myrcene, 
limonene, linalool and terpinen-4-ol (MOOLLA, 2006). In all the samples, sabinene 
was the most dominant component ranging between 25.6% and 44.4% (MOOLLA, 
2006). Most of the variations in the chemical compositions were associated with 
flowering and the results obtained revealed that the chemical composition of the 
essential oil of A. ovata is subject to seasonal variation (MOOLLA, 2006). The 
presence of coumarins may be one of the factors responsible for the antimicrobial 
properties of A. ovata (MOOLLA, 2006). Agathosma ovata varies its secondary 
metabolite production in relation to the prevailing climatic conditions (MOOLLA, 
2006).  
The essential oils from the leaves of M. koenigii yielded 39 compounds with 3-
carene (54.22%) as the major compound followed by caryophyllene (9.49%) 
(CHOWDHURY et al., 2008). Other notable compounds in  the essential oil of M. 
koenigii include; caryophyllene oxide (1.02%), 3-phenylbutyrophe-none(1.15%), cis-
sabinenehydrate (1.46%), α-thujene (1.47%), β-elemene (1.92%), γ-elemene 
(1.96%), α-terpinene (2.39%), allyl(methoxy)dimethylsilane (2.58%), γ-terpinene 
(2.7%), 4-terpineol (2.8%), α-caryophyllene (2.81%) and β-myrcene (3.2%) 
(CHOWDHURY et al., 2008).  
The phyto-constituents isolated from the leaves of M. koenigii include 
mahanine (NARASIMHAN et al., 1970), koenine, koenigine, koenidine 
(NARASIMHAN et al., 1975), girinimbiol, girinimibine (ADEBAJO  et al., 2006), 
koenimbine, O-methyl murrayamine A, O-methyl mahanine, isomahanine, 
bismahanine, bispyrayafoline (TACHIBANA et al., 2003) and coumarin glycosides 
(scopotin, murrayanine) (ADEBAJO and REISCH, 2000). The essential oil from the 





and caryophyllene (GOPALAN et al., 1984). The essential oil of M. paniculata 
leaves from the mountains of the Central Region of Cuba yielded eighteen 
compounds, accounting for 95.1% of the total constituent with beta-caryophyllene 
(30%) as the major component (RODRÍGUEZ et al., 2012). 
Essential oil of M. paniculata contains 58 compounds with caryophyllene 
oxide (16.63%), β-caryophyllene (11.81%), spathulenol (10.21%), β-elemene 
(8.94%), germacrene D(6.95%) and cyclooctene, 4-methylene-6-(1-propenylidene) 
(6.37%) as the major components (CHOWDHURY et al., 2008). The other major 
compounds in the M. paniculata essential oil are cyclohexene, 5,6-dietheyl-3-methyl 
(3.30%), δ-elemene (3.57%), α-cubebene (2.96%), retinal (1%), α-caryophyllene 
(3.13%), copaene (2.33%), cubenol (2.36%), nerolidyl acetate (1.20%), 12-
oxabicyclo(9.1.0)dodeca-3,7-diene,1,5,5,8–tetramethyl (2.07%), eremophilene 
(1.54%), ledol (2.2%) and aromadendrene oxide (1.47%) (CHOWDHURY et al., 
2008).  
Thirty compounds, constituting about 99.7% of the Haplophyllum 
tuberculatum oil were identified and the most abundant compounds were α- and β-
phellandrene, limonene, β-ocimene, β-caryophyllene and myrcene (AL 
BURTAMANI et al., 2005). Five simple coumarins namely; umbelliferone, 
scopoletin, 7-isoprenyloxycoumarin, umbelliprenin, and osthenol, and three 
furanocoumarins; columbianetin, angelicin and psoralen were isolated from 
Haplophyllum patavinum (FILIPPINI et al., 1998).  
The root bark of Zanthoxylum dipetalum contained the pyranocoumarins 
avicennol and xanthoxyletin (FISH et al., 1975). Five coumarins, 50-
methoxyauraptene, 6,50-dimethoxyauraptene, 50-methoxycollinin,7-((20E,50E)-70-
methoxy-30,70-dimethylocta-20,50-dienyloxy)coumarin, and 6-methoxy-7-
((20E,50E)-70-methoxy-30,70-dimethylocta-20,50-dienyloxy)coumarin have been 
isolated from the leaves of Z. avicennae (CHO et al., 2012). 
 Two coumarins, hystrixarin and (+)-hopeyhopin were isolated from the roots 
of Citrus hystrix (PANTHONG et al., 2013). Two coumarin glycosides 8-(1-β-D- 
glucopyranosyloxy-1-methylethyl)-8,9-dihydro-2H-furo-[2,3-h]-1-benzopyran-2-one 
and 8-(3-β-D-glucopyranosyloxy-2-hydroxy-3-methylbutyl)-7-methoxy-2H-1-
benzopyran-2-one have been isolated from aqueous extracts of bitter orange flavedo 





2.5.3. Rutaceae species used in traditional medicine for skin related diseases 
and infections 
Carotenoids from citrus fruits help against sun burns and lipid peroxidation in 
human skin cells induced by UV radiation, among others (AUST et al., 2001). In a 
survey of ethnomedicinal plants used against skin diseases in Darjeeling Himalayas, 
the Rutaceae species were among the plants utilised for skin diseases (SHARMA, 
2013). Citrus aurantifolia, C. limonia, C. medica fruits; Evodia fraxinifolia fruit and 
bark; Zanthoxylum nitidum leaf, fruit and seed are used for skin diseases by topical 
application (SHARMA, 2013). Mode of application was topical but in many cases 
also orally and fresh plants were prevalently used and found to be effective 
compared to the dried or stored plant materials (SHARMA, 2013). A mixture of a 
Rutaceae species, Toddalia asiatica (leaves), coconut oil and three other plants is 
applied externally to cure skin diseases among the Kani tribals in southern India 
(AYYANAR and IGNACIMUTHU, 2005).  
Clausena dentata leaves made into paste and mixed with turmeric is applied 
for skin infection (RAJKUMAR and JEBANESAN, 2010). Leaves of Acalypha 
fruticosa, Zanthoxylum chalybeum and Suregada zanzibariensis are pounded 
together and juice extracted from the mixture is applied to the skin to treat skin 
diseases (HEDBERG et al., 1983; CHHABRA et al., 1991). Clausena anisata 
decoction is used in the treatment of skin diseases, 50% aqueous ethanol extract 
exhibited antifungal activity against Aspergillus niger, Microsporum canis and 
Trichophyton mentagrophytes (ASWAL et al., 1984).  
Clausenol, a carbazole alkaloid isolated from alcoholic extracts exhibited 
antifungal activity against Candida albicans (CHAKRABORTY et al., 1995). Vepris 
louisii is used as a cure for skin diseases of bacterial origin (FOCHO et al., 2009). 
Calodendrum capense is popularly used for “African hair and skin” care (LALL and 
KISHORE, 2014). The bark of C. capense is utilised traditionally as an ingredient for 
skin ointment (VAN WYK and GERICKE, 2000). The leaves and bark of C. capense 
is used as a facial mask, in soap preparations and for skin-hyperpigmentation 
problems (MAPUNYA et al., 2012).  
Antifungal activity of ethanol extracts of grapefruit, Citrus paradisis seed and 
pulp was examined against ten yeast strains (CVETNIC and VLADIMIR, 2004). The 





Leaves, fruits, stems, bark and roots of a Rutaceae species, Zanthoxylum 
americanum Mill., were investigated for antifungal activity with eleven strains of fungi 
representing diverse opportunistic and systemic pathogens, including Candida 
albicans, Cryptococcus neoformans and Aspergillus fumigatus (BAFI et al., 2005). 
All extracts demonstrated a broad spectrum antifungal activity and inhibited at least 
eight fungal species in a disk diffusion assay (BAFI et al., 2005). The results provide 
a pharmacological basis for the very widespread use of this plant in the indigenous 
North American ethnomedical tradition for conditions related to fungal infections 
(BAFI et al., 2005).  
The essential oil extracted from the epicarp of Citrus sinensis (L.) Osbeck 
exhibited absolute fungitoxicity against ten post-harvest pathogens (SHARMA and 
TRIPATHI, 2006). Three preparations from the essential oil of Citrus bergamia 
(bergamot natural essence, furocoumarin-free extract and the distilled extract) 
showed antifungal activity against dermatophytes and yeast pathogens (VERZERA 
et al., 2003; ROMANO et al., 2005; SANGUINETTI et al., 2007).The chemical 
composition and antifungal activity of the essential oil of Haplophyllum tuberculatum 
was analysed (AL BURTAMANI et al., 2005). The oil affected the mycelial growth of 
Curvularia lunata and Fusarium oxysporum in a dose-dependent manner, but had no 
effect on the germination of their spores (AL BURTAMANI et al., 2005). Bioassay-
guided fractionation of the hexane/ethyl acetate/water crude extract of the aerial 
parts of Haplophyllum sieversii  was performed after preliminary screening data 
indicated the presence of growth-inhibitory compounds against Colletotrichum 
fragariae, C. gloeosporioides and C. acutatum (CANTRELL et al., 2005). 
The seeds of Calodendrum capense are crushed and boiled to obtain oil that 
is suitable for soap production (LALL and KISHORE, 2014). Oil extracted from Cape 
Chestnut (C. capense) seeds also known as Yangu oil (RAMOROKA and 
MAPUNYA, 2006) has natural UV protection, a high content of fatty acids (especially 
linoleic) and antioxidants (LALL and KISHORE, 2014). The main fatty acids present 
in the oil of C. capense are palmitic, oleic, linoleic and stearic acid (LALL and 
KISHORE, 2014). Apart from the crude plant extracts, essential oil derived from 
various Rutaceae family plants have also been reported to be effective in the 





2.5.4. Sources and components of essential oil 
Essential oils are produced by blossoms, leaves and fruits of different plants 
and stored in special tissues such as glandular hairs, oil cells and oil ducts 
(WALTERS and ROBERTS, 2008). Essential oil is a complex aromatic volatile 
mixture of several compounds with diverse chemical structures (WALTERS and 
ROBERTS, 2008). It is generally believed that the biological activity of an essential 
oil is the result of both its active and inactive substances (WALTERS and 
ROBERTS, 2008). The inactive components may have an influence on resorption, 
skin penetration, rate of reaction, or bioavailability of the active compounds while 
several active components may have a synergistic effect (WALTERS and 
ROBERTS, 2008).   
Many of the substances that make up essential oil are able to penetrate into 
different layers of the skin and even into the blood stream (WALTERS and 
ROBERTS, 2008). The extent of this penetration into the skin explains why essential 
oils often have systemic side effects after topical application on the skin (WALTERS 
and ROBERTS, 2008). The application of undiluted essential oil on the skin may 
cause irritation (WALTERS and ROBERTS, 2008).  
The components of essential oils are important as their qualitative and 
quantitative composition determine the characteristics of the oils, which in turn could 
be responsible for its antimicrobial potentials (DUGO et al., 2000). Citrus essential 
oils contains 85-99% volatile and 1-15% non-volatile components (FISHER and 
PHILLIPS 2008). The volatile constituents are composed of a mixture of 
monoterpene (limonene) and sesquiterpene hydrocarbons and their oxygenated 
derivatives including: aldehydes (citral), ketones, acids, alcohols (linalool) and esters 
(SMITH et al., 2001; BORGMANN et al., 2004; FLAMINI et al., 2007).  
Component(s) of essential oils can only be regarded as volatile if there is a loss of 
weight over a period of time or temperature (FISHER and PHILLIPS, 2008).  
The activation energies for lemon oil, limonene and linalool are 33.2, 37.87 
and 65.64 kJ mol-1 respectively (HAZRA et al., 2002) implying that they are highly 
volatile especially at temperatures above 25ºC (room temperature) (FISHER and 
PHILLIPS, 2008). Evaporation of the oils results from external factors such as 
temperature, humidity, concentration and pressure (AUMO et al., 2006) i.e. the 





temperature (CLARYS et al., 1998), similar to the evaporation of aldehydes such as 
citral (MAKI-ARVELA et al.,  2006).  
In 1970, various chemical compounds (amounting to 200 in total) had been 
described from orange oil of which 100 had been identified (WOLFORD et al., 
1971). Monoterpenes constitute 97% of citrus oil composition with alcohols, 
aldehydes and esters being the lowest percentage components, ranging from 1.8 to 
2.2% (MOUFIDA and MARZOUK, 2003). The major chemical component of citrus 
oils is limonene, ranging from 32 to 98%, with sweet orange containing 68 to 98%, 
lemon 45 to 76% and bergamot 32 to 45% (SVOBODA and GREENAWAY, 2003).  
2.5.4.1. Scientific methods used for the analysis of antimicrobial activities of 
essential oils 
Various methods have been used to analyse the antimicrobial properties of 
essential oils. The antimicrobial effect of essential oils is assessed by in vitro 
screening method, usually that of the disc diffusion method which involves the 
placing of an impregnated (with antimicrobial agent) filter disc on the surface of 
inoculated agar plate and inhibition of growth is observed (BAUER et al., 1966; 
DEANS and RITCHIE, 1987; SMITH-PALMER et al., 1998; SKANDAMIS and 
NYCHAS, 2001; WANNISSORN et al., 2005; FISHER and PHILLIPS, 2006). In the 
late 1950s, this method was adopted for the screening of essential oil vapours by 
placing the filter disc on the lid of the petri dish (MARUZZELLA and SICURELLA, 
1960). Another method of assessing antimicrobial activity is to make a well in the 
inoculated agar and then add the test substance (DEANS and RITCHIE, 1987; 
DORMAN and DEANS, 2000). None of these screening methods is quantitative as 
they only give an indication of the essential oils having antimicrobial properties 
(FISHER and PHILLIPS, 2008).  
The antimicrobial effect of essential oils vapour has been assessed using the 
direct disc diffusion method and the outcome of the assessment indicated that only 
the water-soluble components diffused across the agar while the re-deposition of the 
vapourised components on the surface of the agar accounted for the remainder of 
the inhibition (FISHER and PHILLIPS 2008). The Minimum Inhibitory Concentrations 
(MICs) of essential oils can be assessed by two protocols (FISHER and PHILLIPS, 
2008). Visible growth can be observed using the agar dilution method; while optical 





observed using the broth dilution method (BURT, 2004). The MIC is determined as 
the lowest concentration at which growth is inhibited. The main problem with 
determination of the level of antimicrobial activities of essential oils in this way is their 
hydrophobic nature which makes them insoluble in water-based media (FISHER and 
PHILLIPS, 2008). This problem can be solved by the use of emulsifiers such as 
Tween 20 or 80 alone or in combination with solvents such as acetone, polyethylene 
glycol or ethanol (TASSOU et al., 2000; BURT, 2004; FISHER and PHILLIPS, 
2006). 
 Another factor to consider when determining the MIC of an essential oil is that 
the absolute concentration of inhibition can be between the lowest MIC and the next 
concentration in which growth is observed (FISHER and PHILLIPS, 2008). Minimum 
inhibitory doses (MID), which is the minimum dose of the essential oil volatiles to 
inhibit growth is determined by a parallel method to the MIC (FISHER and 
PHILLIPS, 2008). This is carried out in a sealed container by either placing the 
essential oil on the surface of the container to give a slow evaporation or an 
impregnated disc to give a faster evaporation (INOUYE et al., 2003; FISHER and 
PHILLIPS, 2006). The incubation temperature can have an effect on the microbial 
inhibition when using this method as the MID value is dependent on the evaporation 
rate of the volatile components (FISHER and PHILLIPS, 2008). The differences 
between MIC/MID in studies against the same organism might be as a result of the 
differences in oil composition, which could have ensued from the regional differences 
in temperature, season of oil extraction and the different methods of extraction used 
(BURT, 2004).  
The evaporation rate of essential oil volatiles can be increased by heating. 
However, some of the components of the essential oil can be altered which can in 
turn affect its resulting antimicrobial activities (FISHER and PHILLIPS, 2008). The 
use of water to disperse oils has also been investigated using an air washer and the 
phenolic components of the oil showed a decreased antimicrobial activity. This is 
assumed to be as a result of their poor solubility in water (FISHER and PHILLIPS, 
2008). The water could also reduce their volatility as the essential oil components 
with hydroxyl groups may be more solvated and thus remain in the water phase 





Terpenoids are some of the substances in essential oils (MELLO et al., 2003) 
and terpene compounds from natural vegetable oils are frequently monoterpenes 
(approximately 90% of the volatile oil) and sesquiterpenes (NEGRI et al., 2014). 
Other terpenoids, such as diterpenes, are found only in volatile oils (MELLO et al., 
2003). Studies have shown that terpenoids may have antioxidant and antimicrobial 
properties against pathogenic fungi, including Candida and dermatophytes 
(HAMMER et al., 2000; PAULI, 2006; BARCHIESI et al., 2008; PALMEIRA-DE-
OLIVEIRA, et al., 2009; MARCOS-ARIAS et al., 2011). Studies of three 
preparations from the essential oil of Citrus bergamia (bergamot natural essence, 
furocoumarin-free extract and the distilled extract) showed antifungal activity against 
dermatophytes and yeast pathogens (VERZERA et al., 2003; ROMANO et al., 
2005; SANGUINETTI et al., 2007). 
 Isolated terpenes should be more thoroughly researched in order to establish 
the mechanism of their antifungal activity (NEGRI et al., 2014). The 
pharmacological, biochemical and therapeutic applications of coumarins are solely 
dependent on the particular substitution patterns (MELLO et al., 2003). Bergamot oil 
is directly obtained from the fruit and consists of a volatile fraction (93%–96%), 
whose main components are, with approximate percentages, limonene (40%), 
linalool (8%) and linalyl acetate (28%), and a non-volatile fraction (4%–7%) 
consisting primarily of coumarins and psoralens (i.e., bergamottin, citroptene, 
bergaptene etc.) (VERZERA et al., 2003; ROMANO et al., 2005). The furocoumarin-
free extract (bergaptene-free) and distilled extract (absolutely devoid of non-volatile 
residues) showed more activity than the natural essence against all of the species 
tested (SANGUINETTI et al., 2007).  
It is recommended that essential oil should only be used in diluted forms for 
external application (CLARKE, 2008; WALTERS and ROBERTS, 2008). Essential 
oils differ in their biological activities against various microbial species (WALTERS 
and ROBERTS, 2008). The variation in the susceptibility of bacteria to different 
essential oils may be due to the variable chemical composition, variation in the cell 
wall structure, lipid and protein composition of the cytoplasmic membrane 
(WALTERS and ROBERTS, 2008). The most common application of essential oils 
is topical application to the skin or mucous membranes with direct skin contact in the 





ROBERTS, 2008). Topical application of essential oils results in clinical side effects 
such as allergic contact dermatitis, skin and mucous membrane irritation, 
hyperpigmentation and cytotoxic effects (DE GROOT and FROSCH, 1997; AHMED, 
2001). 
In order to benefit from the therapeutic activity of essential oil and avoid its 
side effects, it must be used with caution and in diluted form. Several essential oil 
have antifungal activities and can be used to treat skin diseases of fungal origin 
because of their notable antifungal activities and pleasant flavours (RAI and 
MARES, 2003). The Rutaceae plant species are known for their scents and their use 
in African traditional medicine systems for the treatment of skin diseases. A variety of 
extracts, tinctures and oil from Rutaceae plant species have been incorporated into 
hair and skin care products. Essential oil and plant extracts have been incorporated 
into some emollients and ointments used in the treatment of skin inflammation and 
oxidative stress which arise from the manifestation and pathogenesis of skin 
diseases. 
 
2.6. Pathogenesis of skin diseases 
The skin offers an efficient permeability barrier system and protects the body 
from microbial invasion and oxidative stress (SCHAFER et al., 2012). The 
dysfunction in the epidermal barrier system is a major contributory factor in the 
physio-pathogenesis of skin diseases, most especially in AD (RAMOS-E-SILVA, 
and JACQUES, 2012). A prolonged topical steroid therapy on the skin increases the 
Transepidermal Water Loss (TEWL) (RAMOS-E-SILVA, and JACQUES, 2012). 
Damage to the skin epidermal barrier function is caused by changes in skin 
permeability as a result of a reduction in the corneal thickness, depletion of the 
intercorneocyte lipid matrix, and a decrease in the number of lamellar bodies in the 
granular layer (SHEU et al., 1997; SHEU et al., 1998). A deeper knowledge of the 
mechanisms that disrupts the skin epidermal barrier system can give impetus to the 
development of therapies that will improve the quality of life of individuals with skin 
diseases by providing a healthier skin (RAMOS-E-SILVA, and JACQUES, 2012).  
The skin is a continuously self-renewing organ, serving as a cover for the 
body surface and separating it from the outside world, providing protection against 





and electromagnetic radiation (BARONI et al., 2012). The skin is divided into two 
major structural compartments: the epidermis and the in-depth dermis or connective 
component of nutrition (BARONI et al., 2012). The epidermis prevents the loss of 
water and other components of the body to the environment (inside–outside barrier) 
and protects the body from a various environmental insults (outside–inside barrier) 
(BARONI et al., 2012). The stratum corneum which is the outermost layer of the 
epidermis provides a permeability barrier that prevents skin desiccation (WERTZ, 
2000; MADISON, 2003).  
 The movement of water from the stratum corneum into the outer environs is 
referred to as transepidermal water loss (TEWL). Measurements of TEWL may be a 
useful parameter for the identification of skin damage caused by certain chemicals, 
and pathologic conditions such as eczema, because the rates of TEWL increase in 
proportion to the level of skin damage (BARONI et al., 2012). The intercellular space 
of the stratum corneum is composed of a unique mixture of lipids (BARONI et al., 
2012) whose function is to counteract the loss of water and salts from the skin and 
the penetration of water-soluble substances and is thus important in the protection of 
the skin (WERTZ and VAN DEN BERGH, 1988; BOUWSTRA et al., 2006). The 
function of cholesterol in the epidermal barrier system could be the provision of a 
degree of fluidity and flexibility to what could otherwise be a rigid and fragile 
membrane system (BARONI et al., 2012).  
TEWL is influenced by the eccrine sweat gland activity and the stratum 
corneum thickness, and the highest TEWL values are observed on the palms, soles, 
and forehead (PINNAGODA et al., 1990). HIV negative individuals have some 
degree of dysfunction in the epidermal barrier system, with an increase in TEWL 
regardless of antiretroviral therapy and even in the absence of xerosis 
(GUNATHILAKE et al., 2010). As a result of HIV infection, there is an increase in 
the production of Th2 (T helper type 2) cytokines which can lead to an increased 
cutaneous permeability by a decrease in the production of ceramides and changes in 
epidermal differentiation (GUNATHILAKE et al., 2010). 
The main components of the epidermal layer of the skin are keratinocytes, a 
few Langerhans cells which are specialized dendritic cells and some melanocytes 
(FELDMEYER et al., 2010). The keratinocytes are responsible for the production of 





RAGHAVAN, 2002). Different types of immune cells such as macrophages, T-cells 
and mast cells are implanted in the connective tissue of the underlying dermis 
(NESTLE et al., 2009). The connective tissue is made up of an extracellular matrix 
which is produced and secreted by fibroblasts, the major cell type of the dermis 
(SORRELL and CAPLAN, 2004). Under homeostatic conditions, the surface of the 
skin is inhabited by a variety of microorganisms (WAGENER et al., 2013).  
However, a dynamic, healthy balance between the epidermis and the micro 
organismal population is controlled by the production of antibiotic and antifungal 
compounds by dermal sebocytes and the microorganisms themselves (WAGENER 
et al., 2013). In addition, keratinocytes produce antibacterial substances after 
infection or injury (GLASER et al., 2005). Some of the keratinocyte-produced 
antimicrobics and cytokines influence the immunological properties of dendritic cells 
and T-cells (NESTLE et al., 2009; FELDMEYER et al., 2010). Hence, the skin 
creates a balance between ensuring a competent pathogen defense and 
immunosurveillance and to reduce excessive immune responses that can result to a 
disease (CONTASSOT et al., 2012).  
Excess reactive oxygen species produce pathological changes in cells and 
tissues such as in inflammatory skin conditions (WAGENER et al., 2013). 
Inflammatory skin diseases range from severe rashes which involve itching and 
redness to chronic conditions such as dermatitis often referred to as eczema 
(WAGENER et al., 2013). Chronic skin inflammation results from a continuous, 
inflammatory response which negatively affects skin health (WAGENER et al., 
2013). Ordinarily, inflammation of the skin is a beneficial and protective process 
which occurs after injury or infection (NESTLE et al., 2009; FELDMEYER et al., 
2010). The skin can however be subjected to excessive inflammatory responses 
which lead to chronic inflammation, auto-inflammation and auto-immunity (NESTLE 
et al., 2009).  
A continuous release of excess ROS in the skin can intensify inflammatory 
injury and promote chronic inflammation (WAGENER et al., 2013). The cellular 
redox balance is controlled by several (enzymatic) antioxidants and pro-oxidants; 
and in the case of chronic inflammation, the antioxidant system may be depleted, 
and this subsequently leads to prolonged oxidative stress (WAGENER et al., 2013). 





damage of biological molecules (such as DNA, carbohydrates, lipids, and proteins) 
and release of inflammatory cytokines (BRIGANTI and PICARDO, 2003; BICKERS 
and ATHAR, 2006). Lipid peroxidation (LPO) is deleterious as it leads to a diffuse 
spread of free radical reactions (CATALÁ, 2009). Membrane lipids, especially 
phospholipids containing polyunsaturated fatty acids (PUFAs) (DEIGNER and  
HERMETTER, 2008), are particularly prone to peroxidation as a result of their 
association within the cell membrane with enzymatic and non-enzymatic systems 
generating pro-oxidative free radical species (BRACONI et al., 2010).  
Under various pathological conditions, an oxidative cascade may be 
generated which can induce cytotoxicity and apoptosis and may have a significant 
role in inflammation, enhancing the release of cytokines and modifying lipoproteins 
to pro-inflammatory forms (GUTTERIDGE, 1988; DEIGNER and HERMETTER, 
2008). LPO products react with sugars, proteins, and DNA (NIKI, 2009). The end 
products of LPO, such as malondialdehyde, 4-hydroxy-2-nonenal (4-HNE), and 4-
hydroxy-2-hexanal (4-HEE) can damage proteins by reacting with various amino 
acids both in vivo and in vitro (CATALÁ, 2009). Oxidative stress causing the 
production of lipid peroxides may thus be a major factor in the development of skin 
inflammatory diseases (BRACONI et al., 2010; SIVARANJANI et al., 2013).  
Generally, it is recognized that a combination of environmental factors such 
as allergens, microbial infection and genetic factors induce the multiple immunologic 
and inflammatory responses seen in AD patients (LÜ et al., 2009). Atopic dermatitis 
is associated with an impaired oxidative status, and systemic alterations in 
antioxidant patterns of the skin have been found in involved skin of AD patients as 
well as in uninvolved non-lesioned skin as an adaptive response to chronic 
inflammation of the epidermis (BRIGANTI and PICARDO, 2003). Filament 
aggregating protein (filaggrin, FLG) is a key protein that plays a major role in the 
formation of the cornified cell envelope, which is crucial for an effective skin barrier 
(CANDI et al., 2005). Studies have shown that loss-of-function (null) mutations in the 
gene encoding FLG leads to skin barrier impairment in AD (MARENHOLZ et al., 
2006; PALMER et al., 2006; WEIDINGER et al., 2006). Many AD patients acquire a 
deficiency of filaggrin with subsequent barrier disruption as a result of the local 





Free radicals mediate lipid peroxidation, which is considered to be a major 
mechanism involved in cell membrane destruction and cell damage (SEN, 1995; 
MITCHELL and COTRAN, 2003). The skin barrier function of the skin occurs almost 
entirely in the epidermis, most especially in its superficial layer, the stratum corneum 
(KALIA et al., 1996). The stratum corneum (SC) consists of a protein component 
(the corneocyte) which provides mechanical resistance to the SC and a medium for 
the extracellular matrix of the SC which is the second component (DARLENSKI and 
FLUHR, 2012). The extracellular matrix consists of multiple layers of lipids (mortar) 
which functions to mediate the permeability barrier against excess water and 
electrolyte loss (DARLENSKI and FLUHR, 2012).  
Hence, a combination of events such as transepidermal water loss, disruption 
of the skin epidermal barrier system, oxidative stress, inflammation and ultimately, 
invasion by microbial pathogens are responsible for the manifestation of skin 
diseases. In view of this, an effective antifungal should encompass all the activities 
needed to restore skin health to normalcy. As a result of the principal role of ROS in 
inflammatory pathologies, the restoration of redox balance forms a ground-breaking 
therapeutic target in the development of new approaches for the treatment of 
inflammatory skin conditions (WAGENER et al., 2013). Nrf2 links antioxidant 
defense mechanisms in the epidermis with the control of skin permeability barrier 
and antimicrobial defense (SCHAFER et al., 2012). The production of ROS and 
ROS-induced oxidation results in the disruption of the skin barrier (THIELE, 2001). 
This implicates that restoration of redox balance through the use of effective 
antioxidant formulations in combination with an effective antifungal could ameliorate 
skin inflammation, reduce transepidermal water loss and thus restore the skin barrier 
function and prevent further invasion by microbial pathogens. Eight Rutaceae 
species were chosen for this study based on the reports of their use in African 
traditional medicinal systems and the scientific reports of their in vitro activities 
against skin diseases of fungal origin. They are: Agathosma betulina (essential oil), 
A. mucronulata, A. ovata, Coleonema album, C. pulchellum, Calodendrum capense, 
Murraya koenigii and M. paniculata. Herbarium specimens have been deposited in 
the University of KwaZulu-Natal (Pietermaritzburg) herbarium. Three fungal strains: 





Microsporum gypseum (ATCC 24102) were chosen for this study based on the 































CHAPTER 3. ANTIOXIDANT ACTIVITY OF SEVEN RUTACEAE 
PLANT LEAF EXTRACTS 
3.1. Introduction 
Oxidative stress is the underlying mechanism of various diseases, and 
convincing evidence has been produced to demonstrate a link between oxidative 
stress (especially lipid peroxidation) and a variety of inflammatory dermatologic 
conditions which include atopic dermatitis (AD) (BANG et al., 2001; BRIGANTI and 
PICARDO, 2003; BICKERS and ATHAR, 2006; BRACONI et al., 2010; 
SIVARANJANI et al., 2013). Oxidative stress causes the production of lipid 
peroxides which is a major factor in the development of skin inflammatory diseases 
(BRACONI et al., 2010; SIVARANJANI et al., 2013).  
There is increasing interest in the use and quantification of antioxidant 
capacity in the pharmaceutical and cosmetic industries (OU et al., 2001). This 
interest results from the enormous evidence of the importance of reactive 
oxygen/nitrogen species (ROS/RON) in aging and pathogenesis of diseases 
(HALLIWELL and ARUOMA, 1991; WINK et al., 1991; NGUYEN et al., 1992; 
STADTMAN, 1994). The skin is a major target of oxidative stress from reactive 
oxygen species (ROS) which originate from the environment and the skin itself 
(TROUBA et al., 2002). An increase in the amount of the oxidants in the body, 
exceeding the antioxidant defence system capacity is referred to as oxidative stress 
which leads to chronic inflammation, and can subsequently cause collagen 
fragmentation and the disorganization of skin cell functions, and thus contribute to 
the manifestation of skin diseases (KRUK and DUCHNIK, 2014).  
Therapeutic approaches with the potential ability to restore antioxidant levels 
in the skin could be achieved by: reducing the ROS production, increasing the 
endogenous antioxidant enzymatic defences, and enhancing the non-enzymatic 
antioxidant defence system through dietary or pharmacological approaches 
(WAGENER et al., 2013). Preparations composed of natural compounds have been 
used for centuries for the treatment of skin conditions (ABURJAI and NATSHEH, 
2003) and has been evaluated for several pharmacological activities, including 






CAO et al., (1993) developed a method called oxygen radical absorbance 
capacity (ORAC). This method is used to measure antioxidant scavenging activity 
against the peroxyl radicals induced by 2,2'-azobis(2-
amidinopropane)dihydrochloride (AAPH) at 37°C (CAO et al., 1993; CAO et al., 
1995). In this method of antioxidant capacity evaluation, B-phycoerythrin (B-PE), a 
protein isolated from Porphyridium cruentum was the chosen fluorescent probe and 
the assay offers exceptional assessment in which the time and degree of inhibition 
are measured as the reaction goes to completion (OU et al., 2001).  
However, the ORACPE has some limitations which include the use of B-PE as 
the probe which gives inconsistency from lot to lot and leads to variations in reactivity 
to peroxyl radicals (CAO and PRIOR, 1999). Furthermore, B-PE is not photo-stable 
and it can be photo-bleached due to its photo-instability; it interacts with polyphenols; 
lack of accessibility due to the rare availability of the FARA COBAS II analyser and 
more importantly, 75% of the cost of ORACPE is for B-PE (OU et al., 2001). Hence, 
in terms of the criteria for method validation and cost-effectiveness, B-PE is 
ineffective as a fluorescent probe and these shortcomings prompted the validation of 
a stable fluorescent probe to substitute B-PE by OU et al., (2001). Researchers used 
fluorescein (FL) (3',6'-dihydroxyspiro[isobenzofuran-1[3H],9'[9H]-xanthen]-3-one) as 
a fluorescent probe and this improved ORACFL method offers a direct measure of 
hydrophilic chain-breaking antioxidant capacity against peroxyl radicals. Contrary to 
PE, FL and its derivatives are frequently utilised fluorescent probes in the labelling 
and sensing of biomolecules (SRUTKOWSKA et al., 1999).  
Several species of the Rutaceae have been analysed for antioxidant activities 
and the remarkable activities displayed by several species of the family has been 
attributed to the presence of secondary metabolites such as coumarins and terpenes 
which exist in abundance in the family. Members of the family are also known to 
have oil glands on the reverse side of their leaves and thus offer a source of 
essential oil which has been incorporated into formulations/creams/lotions. These 
contain active ingredients with therapeutic effects against skin complaints which 
include skin inflammations (YANG et al., 2009; WAGH et al., 2015) which result 
from oxidative stress during the pathogenesis of skin diseases and itching 





Natural antioxidants, such as essential oils seem to have the potential to offer 
considerable protection against oxidative skin damage (RHIND, 2012). Several 
essential oils have anti-oxidant and anti-inflammatory activities, and some appear to 
be significant specifically in relation to the skin as there’s a possibility that anti-
oxidant activity is linked with keratinocyte differentiation, and hence barrier function 
and texture (RHIND, 2012). Essential oils have been reported to have anti-
inflammatory activities and their constituents such as terpene hydrocarbons, 
sesquiterpene hydrocarbons and sesquiterpene alcohols have been reported to 
display 5-lipoxygenase inhibitory activity (ALEXANDER, 2001; BAYLAC and 
RACINE, 2003). Anti-oxidant activity is one of the major and most important 
biological activities attributed to essential oils and is at the root of many other 
properties which include anti-inflammatory activity (RHIND, 2012). However, 
evaluation of the antioxidant activity of essential oil could be problematic as a result 
of the hydrophobic nature of the essential oil which could lead to inaccurate and 
inconsistent results. The aim of this study was to investigate the antioxidant activity 
of leaf extracts of Agathosma mucronulata, A. ovata, Calodendrum capense, 
Coleonema album, C. pulchellum, Murraya koenigii and M. paniculata. 
 
3.2. Materials and methods 
Fresh plant materials (leaves) were sourced from the South African National 
Biodiversity Institute, Kirstenbosch. The sample was freeze-dried, ground into 
powders and stored in air-tight containers at 23±1ºC. 100 mg of the sample was 
dissolved in 1ml of 80% methanol and sonicated for 30 mins. It was subsequently 
filtered using a syringe filter. The antioxidant activity of the leaf extracts was 
determined using the ORAC method according to OU et al. (2001). Briefly, 100 μL of 
500 nM fluorescein and 25 μL of diluted extracts were pipetted into each working 
well of a microplate preincubated at 37°C. Then 25 μL of 250mM 2,2’-azobis(2-
amidinopropane) dihydrochloride (AAPH) was added and the microplate was shaken 
for 5 s on a shaker. The fluorescence (Ex. 485 nm, Em. 510 nm) was read every 3 
min for 90 min. Net area under the curve was used to calculate antioxidant capacity 






The antioxidant activity expressed as trolox equivalents (µmol trolox 
equivalents/g) of C. album and C. pulchellum leaf extracts are recorded in Table 3.1 
The leaf extracts of C. pulchellum had a higher trolox equivalent value (1126.7 ± 
68.1 µmol Trolox Equivalents/g) compared to that of its sister species C. album 
(942.2 ± 34.9 µmol Trolox Equivalents/g). This indicates that C. pulchellum has a 
higher antioxidant activity than C. album. The leaf extract of M. koenigii displayed 
moderate antioxidant activity (339.8±27.7 µmol Trolox Equivalents/g). However, M. 
paniculata displayed a much higher antioxidant activity (930.7±67.7 µmol Trolox 
Equivalents/g) more than double of what was detected for M. koenigii leaf extract. 
The two Agathosma species have remarkable antioxidant activity. The trolox 
equivalents of A. ovata recorded is particularly noteworthy. The values of the ORAC 
are 1045.5±48.8 and 1202.5±92.0 µmol Trolox Equivalents/g for A. mucronulata 
and A. ovata respectively. Calodendrum capense leaf extract displayed moderate 











































 µmol Trolox Equivalents/g 
Agathosma mucronulata 1045.5±48.8 
Agathosma ovata 1202.5±92.0 
Calodendrum capense 301.7±19.1 
Coleonema album 942.2 ± 34.9 
Coleonema pulchellum 1126.7 ± 68.1 
Murraya  koenigii 339.8±27.7 






There is a growing interest toward antioxidants of natural origin (LARSON, 
1988; GAZZANI et al., 1998; VELIOGLU et al., 1998) and increasing evidence 
highlights a connection between oxidative stress with several human chronic 
diseases including inflammation and skin diseases (HALLIWELL et al., 1992). The 
involvement of ROS in the pathogenesis of atopic dermatitis (eczema) has been 
suggested (CHEESEMAN and SLATER, 1993). Oxidative damage of any cellular 
constituent can be a contributory factor to the development of diseases (SIES, 1991; 
DARR and FRIDOVICH, 1994; DREHER and JUNOD, 1996; WISEMAN and 
HALLIWELL, 1996; HALLIWELL and GUTTERIDGE, 1999; DURACKOWA, 2010). 
Hence, the use of natural antioxidant could help to achieve an effective treatment 
against several diseases, including skin diseases.  
According to BASKARAN et al., (2014), C. pulchellum contains biologically 
potent therapeutic phytochemicals with high antibacterial and antioxidant activities. 
The result of this study support the report of BASKARAN et al., (2014) as the leaf 
extracts of C. pulchellum displayed a remarkable antioxidant activity. The fact that C. 
pulchellum leaf extract displayed a higher antioxidant activity compared to C. album 
extract is noteworthy. Caryophyllene and limonene have been reported to display 
strong 5-lipoxygenase inhibitory activity (BAYLAC and RACINE, 2003). Coleonema 
album extracts possessed significant in vitro antioxidant activity (ESTERHUIZEN et 
al., 2006b).  
In this study, C. pulchellum leaf extracts gave higher antioxidant activity 
compared to the C. album extract. The antioxidant activity in an array of different 
natural sources is often attributed to coumarins (MOURE et al., 2001; HEIM et al., 
2002). The presence of coumarins and various structural derivatives in the genus 
Coleonema have been reported in previous investigations (DREYER et al., 1972; 
GRAY, 1981). Coumarins and flavonoids are phenolic compounds and have been 
demonstrated to have potent antioxidant activities as a result of their phenolic 
hydroxyl groups (DEMMIG-ADAMS and ADAMS, 2002) and a suitable structural 
chemistry for free radical scavenging activity (RICE-EVANS and BURDON, 1994). 
The phenolics have received increased attention as a result of the various scientific 
reports indicating a correlation between consumption of food and beverages rich in 





EVANS and BURDON, 1994; MARTINEZ-CAYUELA, 1995; HEINECKE, 1998; 
CHISOLM and STEINBERG, 2000). 
KRUK and DUCHNIK (2014) recommended that the redox balance should be 
considered in the development of new antioxidant strategies connected to the 
prevention and treatment of skin diseases. A relevant contribution (>1 mmol) to the 
total intake of plant antioxidants  can be achieved by consuming a normal diet of 
culinary herbs containing a very high concentration of antioxidants and thus be a 
good source of dietary antioxidants (DRAGLAND et al., 2003). The plants M. 
koenigii and M. paniculata could offer a natural source of antioxidant as a result of 
the good antioxidant activities they both displayed in this study. Dietary and naturally 
occurring antioxidants such as flavonoids, carotenoids, and several vitamins have 
been shown to support skin health and rejuvenation (SCHAGEN et al., 2012). These 
flavonoids, carotenes, vitamins and other curative bio-compounds beneficial to skin 
health can be derived from spices, skin ointments, antifungal formulations from 
natural origin and cosmetics. 
The epidemiological and in vitro studies of medicinal plants strongly support 
the fact that plant constituents with antioxidant activity have the ability to exert 
protective effects against oxidative stress in biological systems (BLOCK and 
PATTERSON, 1992; CAO et al., 1996; NESS and POWLES, 1997; EASTWOOD, 
1999). Many herbs are composed of antioxidant compounds which shields the cells 
against the harmful effects of reactive oxygen species (NARAYANASWAMY and 
BALAKRISHNAN, 2011). A lot of aromatic, medicinal, spice and other plants are 
composed of chemical compounds that exhibit antioxidant properties (VEERU et al., 
2009). All the plants used in this study have the capacity to shield the skin from 
oxidative stress as they displayed good antioxidant activity.  
Although the body is safeguarded by natural antioxidant defence system, 
there is a continuous demand for antioxidants from natural sources (RIMBACH et 
al., 2005). Free radicals formed within the body react with various biological 
molecules such as lipids, proteins and deoxyribonucleic acids resulting in the 
imbalance between oxidants and antioxidants (NARAYANASWAMY and 
BALAKRISHNAN, 2011). Oxidative stress in atopic dermatitis is usually caused by 
an increase in lipid peroxidation and decreased levels of antioxidants 





through the inactivation of lipoxygenase in order to scavenge free radicals and active 
oxygen species (SUDARAJAN et al., 2006). Among the several naturally occurring 
antioxidants; ascorbic acid, carotenoids and phenolic compounds are more effective 
than other compounds (DUH et al., 1999). They are commonly referred to as radical 
scavengers, reducing agents, metal chelators, singlet oxygen quenchers, and 
hydrogen donors (PROESTOS et al., 2006).  
According to MOOLLA et al., (2007), A. ovata (round-leaf) displayed a weak 
anti-oxidant activity, with IC50 values > 100 μg/ml using the DPPH assay. The report 
of MOOLLA et al., (2007) contradicts the result of the antioxidant activity of A. ovata 
in this study. This could be as a result of the inconsistencies of the DPPH method 
which has been reported in scientific literatures to have various shortcomings 
(BRAND-WILLIAMS et al., 1995; ANCEREWICZ et al., 1998; MIN, 1998; 
SANCHEZ-MORENO et al., 1998; ARNAO, 2000; PRIOR et al., 2005). In this 
study, the ORAC method which is presently one of the best methods for the analysis 
of antioxidant activity was adopted. Agathosma species popularly referred to as 
‘Buchu’ in the South African traditional medicine; are rich in flavonoids (MOOLLA, 
2006) which have been extensively reported to have anti-oxidant activities (YAO et 
al., 2004). The antioxidant activity displayed by leaf extracts of A. ovata and A. 
mucronulata in this study supports the reports of YAO et al (2004). 
 
3.5. Conclusions 
 All seven Rutaceae species examined displayed antioxidant activity though 
the degree varies from plant to plant even among plants of the same genera. The 
antioxidant activity of C. pulchellum is particularly noteworthy as its antioxidant 
activity is higher than that of C. album which is popularly utilised in South African 
traditional medicine. The plant A. mucronulata which has not been reported to be 
utilised for medicinal purposed also displayed a good antioxidant activity. The 
antioxidant activity displayed by the plants used in this study make them potential 
sources for combating oxidative stress involved in the pathogenesis of skin diseases. 
It is therefore necessary to investigate these plants for antifungal activity against 






CHAPTER 4. ANTIFUNGAL ACTIVITY OF SEVEN RUTACEAE 
PLANT LEAF EXTRACTS AGAINST TRICHOPHYTON RUBRUM, T. 
MENTAGROPHYTES AND MICROSPORUM GYPSEUM 
4.1. Introduction 
Preparations composed of natural compounds have been used for centuries 
for the treatment of skin conditions and several dermatological disorders such as 
inflammation, photo-toxicity, psoriasis, atopic dermatitis and alopecia areata 
(ABURJAI and NATSHEH, 2003). It has been evaluated for pharmacological 
activities such as immunoreactivity, antioxidant, antimicrobial, anti-inflammatory, and 
antifungal (LI et al., 1988; ROUT et al., 2007; SHARKER and SHAHID, 2009).  
Skin diseases have become a global burden especially in Africa where the 
incidence of skin diseases is worsened as a result of inadequate number of 
dermatologist and adverse weather condition which supports the manifestation of 
these diseases and growth of the fungi responsible. The increasing incidence of 
HIV/AIDS has escalated the occurrence of skin diseases in Africa. In the last thirty 
years, there has been constant progression of mycoses in immunocompromised 
patients (DI SILVERIO et al., 1991). Most of the fungi responsible for the mycoses 
are dermatophytes, mainly Trichophyton mentagrophytes var. mentagrophytes, T. 
mentagrophytes var. interdigitale and T. rubrum (ANDRÉ and ACHTEN, 1987; 
EVANS, 1990; MIDGLEY et al., 1994). The fungi T. rubrum causes various 
superficial infections, which accounts for at least 60 % of dermatophytosis, such as 
ringworm of the scalp and hair, hand, glabrous skin, nail infections and athlete’s foot 
(GRÄSER et al., 2000).  
In different cultures in Africa and across the world, various plants are used to 
enhance beauty and treat various skin diseases which include ringworm/eczema. 
GEDIYA et al., (2011) identified several plants that are used traditionally to cure skin 
diseases and as cosmetics and discovered some of the plants have dual use as 
cosmetics and as cures for skin diseases. Citrus a genus of the Rutaceae is 
popularly known to be often used in the production of skin beauty products and also 
used in the treatment of skin diseases. ADEOGUN et al., (2014) found that Citrus 
aurantifolia and C. medica leaves/fruits are used for the treatment of skin disease in 





in Abeokuta South Local Government of Ogun State Nigeria. Apart from plants of the 
genus Citrus, other plants from the Rutaceae family are utilized in traditional 
medicinal systems for the treatment of skin diseases. The aim and objective of this 
part of the study was to investigate the antifungal activity of the leaf extracts of 
Calodendrum capense, Coleonema album, C. pulchellum, Murraya koenigii and M. 
paniculata against T. rubrum, T. mentagrophytes and Microsporum gypseum. 
 
4.2. Materials and methods 
Fresh plant materials (leaves) were sourced from the University of KwaZulu-
Natal Botanical Garden. The leaves were dried in an incubator at 40ºC for four days. 
Dried leaves were ground into powders and stored in air-tight containers at 23±1ºC 
in the dark. Known quantities of ground leaf samples were extracted non-
sequentially using 100% petroleum ether, acetone, methanol, ethanol and water. 
Different fractions were filtered using a Buchner filter and evaporated to dryness in a 
vacuum concentrator at 30ºC. The extracts were poured into pill vials, left to dry 
under a fan at room temperature and stored in a sterile container in a walk-in fridge 
before use. The dried extracts (25 mg each) were weighed into separate Eppendorfs 
and dissolved in 1 ml of 70% ethanol, sonicated and then used for antifungal 
bioassays. Trichophyton rubrum (ATCC 28188), T. mentagrophytes (ATCC 9533) 
and Microsporum gypseum (ATCC 24102) were purchased from Quantum 
Biotechnologies, Randburg, Republic of South Africa. They were grown on yeast 
malt agar (Y3127). A small portion of a seven-day-old culture was scraped with a 
scapel into McCartney bottles containing yeast malt broth (Sigma Y3752) and 
incubated at 37ºC for 2 (M. gypseum) and 7 days (T. rubrum and T. mentagrophytes) 
respectively. The suspension was adjusted using a spectrophotometer to an 
absorbence of between 0.25 and 0.28 at 530 nm. The fungal inoculum was prepared 
with 1x106 CFU (Colony Forming Units) in the suspension. Susceptibility testing was 
carried out using the micro-dilution method. One hundred microliters of distilled water 
were pipetted into each of the 96 wells in a microtitre plate and a hundred microliters 
of the diluted leaf extract were added to the 1st well of the column and then serially 
diluted down the wells. One hundred microliters of the diluted fungal suspension 
were added to each of the 96 wells. The microtitre plates were subsequently 





(Sigma 58030-1G-F) indicator was added to each well to determine growth inhibition. 
The microtitre wells were observed 30 min to 1 h after the indicator was added. The 
lowest concentration of clear wells was regarded as the minimum inhibitory 
concentration (MIC) values. 50 µl of broth was added to each well immediately after 
the readings were taken. The microtitre wells were incubated at 37ºC for 48 h and 
then observed in order to determine the minimum fungicidal concentration (MFC). 
Ketoconazole and griseofulvin (1 mg/ml each) were used as positive control. The 
assay was repeated at least three times in order to ensure consistency of results.  
4.3. Results 
Antifungal activity of the leaf extracts is expressed in mg/ml and recorded in 
Table 4.1. MIC values ≤1 mg/ml is regarded as good; MIC ≤0.5 mg/ml is regarded as 
remarkable and MIC≤1.5 mg/ml is regarded as moderate. Methanol extract (0.195 
mg/ml) of C. pulchellum and ethanol extract of M. koenigii (0.391 mg/ml) displayed 
remarkable antifungal activity against T. rubrum. Extracts with good antifungal 
activities against T. rubrum are: C. album acetone and methanol extracts (0.781 
mg/ml); M. koenigii acetone and methanol extracts (0.781 mg/ml); M. paniculata 
acetone extract (0.781 mg/ml); and C. capense methanol and ethanol extracts 
(1.172 mg/ml). Methanol extracts of C. album and C. pulchellum (0.391 mg/ml) 
exhibited the best antifungal activity against T. mentagrophytes. Plant extracts with 
good antifungal activities against T. mentagrophytes are: M. koenigii P.E extract 
(0.781 mg/ml); C. capense methanol extract (0.781 mg/ml); and M. paniculata P.E 
and ethanol extracts (1.022 mg/ml).  
Coleonema pulchellum (0.049 mg/ml) and C. album methanol (0.195 mg/ml) 
extracts gave the best antifungal activity against M. gypseum (Table 4.2). Extracts 
with good antifungal activities against M. gypseum are: C. album acetone and 
ethanol extracts (0.390 mg/ml); M. koenigii ethanol (0.391 mg/ml), methanol (0.391 
mg/ml), acetone (0.586 mg/ml) and P.E (0.781 mg/ml) extracts; C. pulchellum 
acetone and ethanol extracts (0.781 mg/ml); C. capense acetone, methanol and 
ethanol extracts (0.781 mg/ml). A total of 16 extracts out of the 20 extracts from the 
five plants inhibited the growth of at least one fungal strain with MIC values ranging 





very poor antifungal activity (results not shown). All the extracts tested displayed 






 Table 4.1: Antifungal activity (MIC values expressed as mg/ml) of leaf extracts of C. album, C. pulchellum, M. koenigii, M. 








































MIC   MFC 
mg/ml 
C. album 3.125 6.250 0.781 6.250 0.781 3.125 1.563 3.125 3.125 6.250 1.172 3.25 0.391 3.125 1.563 6.250 
C. pulchellum 3.125 6.250 3.125 3.125 0.195 3.125 1.563 6.250 6.25 6.250 3.125 6.250 0.391 6.250 1.563 3.125 
Murraya koenigii 1.563 6.250 0.781 6.250 0.781 6.250 0.391 6.250 0.781 6.250 6.250 6.250 3.125 6.250 6.250 6.250 
Murraya paniculata 1.563 6.250 0.781 6.250 1.563 6.250 1.563 6.250 1.022 6.250 1.563 6.250 1.563 6.250 1.022 6.250 
C. capense 1.563 6.250 1.563 6.250 1.172 3.125 1.172 6.250 3.125 6.250 1.563 6.250 0.781 6.250 1.563 3.125 
Ketoconazole Greater than 1.0 






Table 4.2: Antifungal activity (MIC values expressed as mg/ml) of leaf extracts of C. 
















MIC   MFC 
mg/ml 
Acetone 
MIC   MFC 
mg/ml 
Methanol 
MIC   MFC 
mg/ml 
Ethanol 
MIC   MFC 
mg/ml 
C. album 6.250 6.250 0.391 3.125 0.195 3.125 0.391 3.125 
C. pulchellum 




6.250 0.586 6.250 0.391 6.250 0.391 6.250 
Murraya paniculata 
1.172 6.250 1.172 6.250 1.563 6.250 2.344 6.250 
C. capense 
6.250 6.250 0.781 6.250 0.781 3.125 0.781 3.125 
Ketoconazole Less than 1.0 






Extracts of C. album displayed potent and relevant pharmacological activities, 
with a considerable antifungal activity against several strains responsible for 
important infectious diseases (ESTERHUIZEN et al., 2006a). The compounds from 
C. album could be of great pharmaceutical interest for therapeutic application as 
complementary antifungal agents (ESTERHUIZEN et al., 2006a). Its sister species 
C. pulchellum contains phenylpropenes, phenylpropanoids and terpenoids which 
exhibit antimicrobial properties (BRADER et al., 1997).  
  In this study, methanolic extract of C. pulchellum demonstrated good in vitro 
activity against all the three fungi tested indicating the potency of the plant against 
skin disease of fungal origin. Hence, C. pulchellum (methanolic extract) has good 
prospects for the formulation of an effective cure for skin disease. Isolated 
phenylpropenes from C. pulchellum had good antimicrobial activity (BRADER et al., 
1997). The authors attributed the observed antimicrobial activity to the reactivity of 
the phenolic hydroxyl group (BRADER et al., 1997). The compound responsible for 
the antifungal activity of the leaf extracts recorded in this study is not known.  
 n-Hexadecanoic acid a compound isolated from C. album has been identified 
as one of the compounds that possess fungistatic properties against mammalian 
skin pathogens (ESTERHUIZEN et al., 2006a). It has been reported to possess 
antifungal activity against Trichophyton mentagrophytes, a zoophilic skin fungus 
which is responsible for athlete’s foot (WOOD and WELDON, 2002). In this study, 
methanolic extract of C. album exhibited good activity against T. mentagrophytes. 
Similarly, Clausena excavata methanol leaf extract exhibited a remarkable antifungal 
activity against T. rubrum and T. mentagrophytes with MIC values of 62.5 µg/ml and 
31.2 µg/ml (GUNTUPALLI et al., 2013). The compound, n-Hexadecanoic acid could 
probably be responsible for this activity.  
 A wide range of coumarin derivatives have been isolated from C. album 
(DREYER et al., 1972; GRAY, 1981). Pharmacological activities of C. album are 
attributed to its terpenes and coumarins (and their derivatives). These include: 
antithrombotic, antiplatelet (HOULT and PAYA, 1996) and antimicrobial (KAYSER 
and KOLODZIEJ, 1999; LAURIN et al., 1999; LIS-BALCHIN and HART, 2002; 
OKUNADE et al., 2004; ESTERHUIZEN et al., 2006a; LIEBENBERG, 2008) 





as an herbal remedy. Some compounds isolated from this plant have activity against 
several inflammatory mediators (ELDEEN and VAN STADEN, 2008).  
As a result of the medicinal and commercial values of this plant, it is amongst 
the ‘highly sort for’ South African plants. FAJINMI et al (2014) reported that there is 
currently an increase in demand for, and utilization of, C. album in the South African 
traditional medicinal system. Despite the popularity of C. album in the South African 
traditional medicine, its sister species, C. pulchellum has received little or no 
attention. The two plants, C. album and C. pulchellum have similar morphological 
features on the field and can only be distinguished by the colour of their flowers. 
Coleonema album pharmacological activity is well investigated while there is paucity 
of information on the pharmacological activities and medicinal use of C. pulchellum. 
Many South African natural product companies are now pursuing export markets for 
C. album oil, which may put pressure on the plant’s natural populations in the near 
future (FAJINMI et al., 2013). Apart from the development of an effective 
propagation technique and control of harvesting of C. album wild populations, the 
use of another member of the genus with same medicinal value can help reduce the 
pressure on C. album plants and thus prevent the plant from becoming an 
endangered species in the near future. The result of this study reveals the antifungal 
activity of C. pulchellum. It will be necessary to accord C. pulchellum the same 
attention as C. album as it could contain valuable bioactive compounds that can 
combat several diseases of fungal origin.  
Several bioactive compounds such as alkaloids, flavonoids, phenolic 
compounds, proteins, amino acids, flavonoids, indole alkaloids, spiroquinazoline 
alkaloids, coumarins and isoflavanoids have been isolated from M. paniculata (GILL 
et al., 2014). Its pharmacological activities recorded in the literature include 
antifungal activity (LI et al., 1988; ROUT et al., 2007; SHARKER and SHAHID, 
2009). As a result of the characteristic aroma (JAIN et al., 2012; GILL et al., 2014) 
of Murraya koenigii, it is utilised globally as a spice. It has a high medicinal value 
(JAIN et al., 2012) and is utilised in the production of cosmetics. Herbs and spices 
have been utilized to maintain and enhance human beauty for centuries and there is 
growing scientific evidence that these plants have several active ingredients with the 
ability to calm or smooth the skin and ultimately heal, restore and shield the skin 





this study displayed antifungal activity against the skin fungal strains tested and thus 
justify their use in formulations for skin care and cosmetics. 
The Cape Chestnut (C. capense) seed and bark have been reported to be 
used for skin and hair care. The bark is used traditionally as an ingredient in the 
production of skin ointment (VAN WYK and GERICKE, 2000; NOTTEN, 2001) and 
is sold at traditional medicine markets (NOTTEN, 2001). MOKOKA et al., (2010) 
found that C. capense had promising antifungal activity. Lupeol a purified compound 
isolated from the leaves of C. capense exhibited antifungal activity and negligible 
detectable cytotoxicity (SAKONG, 2012). The compound lupeol has been isolated 
from other plant species and is known to exhibit antimicrobial and anti-inflammatory 
activities (SAKONG, 2012). The antifungal activity of C. capense recorded in this 
study could probably be as a result of the presence of lupeol and other antimicrobial 
compounds.  
4.5. Conclusions 
 The result of antifungal activity of the plants used in this study reveals the 
potency of the plants against the skin disease causing fungal strains tested. The 
plants however displayed fungistatic activity. It is therefore necessary to isolate and 
test compounds from the plants that could probably display a fungicidal activity. Also, 
essential oil derived from the leaves of the plants need to be investigated for 
antifungal activity as essential oil has been reported to contain secondary 
metabolites which include terpenes and have been reported in scientific literature to 












CHAPTER 5. ANTIFUNGAL ACTIVITY OF ESSENTIAL OILS 
DERIVED FROM RUTACEAE PLANT LEAVES AGAINST THREE 
SKIN DISEASE FUNGAL STRAINS 
 
5.1. Introduction 
Harmless fungi are always present on the surface of the skin and infection 
occurs only when these organisms gain access into the body (TABASSUM and 
HAMDANI, 2014). These fungi generally live in the dead, top layer of skin cells on 
moist areas of the human body (TABASSUM and VIDYASAGAR, 2013). They are 
capable of penetrating into the cells and subsequently cause itching, swelling, 
blistering and scaling (PING-HSIEN et al., 2007). The infections they cause are 
superficial as they affect the skin, hair, nails and include skin disease such as 
athlete's foot and ringworm (TABASSUM and HAMDANI, 2014). Globally, millions of 
people are affected by superficial fungal infections (TABASSUM and 
VIDYASAGAR, 2013). Skin disease is a health problem that affect all ages from the 
neonates to the elderly and cause harm in a number of ways (TABASSUM and 
HAMDANI, 2014). Several skin diseases such as ringworm caused by 
dermatophytes are common in the tropical and semi-tropical areas of the world 
(TABASSUM and VIDYASAGAR, 2013).  
Essential oils are used throughout the world for the treatment of various 
conditions which include skin conditions, and have fewer side effects compared to 
synthetic drugs (TAVARES et al., 2008). Essential oils may be effective in the 
treatment of skin problems (PEARLSTINE, 2006). The antimicrobial action of 
essential oils is also beneficial in addressing problems related to the skin 
(PEARLSTINE, 2006). Some skin conditions that tend to be responsive to the use of 
essential oils include eczema and other fungal infections (BUCKLE, 2003). Various 
volatile oils from plants have been reported to have medicinal values for skin 
treatment (LIMA et al., 1993).  
Essential oils may be helpful in the treatment of a chronic eczematous lesion 
(BLAMEY, 2000). An eczematous lesion showed significant healing on the 6th day of 
treatment with a combination of tea tree (Melaleuca alternifolia), lemon (Citrus 





(Melaleuca viridiflora) oils (BLAMEY, 2000). The aim and objective of this part of the 
study was to investigate the antifungal activity of essential oil volatiles of Agathosma 
mucronulata, A. ovata, Calodendrum capense, Coleonema album, C. pulchellum, 
Murraya koenigii and M. paniculata against T. rubrum and T. mentagrophytes. 
5.2. Materials and methods 
Leaves of Agathosma mucronulata, A. ovata, Coleonema album, C. 
pulchellum were sourced (in September) from the South African National Biodiversity 
Institute, Kirstenbosch. Calodendrum capense, M. koenigii and M. paniculata leaves 
were sourced from the University of KwaZulu-Natal botanical garden, 
Pietermaritzburg. The leaves were freeze-dried and stored in sealed plastic bags. 
Essential oil was extracted from 20 g each of freeze dried leaves using a soxhlet 
apparatus. The extraction of oil was done according to the Czech Pharmacopeia. 
Trichophyton rubrum (ATCC 28188) and T. mentagrophytes (ATCC 9533) were 
grown in yeast malt broth for one week and the fungal suspension was subcultured 
on fresh yeast malt agar for one week. The plates had a good mycelia growth from 
which 0.3 cm diameter of mycelia was taken. The agar supporting the mycelia was 
sliced off and the mycelia were placed on fresh agar plates. Filter paper was placed 
on the upper lid of the fresh agar petri dishes. The filter paper was impregnated with 
20 µl of essential oil in such a way that the mycelia placed on the agar plate were 
directly exposed to the essential oil volatiles. Plates with similar diameter (0.3 cm) of 
T. rubrum and T. mentagrophytes but without essential oil were used as controls. 
The plates were incubated for a week and the diameter of the mycelia was recorded. 
A formula, Fungal Growth Index (FGI) was used to calculate the percentage increase 
in the size of the mycelia in order to be able to determine the extent of the inhibition 
of the fungi by the EO volatiles. 
 
FGI =   (Final diameter of mycelia – Initial diameter of mycelia) X 100 
   Initial diameter of mycelia 
 
The mycelia from each petri dish were subcultured on fresh agar plates and 
incubated for another seven days at 37ºC in order to determine if the treatments 






The essential oil of A. ovata and A.  mucronulata totally inhibited the growth of 
T. rubrum but did not have a total inhibition on T. mentagrophytes (Table 5.1). The  
T. mentagrophytes mycelia exposed to volatiles from 20 µl of A. ovata and A.  
mucronulata essential oil gave rise to 100 and 133.33% FGI respectively (Table 5.2). 
These inhibitions are moderate as compared with the control that gave FGI of 
233.33%. 
The essential oil volatiles from both C. album and C. pulchellum inhibited the 
growth of T. rubrum in vitro with final mycelia diameter of 0.3 and FGI of 0% (Table 
5.3 and 5.4) each. Essential oil volatiles of C. album showed total inhibition on both 
fungi of T. rubrum and T. mentagrophytes (Table 5.3). However, C. pulchellum 
essential oil volatiles did not yield total inhibition on the growth of T. mentagrophytes 
mycelia as the final mycelia diameter of T. mentagrophytes treated with the essential 
oil volatiles was 0.5 cm resulting in a 66.67% FGI (Table 5.4). Overall, essential oil 
of both C. album and C. pulchellum inhibited the growth of the fungi T. rubrum and T. 
mentagrophytes compared to the final diameter of the mycelia controls of 2.0 and 1.0 
cm respectively. 
Essential oil volatiles of both M. koenigii and M. paniculata inhibited mycelia 
growth of T. rubrum and T. mentagrophytes compared to the control (Table 5.5). 
However, antifungal activity of M. koenigii essential oil volatiles is low compared to 
M. paniculata essential oil volatiles. The FGI of M. paniculata essential oil volatiles 
against both T. rubrum and against T. mentagrophytes was 0% (Table 5.6) indicating 
a total inhibition of mycelia growth of both fungi.  The essential oil volatiles of M. 
koenigii resulted in 366% FGI for T. rubrum and 200% for T. mentagrophytes 
respectively. Hence, M. paniculata essential oil volatiles displayed fungistatic and 
fungicidal effects while M. koenigii essential oil volatiles displayed fungistatic effect 









Table 5.1: The effect of essential oil (20 µl) volatiles of A. mucronulata, A. ovata and 
C. capense on mycelia growth of T. rubrum and T. mentagrophytes after 7 days of 







Table 5.2: Effect of A. mucronulata, A. ovata C. capense essential oil volatiles on 
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Table 5.3: The effect of essential oil (20 µl) volatiles of C. album and C. pulchellum 








Table 5.4: Effect of C. album and C. pulchellum essential oil volatiles on Fungal 



































Fungus tested C. album oil 
FGI (%) 
C. pulchellum 















Table 5.5: The effect of essential oil (20 µl) volatiles of Murraya koenigii and M. 
paniculata on mycelia growth of T. rubrum and T. mentagrophytes after 7 days of 







Table 5.6: Effect of M. koenigii and M. paniculata essential oil volatiles on Fungal 
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Essential oils are known to have several properties which are of great 
importance in skin health (RHIND, 2012). Such properties include skin barrier 
function, maintenance and restoration of texture and hydration levels, reduction of 
inflammation, stimulation of cell regeneration, prevention or control of infections and 
allergic responses and alleviation of itching (RHIND, 2012). ‘Buchu’ (Agathosma 
species) has been an indispensable part of the San and Khoi traditional healing 
culture in the Cape and is still being used for this purpose throughout South Africa 
(MOOLLA et al., 2007). The San people used aromatic plants lubricated with fat to 
keep their skin soft and moist in the desert climate, and as an antifungal agent to 
promote good health through the uptake of aromatic substances by the skin 
(SIMPSON, 1998). The result of this study supports the use of these plants as skin 
antifungal agents.  
Agathosma ovata is still used for medicinal purposes amongst the Cape 
people (VAN WYK and GERICKE, 2000). The antifungal activity of the essential oil 
of A. ovata displayed in this study justifies its use for medicinal purposes. There is 
paucity of information on the antimicrobial activity of A. mucronulata in scientific 
literature. According to JODAMUS and NOTTEN (2002), A. mucronulata is not a 
medicinal plant. Based on the result of this study, the plant should be utilized for 
medicinal purpose just like some notable members of the Agathosma genus. A plant 
that is yet to be utilized as a cure for diseases could be a storehouse of several 
therapeutic substances and could possess remarkable antimicrobial activity. 
Essential oil derived from C. album is incorporated into several skin care 
products including ‘Savane’, an organic anti-aging lift serum which costs up to $100 
per 30 ml. The result of this study shows its ability to also inhibit the growth of skin 
disease fungal strains thus having a dual effect on the skin. The result of this study 
shows the therapeutic value of C. pulchellum essential oil and can thus be used as 
an alternative to C. album in skin care formulations. Antimicrobial activities of 
essential oil have been attributed mainly to its volatile components such as 
monoterpenes which in many cases are the main composition of essential oil. The 
genus Coleonema has been reported to have an abundance of terpenes and other 
metabolites (such as coumarins) and could be at the root of the activity displayed in 





The oil of M. paniculata is utilized externally to treat bruises, eruption and 
incorporated in the soap and perfume industry (PRAJAPATI et al., 2003). The 
essential oil of M. koenigii and M. paniculata have been reported to be used as a 
spice, cosmetics and a cure for skin diseases in different parts of the world. The 
antifungal activity of M. koenigii and M. paniculata recorded in this study could be 
responsible for their effectiveness in the treatment of skin diseases and their use in 
skincare. Murraya paniculata has been reported to contain caryophyllene oxide 
which has antifungal activities (YANG et al., 1999). The essential oil derived from M. 
koenigii is utilized in the soap, cosmetic and aromatherapy industry (RAO et al., 
2011).  
The essential oil from leaves of M. koenigii showed antifungal activity against 
A. niger, A. fumigatus, C. albicans, C. tropicalis, and M. gypseum (SAINI and 
REDDY, 2013). In this study, M. koenigii leaf extracts gave remarkable antifungal 
activity against M. gypseum. However, the essential oil of M. koenigii displayed low 
activity against the two skin fungal strains tested while that of M. paniculata gave 
remarkable activity. The efficacy of essential oil varies and depends solely on the 
type and concentration of the oil, and the tested microbial strain (PUROHIT and 
KAPSNER, 1994; MANGENA and MUYIMA, 1999). Essential oil from several 
species of the family Rutaceae has been reported to exhibit antifungal activity in vitro 
at various degrees. 
The essential oil extracted from the epicarp of Citrus sinensis (L.) Osbeck 
exhibited absolute fungitoxicity against ten post-harvest pathogens (SHARMA and 
TRIPATHI, 2006). BALAKUMAR et al., (2011) reported the potent antifungal activity 
of the essential oil of Aegle marmelos (Correa) leaves against the clinical isolates of 
dermatophytes. The seeds of C. capense are crushed and boiled to obtain oil that is 
suitable for soap production (NOTTEN, 2001; LALL and KISHORE, 2014). Essential 
oil derived from Cape Chestnut seed is popularly known as Yangu oil (RAMOROKA 
and MAPUNYA, 2006) and has natural UV protection. The leaves and bark of C. 
capense is used as a facial mask and in soap preparations (MAPUNYA et al., 2012). 
The result of the antifungal activity of the essential oil of C. capense leaves in this 
study highlight its therapeutic value and can thus be used on the skin just like the oil 
from the seeds of the plant. However, the cytotoxicity profile of the leaves need to be 






The essential oil volatiles from all the species tested in this study displayed 
antifungal activity against T. rubrum and T. mentagrophytes. The degree of 
antifungal activity displayed however varies from one plant to the other and between 
plants of the same genus. The essential oil volatiles which exhibited fungicidal 
effects against the fungi are particularly noteworthy. The essential oil of all the plant 
species which exhibited fungicidal activity can be combined to formulate an effective 
ointment/antifungal that can combat skin diseases associated with T. rubrum. The 
essential oil used in this study can provide a novel source of antifungals for the 
treatment of skin diseases. It is necessary to analyse the essential oil for the 
presence of bioactive compounds as it will help to deduce the compounds that could 























CHAPTER 6. ANALYSIS OF THE ESSENTIAL OIL COMPONENTS OF 
SEVEN RUTACEAE SPECIES 
6.1. Introduction 
Essential oils are composed of volatile, natural, compounds with a strong 
scent, formed by aromatic plants as part of their secondary metabolites (BURTS, 
2004). They are produced by many parts of the plants such as flowers, buds, seeds, 
leaves, twigs, bark, wood, fruit and roots (BAKKALI et al., 2008). In nature, these 
compounds play a crucial role in the protection of the plants as antibacterial, 
antiviral, antifungal and insecticidal agents (RAJENDRAN et al., 2014).  
Essential oils are valuable products of natural origin utilised as raw materials 
in the production of perfumes, cosmetics, aromatherapy oils, medicines, 
phytotherapy oils, spices and nutraceuticals (BUCHBAUER, 2000). Essential oils 
are well known for their various therapeutic properties and are used in the treatment 
of a variety of infections caused by both pathogenic and non-pathogenic 
microorganisms (HAMID et al., 2011). The increasing importance of essential oil in 
pharmaceuticals, aromatherapy oils, and their beneficial role in cosmetics 
(RAJENDRAN et al., 2014) has increased the need to analyse the essential oil 
components of a variety of plants. Essential oils are primarily composed of mono- 
and sesquiterpenes and aromatic polypropanoids (RAJENDRAN et al., 2014).  
The monoterpenes are known to comprise 25 different classes, 
sesquiterpenes are composed of 147 classes and 118 classes of diterpenes exist 
(BAŞER and DEMIRCI, 2007). The term “terpene” was coined by Kekulé in 1880, as 
they were first discovered in turpentine (MOUSSAIEFF et al., 2008). A single 
terpene (monoterpene) is formed from two isoprene units connected head to tail 
(SADGROVE and JONES, 2015). Hemi- (1 isoprene), mono- (2 isoprenes), sesqui- 
(3 isoprenes) and di- (4 isoprenes) terpenes are the most common essential oil 
components, followed by the non-terpenoid group, phenylpropanoids (SADGROVE 
and JONES, 2015).  
In the earlier literature the term “terpene” was often used to describe 
terpenoid compounds which include oxygenated terpenes (SELL, 2010). However, 
in modern terminology “terpene” is used to describe monoterpene hydrocarbons (two 





essential oil is often composed of mono- and sesquiterpenes (RAJENDRAN et al., 
2014). The aim of this part of the study was to analyse the components of essential 
oil derived from the leaves of Agathosma mucronulata, A. ovata, Calodendrum 
capense, Coleonema album, C. pulchellum, Murraya koenigii and M. paniculata. 
 
6.2. Materials and methods 
Leaves of Agathosma mucronulata, A. ovata, Coleonema album, C. 
pulchellum were sourced (in September) from the South African National Biodiversity 
Institute, Kirstenbosch. Calodendrum capense, M. koenigii and M. paniculata leaves 
were sourced from the University of KwaZulu-Natal botanical garden, 
Pietermaritzburg. The leaves were freeze-dried and stored in sealed plastic bags. 
Essential oil was extracted from 20 g each of freeze-dried leaves using a soxhlet 
apparatus. The extraction of oil was done according to the Czech Pharmacopeia. 
The essential oil derived was subjected to analysis using Gas Chromatography Mass 
Spectrometry (GCMS) (Agilent 5975C). Sample injection volume was 1 uL at 50°C 
for 15 min, increase to 250°C - 2°C / min, hold at 250°C for 15 min 
- injection at 220°C 
- column HP-5, 30 µm x 250 mm x 0,25 µm 
- carrier gas He 1ml / min 
- MS detection 
The percentages of the major constituents (≥1.5%) were recorded individually while 
the minor constituents (≤1.5%) were recorded as ‘others’.  
6.3. Results 
Agathosma ovata leaves essential oil yielded  forty-three components with  β-
myrcene (22.03%), 1,6-octadiene-3-ol, 3, 7-dimethyl-2-aminobenzoate (18.75%), 
trifluoroacetyl-lavandulol (12.97%), trans-β-ocimene (11.81%), β-ocimene (5.65%), 
bicyclogermacrene (5.10%), β-phellandrene (3.47%), thujone (2.07%), β-pinene 
(1.88%) and caryophyllene (1.74%) as the major compounds (Table 6.1). The major 
components of A.  mucronulata leaves essential oil are: β-myrcene (34.05%), β-
pinene (18.24%), caryophyllene (7.4%), (1S)-2,6,6-trimethylbicyclo[3.1.1]hept-2-ene 
(6.09%), D-limonene (6.06%), eucalyptol (5.46%), bicyclogermacrene (5.38%), 





β-ocimene  (2.36%) of the thirthy-three components (Table 6.1).  Compounds found 
in essential oil of both  A. ovata and A. mucronulata are trans-β-ocimene, β-ocimene, 
caryophyllene, β-myrcene and bicyclogermacrene.  
The essential oil  of C. capense leaves is composed of sixty- three 
compounds of which cis-β-farnesene (44.30%), naphtalene,1,2,3,5,6,8a-hexahydro-
4,7-dimethyl-1-(1-methylethyl)-,(1S-cis) (4.88%), β-phellandrene (4.07%), 1,6-
cyclodecadiene,1-methyl-5-methylene-8-(1-methylethyl)-,[S-(E,E)] (3.68%), cis-β-
farnesene (3.29%), β-bourbonene (2.87%), caryophyllene (2.86%), gamma-
muurolene (4.01%), bicyclo[5.2.0],nonane,4-methylene (2.03%), isolongifolene, 9,10-
dehydro (1.64%), trans-α-bergamotene (1.59%) and trans-β-ocimene (1.53%) are 
the major components (Table 6.4). 
Caryophyllene (24.91%), trans-β-ocimene (9.49%), β-myrcene (7.96%) and 
octahydro-7-methyl-3-methylene-4-(1-methylethyl)-β-copaene (7.53%) are the major 
components of C. album essential oil while bicyclo[3.1.0]hex-2-ene,4-methyl-1-(1-
methyethyl)-β-phellandrene (32.04%), (+)-3-carene (10.88%), β-ocimene (9.46%), 
gamma-elemene (8.95%) and α-pinene (7.43%) are the major components of C. 
pulchellum essential oil. The components of the oil greater than 1.5%, found in both 
essential oil of C. album and C. pulchellum are caryophyllene, bicyclo[3.1.0]hex-2-
ene,4-methyl-1-(1-methyethyl)-β-phellandrene, α-pinene, gamma-elemene and 
carene (Table 6.2). However, the common bioactive compounds exist in both 
essential oil in different quantities. 
Essential oil of M. koenigii yielded a total of twenty-three components. The 
major components of the essential oil are: caryophyllene (42.54%), (4aR-trans)-
guaia-9, 11-diene (23.35%), alpha-guaiene (10.71%) and humulene (6.93%). The 
sister species, M. paniculata essential oil yielded forty-two components of which 1, 6, 
10-dodecatriene,7,11-dimethyl-3-methylene (38.62%), 1,6-cyclodecadiene,1-methyl-
5-methylene-8-(1-methylethyl) (19.0%), caryophyllene (10.63%), Gamma-elemene 
(8.55%) and bicyclo[3.1.1]hept-2-ene,2,6-dimethyl-6-(4-methyl-3-pentenyl) (5.42%) 
are the major components. Among components greater than 1.5%, there are two 
compounds common to both species (Table 6.3). These compounds are: 
caryophyllene and bicyclo[3.1.1]hept-2-ene,2,6-dimethyl-6-(4-methyl-3-pentenyl). 
However, the two compounds are present in different quantities in the essential oil of 




Table 6.1: List of major compounds present in the essential oils of Agathosma ovata  and A. mucronulata 
 
Agathosma ovata Agathosma mucronulata 
Compound % Compound % 
β-Myrcene 22.03 β-Myrcene 34.05 
1,6-Octadiene-3-ol, 3, 7-dimethyl-2-aminobenzoate 18.75 β-Pinene 18.24 
Trifluoroacetyl-lavandulol 12.97 Caryophyllene 7.4 
Trans-β-Ocimene 11.81 (1S)-2,6,6-Trimethylbicyclo[3.1.1]hept-2-ene 6.09 
β- Ocimene 5.65 D-Limonene 6.06 
Bicyclo germacrene 5.10 Eucalyptol 5.46 
β-Phellandrene 3.47 Bicyclo germacrene 5.38 
D-Limonene 2.79 Trans-β-Ocimene 4.21 
Thujone 2.07 2,4,4-trimethyl-2-vinyl-Guaia-1(10),11-diene 3.00 
β-Pinene 1.88 β- Ocimene 2.36 
Caryophyllene 1.74 Others 7.75 




Table 6.2: List of major compounds present in the essential oils of C. album and C. pulchellum 
 
Coleonema album Coleonema pulchellum 




Trans-β-Ocimene 9.49 (+)-3-Carene 10.88 
β-Myrcene 7.96 β-Ocimene 9.46 
Octahydro-7-methyl-3-methylene-4-(1-methylethyl)-β-
copaene 
7.53 Gamma-Elemene 8.95 
β-Pinene 7.00 α-Pinene 7.43 
(+)-3-Carene 5.98 Caryophyllene 6.98 
Bicyclo[3.1.0]hex-2-ene,4-methyl-1-(1-methyethyl)-β-
phellandrene 
5.97 β-Pinene 5.36 
Bicyclogermacrene 5.11 β-Myrcene 4.47 
Α-Terpineol 3.69 (+)-4-Carene 3.76 
Eucalyptol 2.58 β-Phellandrene 3.73 
1,3,6-Octatriene,3,7-dimethyl-, (Z) -β-Ocimene 2.25 α-Phellandrene 1.60 
Gamma-Elemene 1.84 Others 5.34 




Table 6.3: List of major compounds present in the essential oils of M. koenigii  and M. paniculata 
 
M. koenigii M. paniculata 
Compound  %  Compound % 




Alpha-Guaiene 10.71 Caryophyllene 10.63 






2.22 Cis-beta-Farnesene 3.12 
Naphthalene,decahydro-4a-methyl-1-methylene-7-(1-
methylethylidene) 





























According to MOOLLA (2006), sabinene was the most dominant component 
ranging between 25.6% and 44.4% in all the ten samples of A. ovata oil analysed. 
However, β-myrcene is the major component of the essential oil of A. ovata analysed 
in this study. This could be as a result of the fact that the chemical composition of A. 
ovata essential oil is subject to seasonal variation as reported by MOOLLA (2006). 
The similar components found in all the ten samples of A. ovata essential oil 
analysed by MOOLLA (2006) include: sabinene, p-cymene, β-pinene, α-pinene, α-
thujene, myrcene, limonene, linalool and terpinen-4-ol. In this study, myrcene, 
limonene and β-pinene also form part of the major components of the essential oil 
while, p-cymene and terpinen-4-ol were part of the components in the minor (others) 
category. It is however not know which of the components are responsible for the 
antifungal activity of A. ovata essential oil in this study. The results of MOOLLA 
(2006) revealed that the antimicrobial activity of the essential oil of A. ovata may not 
depend on the level of one component but rather the ratio of several components.  
Globally, there is a growing need to discover a reservoir of medicinal plants 
that are yet to be fully exploited for their medicinal and antioxidant activities. 
Agathosma mucronulata leaves used in this study displayed remarkable antifungal 
(against T. rubrum) and antioxidant activity and it is the first time its medicinal value 
has been recorded in scientific literature. Herbs which have no specific nutritional 
value can also be an important source of antioxidants (WARREN, 1999). In this 
study, A. mucronulata essential oil is composed of compounds such as limonene, 
myrcene and caryophyllene which have been reported previously in literature to 
exhibit antifungal activity. The antifungal compound caryophyllene is also present in 
the essential oil of C. capense. 
The major components of C. album oil are β-phellandrene (29.1%) and 
myrcene (20.5%) among the 43 components characterized (BAŞER et al., 2006). 
However, the major components of the C. album oil analysed in this study are 
caryophyllene (24.91%), trans-β-ocimene (9.49%), β-myrcene (7.96%) and 
octahydro-7-methyl-3-methylene-4-(1-methylethyl)-β-copaene (7.53%). The 
difference could be as a result of the age of plant used and the season of harvest. 
Essential oil from leaves of C. pulchellum sourced from Australia was found to 
consist mainly (50%) of monoterpene hydrocarbons (BROPHY and LASSAK, 1986). 




monoterpenes dominated with 92.2%, 81.4%, and 97.0% in plant samples from the 
Witwatersrand Botanical Garden, Schoenmakerskop (Port Elizabeth) and RAU 
Garden (Johannesburg) respectively. β-phellandrene (17.7%), β-pinene (11.8%), 
linalool (11.8%) and α-pinene (9.7%) were the main components in the 
Witwatersrand Botanical Garden sample; α-pinene (16.8%), sabinene (15.1%), β-
pinene (11.6%) and linalool (10.5%) were the predominant components in the 
Schoenmakerskop essential oil sample and in the RAU gardens sample oil, α-pinene 
(17.4%), β-pinene (13.6%), β-phellandrene (10.3%) and linalool (10.0%) were the 
main constituents (BAŞER et al., 2006).  
α-pinene (7.43%) also formed one of the major components of the C. 
pulchellum essential oil analysed in this study. However, bicyclo[3.1.0]hex-2-ene,4-
methyl-1-(1-methyethyl)-β-phellandrene (32.04%) formed one-third of the oil 
component composition which deviates from what was discovered by BAŞER et al., 
(2006). The difference could be as a result of the age and season of harvest of the 
plant material and the geographical location of the plants. Monoterpene composition 
of the oil of South African C. pulchellum was more than that of the Australian sample 
(BROPHY and LASSAK, 1986). Monoterpenes were the major components of the 
oils analysed by BAŞER et al., (2006). The various reports of essential oil analysis 
available in scientific literature reveals the crucial role climatic and physiological 
factors play in the chemical composition of essential oil. This explains why the 
results of essential oil analysis of these species in the present study differ from what 
has been reported by other researchers. 
Essential oil is a complex mixture of naturally occurring compounds mainly 
monoterpenes and sesquiterpenes and is considered as an alternative natural 
antimicrobial agent (CHEE et al., 2009). The plant M. paniculata has been reported 
to contain caryophyllene oxide which has antifungal activities (YANG et al., 1999). In 
this study, caryophyllene is recorded as one of the major components in both 
essential oil of M. koenigii and M. paniculata (Table 6.3).  This compound is reported 
as one of the major components of essential oil of M. koenigii (GOPALAN et al., 
1984; CHOWDHURY et al., 2008) and M. paniculata (CHOWDHURY et al., 2008; 
RODRÍGUEZ et al., 2012) in most of the literature available. Hence, caryophyllene 







The array of compounds in each of the essential oils of the plants analysed in 
this study have been recorded in various scientific publications to exhibit 
antimicrobial activity. The compounds could have acted synergistically to bring about 
the antifungal activity recorded in chapter 5 of this study. It is not certain if essential 
oil purchased from organic product companies will comprise the same compounds 
and exhibit the same level of antifungal activity. The mode of action of the essential 
oil volatiles on the mycelia growth is also not known. It is therefore necessary to 
investigate the antifungal activity of essential oil derived from two highly utilised 


















CHAPTER 7. ANTIFUNGAL ACTIVITY OF ESSENTIAL OILS OF 
AGATHOSMA BETULINA AND COLEONEMA ALBUM AND ITS 
EFFECT ON THE MORPHOLOGY OF T. RUBRUM AND T. 
MENTAGROPHYTES 
7.1. Introduction 
The use of essential oil to enhance skin beauty is an ancient practice. In this 
age of civilisation, essential oils have diverse application, among which is the 
production of organic beauty products. Hence, if essential oil could enhance skin 
beauty, it can also have therapeutic effects on the skin. Essential oils extracted from 
several plants have been of interest as a result of their potential use as a 
replacement of synthetic antifungal agents. Essential oils are produced by blossoms, 
leaves and fruits of different plants and stored in special tissues such as glandular 
hairs, oil cells and oil ducts (WALTERS and ROBERTS, 2008). Essential oil is a 
complex, aromatic, volatile mixture of several compounds with diverse chemical 
structures (WALTERS and ROBERTS, 2008).  
It is generally believed that the biological activity of an essential oil is the 
result of both its active and inactive substances (WALTERS and ROBERTS, 2008). 
The inactive components may have an influence on resorption, skin penetration, rate 
of reaction, or bioavailability of the active compounds while several active 
components may have synergistic effects (WALTERS and ROBERTS, 2008). 
Essential oils mainly consist of monoterpenes and sesquiterpenes, and are the 
lipophilic secondary metabolites of plants, which are derived from mevalonate and 
isopentenyl pyrophosphate (SPURGEON and PORTER, 1981). Essential oil occurs 
widely in nature with a diversity of terpenoid structures in plants and are generally 
responsible for the plant distinctive scent (PARK et al., 2009).  
Scents emitted from essential oil-bearing organs of plants are often referred to 
as volatiles which are important as scents in plants as they are responsible for the 
attraction of insects to pollinate flowers (ROWAN, 2011). Plants release volatiles 
from their roots, fruit, flowers and leaves (FROST et al., 2008; DICKE et al., 2009). 
Members of the family Rutaceae are known for their distinctive scent and the 
presence of oil glands on the reverse side of their leaves. Essential oil derived from 
several Rutaceae species have been incorporated into skin care products. The 




among the most popularly used medicinal plant in the family Rutaceae in the South 
African traditional medicine system. This has resulted to the local cultivation of these 
plants by farmers, indigenous nurseries and National conservation bodies. Essential 
oil of C. album and Agathosma betulina are marketed by several local and 
international natural product companies. Buchu, Agathosma betulina oil is used for 
medicinal and cosmetic purposes (VAN WYK et al., 1997). Globally, Buchu is highly 
sought after for its essential oil which has a high diosphenol content (MOOLLA et 
al., 2007). MOOLLA and VILJOEN (2008) reported that a kilograme of A. betulina 
oil sells on the international market for about 700 Euros.  
The biological activities of essential oils have been extensively researched 
and several reports exist in the scientific literature. However, the growth and 
morphological changes in the structure of dermatophytes exposed to essential oil 
volatiles/scents is not well documented. The aim of the study was to: investigate the 
effect of ‘commercial’ A. betulina and C. album essential oil on Trichophyton rubrum 
and T. mentagrophytes growth and morphology, and analyse the compounds 
present in the essential oil of the two plants.  
 
7.2. Materials and methods 
7.2.1. Antifungal activity of essential oil volatiles and essential oil analysis 
Essential oil of C. album (EOCM10) and A. betulina (EOBUCB10) were 
purchased from Still Pure, Cilliers Street, Western Cape. Yeast Malt broth (Sigma 
Y3752) and Yeast Malt agar (Y3127) were purchased from Sigma, Trichophyton 
rubrum (ATCC 28188) and T. mentagrophytes (ATCC 9533) were purchased from 
Quantum Biotechnologies, Randburg, South Africa. Agathosma betulina and C. 
album oil (10 µl each) was subjected to analysis using GCMS (same as in section 
6.2 of chapter 6). The percentages of the major constituents (≥1%) were recorded 
individually while the minor constituents (≤1%) were recorded as ‘others’ 
Trichophyton rubrum and T. mentagrophytes were grown in yeast malt broth for one 
week and the fungal suspension was subcultured on fresh yeast malt agar for one 
week. The plate showed good mycelia growth from which 1.4 cm diameter of mycelia 
was taken using an autoclaved pill vial. The agar supporting the mycelia was sliced 
off and the mycelia were placed on fresh agar plates. Filter paper was placed on the 




and 40 µl of essential oil in such a way that the mycelia placed on the agar plate are 
directly exposed to the essential oil volatiles. A plate with similar diameter (1.4 cm) of 
Trichophyton rubrum and T. mentagrophytes but without essential oil was used as 
control. The plates were incubated for a week. The diameter of the mycelia was 
recorded after 7 days of incubation and the Fungal Growth Index (FGI) was 
calculated.  
FGI = (Final diameter of mycelia – Initial diameter of mycelia) X 100 
   Initial diameter of mycelia 
 
The mycelia from each petri dish were subcultured on fresh agar plates and 
incubated for another seven days at the same temperature in order to determine if 
the treatments have a fungistatic or fungicidal effect. 
  
7.2.2. Effect of essential oil volatiles on morphology of fungal mycelia 
Sections from the initial mycelia 1.4 cm used, and the outgrowth after one 
week was prepared for viewing under scanning electron microscope (SEM) (Zeiss 
EVO LS15, Carl Zeiss, Germany). Sections were fixed in 3% buffered glutaraldehyde 
overnight, washed twice in 0.05 M  of sodium cacodylate buffer, dehydrated in 10, 30, 
50, 70 and 90% ethanol for 10 min each and 3 times in 100% ethanol for 10 mins. 
Samples were subjected to critical point drying using a Quorum K850 Critical Point 
Dryer, United Kingdom, mounted on SEM stubs and sputter coated with gold using 
Eiko IB-3 Ion Sputter Coater, Japan. Dried coated samples were viewed with the 
SEM using 2000 and 5000 magnification.  
 
7.3. Results 
7.3.1. Antifungal activity of essential oil volatiles and essential oil analysis 
There was inhibition/reduction of fungal growth in all the plates exposed to 
essential oil volatiles. However, the rates of inhibition varied between the fungal 
species, oil tested and the different volumes tested. The volatiles from A. betulina oil 
has a stronger inhibitory effect than C. album oil volatiles; with the highest inhibition 
recorded in 40 µl. Susceptibility to essential oil volatiles is more pronounced in T. 




recorded in T. rubrum exposed to volatiles from 40 µl of A. betulina oil (Table 7.1) 
with a fungal growth index of 0%, indicating its fungicidal activity (Table 7.2). The 
same volume of A. betulina oil had a fungistatic effect on T. mentagrophytes with a 
FGI of 7% (Table7. 2).  
Mycelia from T. rubrum exposed to 40 µl essential oil volatiles did not grow 
when subcultured on a fresh plate of agar. This is an indication that the volatiles 
totally degraded the hyphae and spores and hence has a fungicidal effect. However, 
all the other petri dishes subcultured produced mycelia after 7 days of incubation. 
Essential oil analysis of A. betulina and C. album using GCMS revealed the 
presence of terpenes. The major components of the essential oil of A. betulina is 1-
menthone (36.35%), D-limonene (29.84%) and 6-methoxy-3(2H)-pyridazinone 
(8.35%) while that of C. album is β-pinene (28.92%), (1R)-2,6,6-
trimethylbicyclo[3.1.1]hept-2-ene (27.37%) and β-phellandrene (22.70%) (Table 7.3). 
The essential oils from both plant species is composed mainly of volatile 
monoterpenes. 
  
7.3.2. Effect of essential oil volatiles on morphology of fungi mycelia  
The mode of action of the essential oil volatiles was revealed using an 
electron microscope. The volatiles inhibited fungal growth by inhibiting the production 
of spores (Figures 7.3 and 7.4). The best mode of action recorded (40 µl A. betulina 
oil) revealed the total destruction of hyphae and spores (Figures 7.3 and 7.5) of T. 
rubrum. This total destruction is irreversible as the subcultured mycelia did not grow 
after 7 days of incubation on fresh agar, thus indicating the fungicidal action of the 










Table 7.1: Effect of A. betulina (Aga oil) and C. album essential oil (Col oil) volatiles 
from different volumes on mycelia growth/diameter of T. rubrum and T. 







































Table 7.2: Effect of A. betulina and C. album essential oil volatiles on Fungal Growth 
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A-Control, B-10 µl A. betulina oil, C- 20 µl A. betulina oil, D-40 µl A. betulina oil , E-10 µl C. album oil ,  
F-20 µl C. album oil, G-40 µl C. album oil 
 Figure 7.1: Effect of A. betulina and C. album essential oil volatiles on mycelia 





























A-Control, B-10 µl A. betulina oil, C- 20 µl A. betulina oil, D-40 µl A. betulina oil, E-Control, F-10 µl  
C. album oil, G-20 µl C. album oil, H-40 µl C. album oil 
Figure 7.2: Effect of A. betulina and C. album essential oil volatiles on mycelia 
growth/diameter of T. mentagrophytes on yeast malt agar after 7 days
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Agathosma betulina Coleonema album 
Compound (%) Compound (%) 
1-Mentone  36.35 β-Pinene 28.92 
 D-Limonene 29.84 (1R)-2,6,6-Trimethyl bicyclo[3.1.1]hept-2-ene 27.37 
6-Methoxy-3(2H)-pyridazinone 8.35 β-Phellandrene 22.70 
1,4,4-trimethyl-3-Ethoxy-4-methoxyphenol 7.25 Trans-β-Ocimene 7.14 
Eucalyptol 4.43 β-Ocimene 4.27 
Cyclohexanone,2-(2-methylpropylidene 3.05 Gamma-Terpinene 1.44 
Pulegone 2.97 (+)-4-Carene 1.37 
β-Myrcene 2.25 Eucalyptol 1.35 
(1R)-2,6,6-Trimethyl bicyclo[3.1.1]hept-2-ene 1.33 р-Cymene 1.09 







































A-Control, B-40 µl A. betulina oil, C- 20 µl A. betulina oil, D-40 µl C. album oil  




























 A- Control, B-40 µl A. betulina oil, C-20 µl A. betulina oil, D-40 µl C. album oil 


















































Essential oils can have a practical use in the inhibition of dermatophyte growth 
(PEREIRA et al., 2011). Trichophyton species produce hyphae which are capable of 
penetrating the innermost skin layer and cause damage in the host (ZURITA and 
HAY, 1987; GUPTA et al., 2003). Hence, researchers are investigating the potential 
of essential oils in inhibiting mycelial growth of pathogenic fungi as a result of their 
importance in the manifestation of mycosis (PEREIRA et al., 2011). 
 In this study, the essential oil volatiles inhibited the production of spores on 
the hyphae. The spores are asexual reproductive structures which can initiate the 
development of skin disease under favourable conditions and are capable of 
transmitting the infections to other individuals. In T. rubrum, asexual sporulation is an 
important means of propagation and the conidia produced asexually are regarded as 
the primary cause of skin disease in humans (LENG et al., 2008). The conidia which 
are a primary means of dispersion also provide a “safe house” for the filamentous 
fungal genome during adverse environmental conditions (LENG et al., 2008). 
Asexual sporulation remains a vital means of reproduction for the fungus T. rubrum 
(LENG et al., 2008). Under favourable conditions, T. rubrum produces several pear-
shaped or club-shaped microconidia, which are assumed to be the primary cause of 
skin and nail infections in humans (KANE, 1997; GUPTA et al., 2003).  
In many filamentous fungi, the production of arthrospores and microconidia 
occurs regularly during the asexual cycle and can be differentiated using their 
morphology and development (COELHO et al., 2008). Microconidia are produced on 
the ends of conidiophores which are formed laterally from the hyphae, while 
arthrospores are formed by the fragmentation of hyphae resulting from prolonged 
cultivation (HOFF et al., 2005). Arthroconidia are genetically programmed 
disarticulation of septate hyphae (RASHID, 2001) which forms both short-chained, 
spherical or oval single arthrospores (HASHIMOTO and BLUMENTHAL, 1977) and 
is considered the major cause of infections in the host (GUPTA et al., 2003).  
Fungal spores (conidia) can lodge in the furrows and crevices of dry, cracked 
skin and subsequently penetrate under the top layers of the epidermis. When 
individuals with skin diseases scratch the area affected, the spores are released unto 
the fingers, nails, palm and surfaces such as bedsheets, carpets, blankets, clothing 
and couch. When fingers and nails with spores are used to touch other parts of the 




the spores bring about skin disease under favourable condition for fungal growth. 
The spores released onto surfaces remain there until they are transferred to an 
individual with a low or compromised immune system and then cause skin disease. 
Hence, skin diseases can be transferred from one member of the family to the other 
through fungal spores. 
Spores are metabolically active cells enhanced with lipid-containing vacuoles 
and intracellular organs and thus have the ability to be resistant to some antifungal 
agents and adverse environmental conditions (YAZDANPARAST and BARTON, 
2006). However, in spite of their importance in pathogenesis and physiology of skin 
disease, the conidia of T. rubrum remain little studied (LENG et al., 2008). The 
studies on T. rubrum focus mainly on issues such as epidemiology, clinical case 
reports, strain relatedness, and drug susceptibilities (KANE, 1997). In this study, the 
inhibitory effect of essential oil volatiles on the production and its deleterious effect 
on the morphology of conidia/spores were demonstrated. This study reveals the 
ability of essential oil volatiles to stop the transmission of skin disease and 
reinfection of treated individuals. 
The components of essential oils are important as their qualitative and 
quantitative composition determine the characteristics of the oils, which in turn could 
be responsible for its antimicrobial potentials (DUGO et al., 2000). Various methods 
have been used to analyse the antimicrobial properties of essential oils. The 
antimicrobial effect of essential oils is determined by in vitro screening methods, 
usually that of the disc diffusion method which involves the placing of an 
impregnated (with antimicrobial agent) filter disc on the surface of inoculated agar 
plates and inhibition of growth is observed (BAUER et al., 1966; DEANS and 
RITCHIE, 1987; SMITH-PALMER et al., 1998; SKANDAMIS and NYCHAS, 2001; 
WANNISSORN et al., 2005; FISHER and PHILLIPS, 2006). In the late 1950s, this 
method was adopted for the screening of essential oil vapours by placing the filter 
disc on the lid of the petri dish (MARUZZELLA and SICURELLA, 1960).  
 Another factor to consider when determining the MIC of an essential oil is that 
the absolute concentration of inhibition can be between the lowest MIC and the next 
concentration in which growth is observed (FISHER and PHILLIPS, 2008). Minimum 
inhibitory doses (MID), which is the minimum dose of the essential oil volatiles to 
inhibit growth is determined by a parallel method to the MIC (FISHER and 




essential oil on the surface of the container to give a slow evaporation or an 
impregnated disc to give a faster evaporation (INOUYE et al., 2003; FISHER and 
PHILLIPS, 2006). The incubation temperature can have an effect on the microbial 
inhibition when using this method as the MID value is dependent on the evaporation 
rate of the volatile components (FISHER and PHILLIPS, 2008). Another method of 
assessing antimicrobial activity is to make a well in the inoculated agar and add the 
test substance (DEANS and RITCHIE, 1987; DORMAN and DEANS, 2000). None 
of these screening methods is quantitative as they only give an indication of the 
essential oils having antimicrobial properties (FISHER and PHILLIPS, 2008).  
In this study, the agar plate method was used in the presence of the fungi 
mycelia. This method was adopted in order to mimic the presence and full 
manifestation of skin disease and thus test if the essential oil volatiles will inhibit the 
spread of the disease or growth of the fungus and its reproductive structures or 
otherwise. The majority of the methods reported in the literature involve subculturing 
of the fungal suspension on fresh agar plates and introducing the essential oil 
volatiles to the plate by placing an impregnated disc near the middle of the agar on 
the upper lid of the petri dish. These methods demonstrate the introduction of the 
essential oil/antifungal and the disease or fungi at the same time. However, in clinical 
practice and traditional medicine, an antimicrobial/antifungal is only prescribed when 
there is an existing disease or infection and there is already a full manifestation of 
the skin disease in which there is the presence of adequate reproductive structures 
(spores) capable of aggravating the degree of the disease. 
The antimicrobial effect of essential oils vapour has been assessed using the 
direct disc diffusion method and the outcome of the assessment indicated that only 
the water-soluble components diffused across the agar while the re-deposition of the 
vapourised components on the surface of the agar accounted for the remainder of 
the inhibition (FISHER and PHILLIPS 2008). The Minimum Inhibitory Concentrations 
(MICs) of essential oils can be assessed by two protocols (FISHER and PHILLIPS, 
2008). Visible growth can be observed using the agar dilution method; while optical 
density, absorbance or viable counts are measured in addition to visible growth 
observed using the broth dilution method (BURT, 2004). The MIC is determined as 
the lowest concentration at which growth is inhibited. The main problem with 
determination of the level of antimicrobial activities of essential oils in this way is their 




PHILLIPS, 2008). This problem can be solved by the use of emulsifiers such as 
Tween 20 or 80 alone or in combination with solvents such as acetone, polyethylene 
glycol or ethanol (TASSOU et al., 2000; BURT, 2004; FISHER and PHILLIPS, 
2006). However, the presence of surfactants has a major influence on the results of 
antimicrobial studies (MATSUZAKI et al, 2013). These reasons prompted the use of 
fungi mycelia and essential oil in the form of volatiles in this study. 
Essential oils are a complex mixture of naturally occurring compounds mainly 
monoterpenes and sesquiterpenes and are considered alternative natural 
antimicrobial agents (CHEE et al., 2009). Evaporation of essential oils results from 
external factors such as temperature, humidity, concentration and pressure (AUMO 
et al., 2006) i.e. the diffusion across a homogenous membrane increases with an 
increase in temperature (CLARYS et al., 1998) and hence determines the level of 
antimicrobial activity in vitro. Volatile components of essential oils have been 
reported to exhibit antifungal effects (JAIN and AGRAWAL, 2002). A naturally 
occurring monoterpene, limonene has been detected in essential oil of several plants 
(PEPELJNAK et al., 2005; SONBOLI et al., 2006). Limonene is a volatile, 
colourless liquid with an intense aroma of oranges (CHEE et al., 2009). Studies have 
shown that terpenes and terpenoids may have antioxidant and antimicrobial 
properties against pathogenic fungi, including dermatophytes (HAMMER et al., 
2000; PAULI, 2006; BARCHIESI et al., 2008; PALMEIRA-DE-OLIVEIRA et al., 
2009).  
The antifungals used clinically in the therapy of skin diseases vary in their 
mode of action. Mode of action involves: direct membrane damage, disruption of 
microtubules and inhibition of mitosis, inhibition of other processes within the fungal 
cell such as protein, glucan and ergosterol synthesis (MURRAY et al., 2013). 
Damage to microorganism membranes, collapse of the proton pump, cytoplasm 
granulation and break down of the electron transport chain are some events possibly 
related to the antifungal property of essential oils (SIKKEMA et al., 1995; COX et 
al., 2000). Several records in the scientific literature worldwide reported that 
macromolecules found in fungi of which functionality is related to growth, survival, 
cell morphogenesis and virulence, are identified as promising targets for new 
antifungal agents (ODDS et al., 2003). However, there is little study related to the 
investigation of compounds, which are responsible for the bioactivities of essential 




  In this study, A. betulina essential oil analysis revealed two monoterpenes as 
the most abundant compounds. Menthone and limonene have been reported to have 
antimicrobial activities in vitro. Menthone had in vitro antibacterial activity against 
Enterobacter aerogenes, Escherichia coli, Klebsiella pneumoniae, Listeria 
monocytogenes, Pseudomonas aeruginosa, Saccharomyces cerevisiae, Salmonella 
typhimurium, Staphylococcus aureus and Staphylococcus epidermidis (ISCAN et al., 
2002; SCHELZ et al., 2006). Menthone showed antifungal activity against Botrytis 
cinerea and is the major antifungal agent in Schizonepeta tenuifolia (LEE et al., 
2007). Hence, the presence of menthone in the A. betulina essential oil used in this 
study could be the reason for its remarkable antifungal activity.  
Limonene is a volatile compound (RANGANNA et al., 1983; POURBAFRANI 
et al., 2010) with antifungal activity (OMRAN et al., 2011).It prevented the growth of 
fungal mycelium within 2 h (MATSUOKA, 1990). Limonene had fungicidal effects on 
T. rubrum, induced changes in its cell membrane integrity and metabolic activity in 
vitro (CHEE et al., 2009). Fungicidal agents are more preferred as compared to 
fungistatic agents for the treatment of fungal infections as the utilization of fungistatic 
agents could lead to recurrence of the infection (CHEE et al., 2009). In this study, A. 
betulina essential oil (40 µl) volatiles displayed fungicidal effects on T. rubrum and 
hence could offer an effective antifungal of natural origin. Its effect on T. 
mentagrophytes is however fungistatic. The variation in the susceptibility of 
microorganisms to essential oils could be as a result of the variation in the cell wall 
structure, lipid and protein composition of the cytoplasmic membrane (WALTERS 
and ROBERTS, 2008).  
The essential oil components of C. album reported in this Chapter is different 
from the profile of the C. album essential oil reported in the previous Chapter 
(Chapter 6). This could be as a result of the difference in sources of the oil as the oil 
analysed in this Chapter was purchased from an organic product company in South 
Africa while the sample used in the previous Chapter was derived from plants 
sourced from the South African National Botanical Garden in Kirstenbosch. The 
source of the C. album leaves from which the essential oil used in this Chapter was 
sourced is not known.  
Harvesting related factors such as season of harvest, geographical location 
and age of the plant at the time of harvest play a crucial role on the essential oil yield 




essential oil (PREEDY, 2015). Cavacrol, the major component of oregano essential 
oil was higher during the drier and warmer season (70.75-84.88%) while several 
other compounds accumulated at higher levels during the wetter and colder season 
along with very low levels of cavacrol (56.46-75.12%) (KARAMANOS and 
SOTIROPOULOU, 2013).  In the essential oil sourced from typically cultivated 
Origanum vulgare (subspecies hirtum), thymol and y-terpinene were the main 
components while the commercial sample showed a different profile as carvacrol 
(˃77%) was the main component (BONFANTI et al., 2012).  
BAŞER et al., (2006) analysed the essential oil of C. pulchellum sourced from 
3 different geographical areas within South Africa and there was slight similarity in 
the major components but there were differences in the levels of the similar 
components. Monoterpenes dominated in all the oil samples tested. Several small 
scale industries use essential oil purchased from commercial companies for the 
production of creams, lotions, soap, body wash and ointments. The antifungal 
activity and bioactive compounds of commercial essential oil was investigated in this 
study in order to compare the antifungal activity and presence of active compounds 
to the essential oil extracted from plants sourced from the garden to the essential oil 
purchased from the commercial companies. Another reason was also to ensure that 
the essential oil purchased commercially contains active ingredients with activities 
that will make its use by the populace worthwhile.  
7.5. Conclusions 
 The laboratory prepared C. album EO gave a remarkable and higher 
antifungal activity(Chapter 5) as compared with the commercial EO (of the same 
species) used in this part of the study. The essential oil volatiles of A. betulina had 
good inhibitory effect on the mycelia growth of T. rubrum and T. mentagrophytes. 
The fungicidal effect of the essential oil volatiles on T. rubrum is noteworthy. The 
mode of action of A. betulina essential oil volatiles on the growth of T. rubrum 
mycelia is through the inhibition of spore growth and production; alteration of the 
morphology by total destruction of the hyphae and spores. Essential oil induced 
different actions on the mycelia at different concentrations. The major components of 
the essential oil of A. betulina, 1-menthone (36.35%) and D-limonene (29.84%) are 




possess antimicrobial activity. The remarkable activity recorded in this study give an 




































CHAPTER 8. GENERAL DISCUSSION 
A combination of inflammatory conditions and an overwhelmed antioxidant 
system could result in pathological levels of ROS and thus, oxidative stress which 
further exacerbates the disease state (WAGENER et al., 2013). Oxidative stress 
plays a crucial role of in pathogenesis of dermatologic diseases (SIVARANJANI et 
al., 2013; KRUK and DUCHNIK, 2014) and affects the defensive systems against 
ROS/RNS (KRUK and DUCHNIK (2014). ROS and RNS are produced during 
normal cellular metabolism, and can be either beneficial or harmful to the organism 
(HALLIWELL and GUTTERIDGE, 1999; TROUBA et al., 2002; VALKO et al., 
2006). Antioxidants block the damaging effects of ROS and can inhibit and/or 
reverse several processes that contribute to epidermal toxicity and disease 
(TROUBA et al., 2002). Eczema or atopic dermatitis’ refers to several persistent skin 
conditions with various hallmarks such as chronic relapsing form of skin inflammation 
(SIVARANJANI et al., 2013; WAGENER et al., 2013), disturbance of the epidermal-
barrier function (SHEU et al., 1997; SHEU et al., 1998; RAMOS-E-SILVA, and 
JACQUES, 2012) which at its climax results in dry skin (SIVARANJANI et al., 
2013).  
Eczema is a chronic inflammatory skin disease which infects individuals 
globally. In most people with eczema, the development of skin inflammation occurs 
first before any skin lesions become visible during the manifestation of the disease 
(SIVARANJANI et al., 2013). The skin is continuously subjected to ROS formation 
through UV irradiation and environmental exposure; and is rich in antioxidant 
systems with the ability to lower the ROS levels (WAGENER et al., 2013). Oxidative 
stress leads to the production of oxidation products, such as 4-hydroxy-2-nonenal or 
malonaldehyde (MEFFERT et al., 1976), which denature proteins, alter apoptosis, 
and cause the release of pro-inflammatory mediators, such as cytokines, which can 
be critical in the induction of inflammatory skin diseases (MEFFERT et al., 1976). A 
decrease in inflammation and an improved rate of recovery could be achieved in the 
treatment of inflammatory skin conditions by targeting oxidative stress (WAGENER 
et al., 2013).  
Vitamin E and vitamin A are lipophilic antioxidants while vitamin C is a water 
soluble vitamin (SIVARANJANI et al., 2013). Vitamin E acts as a chain breaking 




unsaturated lipids of the cell membrane (HAMID et al., 2010). Vitamin C acts to 
neutralize free radicals through the donation of H+ ions to free radical R, (HOSSAIN 
and ASADA, 1985). Vitamin C not only neutralizes the alkoxyl, hydroxyl, and peroxyl 
radicals by donating H+; ascorbate (a form of vitamin C) can also neutralize the 
radical forms of some other antioxidants such as vitamin E and GSH (BUETTNER 
and JURKIEWICZ, 1996). Beta-carotenes display effective scavenging activity 
against alkoxyl and peroxyl radicals (DEBAJYOTHI, 2008). People deficient in 
essential nutrients such as beta-carotene, the vitamin B complex, C and E often 
suffer from the drying of the skin (TABASSUM and HAMDANI, 2014). In the 
treatment of atopic dermatitis, the use of natural antioxidants like vitamins A, C and 
E in combination with corticosteroids and immunosuppressant is a valuable addition 
to the conventional therapy (SIVARANJANI et al., 2013). 
In traditional medicine, plant essential oil, extracts, tinctures and formulations 
are used as a source of antioxidants in the place of beta-carotene and vitamins. 
These whilst inhibiting the growth of the fungi responsible for the skin disease also 
restore skin health by combating inflammation which results from oxidative stress, 
restores the skin barrier function and improve skin texture.  A combination of all 
these functions restores the skin health to normality and in the process adds to skin 
beauty. However, a very important factor to consider is the degree of antifungal 
activity of the plant essential oil, extract, tincture or formulation. A fungicidal activity 
results in better treatment of skin disease as compared to a fungistatic activity as 
fungistatic activity results in prolonged use of an antifungal and can also lead to 
resistance of the organism which is a major problem often encountered in clinical 
treatment of skin diseases. Some of the essential oil tested in this study exhibited 
remarkable fungicidal action. 
The incidence of resistance to antifungal agents may be increasing 
(DENNING, 1995; JOHNSON et al., 1995; WALSH et al., 2000; DODGSON et al., 
2004; PUJOL et al., 2004; BLIGNAUT et al., 2005) with drug resistant fungal strains 
particularly common causative pathogens of infection in high-risk patient groups, 
such as HIV/AIDS patients (JOHNSON et al., 1995; PANKHURST, 2001). The 
reports of recurrences of infections are usually attributed to the discontinuation of 
therapy (SOARES et al., 2013). The frequent use of azoles (especially fluconazole) 
in the treatment and prevention of fungal infections has led to reports of emerging 




been reported in 32% of symptomatic and in 14% of asymptomatic patients 
(REVANKAR et al., 1996; MAENZA et al., 1997; MARTINS et al., 1997). The 
prevalence correlates with the amount of cluster of differentiation 4 (CD4) cells, the 
fungal load, and the duration and doses of therapy (MAENZA et al., 1996). 
VUFFRAY et al., 1994, showed that resistance can also occur in patients with high 
single doses of fluconazole. PELLETIER et al., (2000) documented resistance of C. 
albicans to clotrimazole in HIV-infected children. Antifungal resistance genes are not 
transmissible from cell to cell in fungi (MURRAY et al., 2013).   
The biochemical mechanisms that may be responsible for drug resistance in 
fungus involves a decrease in drug uptake, structural alterations in the target site 
and an increase in drug efflux or in intracellular target levels, gene amplification, 
gene transfer, gene deletion, point mutations, loss of cis -and trans-acting regulatory 
elements and transcriptional activation (KAMAI et al., 2004). Fungal resistance to 
antifungal treatment develops slowly and involves the emergence of intrinsically 
resistant species or a gradual and stepwise alteration of the functions and structures 
of the fungal cell that leads to resistance to an agent which the species have been 
prior exposed to (MURRAY et al., 2013).   
The use of immune-modulating drugs, concomitant infections such as HIV and 
the nutritional status of the host are more crucial factors that determine the outcome 
of the infection than the ability of an antifungal to inhibit or totally destroy the 
infecting organism (MURRAY et al., 2013).  The in vitro resistance of an isolate can 
be classified as either intrinsic or acquired (SOARES et al., 2013). Intrinsic 
resistance allows all normal members of a species to tolerate a particular drug while 
acquired resistance means that a resistant strain emerges from a population that 
was previously drug-sensitive (KAMAI et al., 2004). The clinical resistance to 
griseofulvin, or relapses after treatment, is common in dermatophytoses (SOARES 
et al., 2013).  
Fluconazole and itraconazole are still not the perfect antifungals, since they 
have some non-negligible drug interactions with such drugs that are used in 
chemotherapy or with AIDS treatment. These interactions can result in a decrease in 
azole concentration or even an increase in toxicity (ALBENGRES et al., 1998). At 
present, antibiotics and antifungals play a vital role in the control of fungal diseases 
(SOARES et al., 2013). However, some of these antifungals have shortcomings 




(GARCÍA-SOSA et al., 2011). As a result of these shortcomings, there is a need to 
develop innovative antifungal products of natural origin (ZIMMERMAM-FRANCO et 
al., 2013). It is therefore important to find an effective solution to the increasing 
incidence of skin diseases, most especially the issue of fungi resistance to 
antibiotics. 
Traditional medicinal resources, especially plants; play a major role in the 
management of skin diseases (ABBASI et al., 2010). Among the rural people of 
Maputaland (South Africa), at least 50 remedies derived from 47 plant species are 
utilized for the treatment of skin disorders (DE WET et al., 2013). EGHAREVBA and 
IKHATUA (2008) investigated the ethno-medical uses of plants used in the 
treatment of various skin diseases in Ovia North East of Edo State, Nigeria. They 
discovered that a decoction of Cassia alata leaves added to kerosene is applied on 
the skin to treat eczema and ringworm. Ficus exasperate leaves are rubbed on the 
affected part of the skin and Vitex doniana leaf juice is applied on the skin to treat 
ringworm (EGHAREVBA and IKHATUA, 2008). 
Chamomile extract, essential oil and its isolated bioactive compounds have 
been reported to possess anti-inflammatory activity and are thus useful in the 
treatment of skin inflammation, eczema and the prevention of skin disorders (CARLE 
and GOMAA, 1992; HOERMANN and KORTING, 1994; BRUNETON, 1999). Other 
plant extracts, essential oil and bioactive compounds used in skin and hair care; and 
treatment of skin diseases are well documented in scientific literature. Extracts of 
Aloe vera acts to reverse aging by stimulating the synthesis of collagen and elastin 
fibres (DAVIS et al., 1994). Aloe is an ingredient in many cosmetics as it heals, 
softens and ultimately moisturizes the skin (GEDIYA et al., 2011). A study revealed 
the effectiveness of extra virgin coconut oil as a moisturizer (AGERO and 
VERALLO-ROWELL, 2004). Coconut oil helped to prevent protein loss during the 
wet combing of hair when used for fourteen hours prior to combing (AARTI and 
MOHILE, 2003).  
Several essential oils have anti-inflammatory activity including bisabolol a 
compound found in chamomile and the volatile oil of turmeric (RAO et al., 1982; 
PUROHIT and KAPSNER, 1994). Essential oils have various benefits which include 
shine or conditioning in hair care products, and improvement of skin elasticity 
(ABURJAI and NATSHEH, 2003).  The efficacy of tea tree oil as an antifungal 




(BUDHIRAJA et al., 1999), antiviral and topical antibacterial agent (CARSON and 
RILEY, 1994; CARSON and RILEY, 1995; CARSON et al., 1995; SHAPIRO et al., 
1996; COX et al., 2000) have been confirmed by scientific studies and clinical trials. 
In the treatment of dandruff caused by the yeast Pityrosporum ovale, tea tree oil is 
useful as a result of its antifungal properties (SATCHELL et al., 2002).  
Apart from the plants discussed above, essential oil, plant extracts, herbal 
formulations and tinctures from several species of the Rutaceae have been 
incorporated in skin and haircare products and utilized in the treatment of several 
skin diseases globally. The peel of Citrus limon is used to prevent hair loss (GEDIYA 
et al., 2011). Citrus aurantium peel is used in the production of soaps and shampoos 
(GEDIYA et al., 2011). D-limonene, a compound found in all citrus fruit peel oils is 
used in a wide range of skin cleansing applications (DELLUTRI, 1986). Some of the 
Rutaceae family plants used in traditional medicine as a cure for skin diseases have 
also been found to inhibit the growth of skin disease fungal strains in vitro. The 
results of this study give credence to the use of some of the plants studied for the 















CHAPTER 9. CONCLUSIONS AND RECOMMENDATIONS 
The improvement of previously used antibiotics and the introduction of a new 
range of antibiotics for the treatment of skin diseases of fungal origin have not been 
able to significantly solve the problem of increasing incidence of skin disease 
resistance to antibiotics. Hence, the search for an effective skin ointment or 
antifungal of natural origin could present a lasting solution to the shortcomings of 
antibiotics. Natural products could offer a source of low cost, effective and chemically 
diverse compounds with the ability to subdue resistant skin disease fungal strains.  
An antifungal from natural origin can be effective in the treatment of 
eczema/ringworm often referred to as atopic dermatitis if it can address the biological 
processes involved in the pathogenesis and manifestation of the disease. These 
include inflammation, oxidative stress and total inhibition of the fungal strains 
involved. Inflammation of the skin can be dealt with by addressing the issue of 
oxidative stress as inflammation arises as a result of oxidative stress and most 
natural compounds with antioxidant activity are known to also exhibit anti-
inflammatory activity. Hence, targeting oxidative stress in a chronic inflammatory skin 
condition such as atopic dermatitis may improve the disease state by reducing 
inflammation and thus improving recovery.  
The leaf extracts of the Rutaceae plants selected for this study displayed 
antifungal activity (fungistatic) at different degrees. The antifungal activity displayed 
by some of the plant essential oil volatiles is quite remarkable as they displayed 
fungicidal activity. The essential oil of all the plants sourced from SANBI and the 
UKZN garden contain caryophyllene as part of their main components. This 
compound could probably be one of the major components responsible for the 
antifungal activity displayed in this study. The activity of the essential oil volatiles 
against T. rubrum is particularly noteworthy as it is responsible for the majority of 
skin diseases of fungal origin. 
Essential oil volatiles of A. betulina have remarkable antifungal activity 
(fungicidal) against T. rubrum. The essential oil volatiles have the ability to inhibit 
growth of T. rubrum, stop the transmission of skin disease caused by T. rubrum from 
one individual to the other or from one part of the body to another and ultimately deal 
with resistance or reinfection in individuals with a compromised immune systems 




this study that exhibited fungicidal activity can therefore be used in the production of 
sprays that can be used on the body parts where there is skin infection. In addition, 
they can also be formulated into a product that can be used to fumigate a house/ 
room of an infected individual or family in order to kill the spores and avoid 
reinfection. Hence, the result of this study can give impetus to the production of an 
effective antifungal from natural origin. It will be worthwhile to establish the level of 
cytotoxicity of the extracts and essential oil used in this study as the skin can easily 
absorb any substance rubbed onto it. These substances can find their way into other 
parts of the body. It is therefore necessary to carry out clinical trials to ensure 
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